UNITED STATES SECURITIES AND
	EXCHANGE COMMISSION
	Washington, D.C.
	20549
	 
	Form 10-K
	 
	ANNUAL REPORT
	PURSUANT TO SECTIONS 13 OR
	15(d)
	OF THE SECURITIES EXCHANGE ACT
	OF 1934
	 
| 
	 
 | 
	 
 | 
	 
 | 
| 
	(Mark One)
 | 
	 
 | 
	 
 | 
| 
	 
 | 
| 
 
	þ
 
 | 
	 
 | 
	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
	SECURITIES EXCHANGE ACT OF 1934
 | 
| 
	 
 | 
	 
 | 
	For the fiscal year ended
	December 31, 2006
 | 
| 
 
	or
 
 | 
| 
 
	o
 
 | 
	 
 | 
	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
	SECURITIES EXCHANGE ACT OF 1934
 | 
| 
	 
 | 
	 
 | 
	For the transition period
	from          to          
 | 
	 
	Commission File
	Number 0-21074
	SUPERCONDUCTOR TECHNOLOGIES
	INC.
	(Exact name of registrant as
	specified in its charter)
	 
| 
	 
 | 
	 
 | 
	 
 | 
| 
	Delaware
 | 
	 
 | 
	77-0158076
 | 
	(State or other jurisdiction
	of
 
	incorporation or organization)
 | 
	 
 | 
	(IRS Employer
 
	Identification No.)
 | 
	 
	460 Ward Drive, Santa Barbara, California
	93111-2310
	(Address of principal executive
	offices) (Zip Code)
	 
	Registrants telephone number, including area code:
	(805) 690-4500
	 
	Securities registered pursuant to Section 12(b) of the
	Act:
	None
	 
	Securities registered pursuant to Section 12(g) of the
	Act:
	Common Stock, $0.001 par value per share
	 
	Indicate by check mark if the registrant is a well known
	seasoned issuer, as defined in Rule 405 of the Securities
	Act.  Yes 
	o
	  or  No 
	þ
	 
	Indicate by check mark whether the registrant is not required to
	file reports pursuant to Section 13 or Section 15(d)
	of the
	Act.  Yes 
	o
	  or  No 
	þ
	 
	Indicate by check mark whether the Registrant (1) has filed
	all reports required to be filed by Section 13 or 15(d) of
	the Securities Exchange Act of 1934 during the preceding
	12 months (or for such shorter period that the registrant
	was required to file such reports), and (2) has been
	subject to such filing requirements for the past
	90 days.  Yes 
	þ
	  or  No 
	o
	 
	Indicate by check mark if disclosure of delinquent filers
	pursuant to Item 405 of
	Regulation S-K
	is not contained herein, and will not be contained, to the best
	of Registrants knowledge, in definitive proxy or
	information statements incorporated by reference in
	Part III of this
	Form 10-K
	or any amendment to this
	Form 10-K.  
	o
	 
	Indicate by check mark whether the registrant is a large
	accelerated filer, an accelerated filer or non-accelerated
	filer. See definition of accelerated filer and large
	accelerated filer in
	Rule 12b-2
	of the Exchange Act.
	 
	Accelerated
	Filer 
	o
	     Accelerated
	Filer 
	o
	     Non-Accelerated
	Filer 
	þ
	 
	Indicate by check mark whether the registrant is a shell company
	(as defined in
	Rule 12b-2
	of the Exchange
	Act).  Yes 
	o
	  or  No 
	þ
	 
	The aggregate market value of the common stock held by
	non-affiliates was $20.6 million as of July 1, 2006
	(the last business day of our most recently completed second
	fiscal quarter). The closing price of the common stock on that
	date was $2.04 as reported by the NASDAQ Stock Market. For
	purposes of this determination, we excluded the shares of common
	stock held by each officer and director and by each person who
	owns 5% or more of the outstanding common stock. The exclusion
	of shares owned by the aforementioned individuals and entities
	from this calculation does not constitute an admission by any of
	such individuals or entities that he or it was or is an
	affiliate of the company.
	 
	We had 12,483,367 shares of common stock outstanding as of
	the close of business on February 28, 2007.
	 
	DOCUMENTS INCORPORATED BY REFERENCE
	 
	Item 5 of Part II and Items 10, 11, 12,
	13 and 14 of Part III incorporate information by reference
	from the definitive proxy statement for the Registrants
	2007 Annual Meeting of Stockholders.
	 
 
	 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	FORM 10-K
	ANNUAL REPORT
	Year Ended December 31, 2006
	 
	Unless otherwise noted, the terms we,
	us, and our, refer to the combined and
	ongoing business operations of Superconductor Technologies Inc.
	and its subsidiaries
	 
	i
 
	 
	SPECIAL
	NOTE REGARDING FORWARD-LOOKING STATEMENTS
	 
	This Report contains forward-looking statements within the
	meaning of Section 27A of the Securities Act of 1933, as
	amended, and Section 21E of the Securities Exchange Act of
	1934, as amended. You can find many (but not all) of these
	statements by looking for words such as
	approximates, believes,
	expects, anticipates,
	estimates, intends, plans
	would, may or other similar expressions
	in this Report. We claim the protection of the safe harbor
	contained in the Private Securities Litigation Reform Act of
	1995. We caution investors that any forward-looking statements
	presented in this Report, or which we may make orally or in
	writing from time to time, are based on the beliefs of,
	assumptions made by, and information currently available to, us.
	Such statements are based on assumptions and the actual outcome
	will be affected by known and unknown risks, trends,
	uncertainties and factors that are beyond our control or ability
	to predict. Although we believe that our assumptions are
	reasonable, they are not guarantees of future performance and
	some will inevitably prove to be incorrect. As a result, our
	actual future results can be expected to differ from our
	expectations, and those differences may be material.
	Accordingly, investors should use caution in relying on past
	forward-looking statements, which are based on known results and
	trends at the time they are made, to anticipate future results
	or trends.
	 
	Some of the risks and uncertainties that may cause our actual
	results, performance or achievements to differ materially from
	those expressed or implied by forward-looking statements include
	the following: limited assets and a history of losses; limited
	number of potential customers; limited number of suppliers for
	some of our components; no significant backlog from quarter to
	quarter; our market is characterized by rapidly advancing
	technology. For further discussion of these and other factors
	see Item 1A. Risk Factors of this Report.
	 
	This Report and all subsequent written and oral
	forward-looking statements attributable to us or any person
	acting on our behalf are expressly qualified in their entirety
	by the cautionary statements contained or referred to in this
	section. We do not undertake any obligation to release publicly
	any revisions to our forward-looking statements to reflect
	events or circumstances after the date of this Report.
	 
	WHERE
	YOU CAN FIND MORE INFORMATION
	 
	As a public company, we are required to file annually, quarterly
	and special reports, proxy statements and other information with
	the SEC. You may read and copy any of our materials on file with
	the SEC at the SECs Public Reference Room at
	450 Fifth Street, N.W., Judiciary Plaza, Washington, DC
	20549, as well as at the SECs regional office at 5757
	Wilshire Boulevard, Suite 500, Los Angeles, California
	90036. Our filings are available to the public over the Internet
	at the SECs website at http://www.sec.gov. Please call the
	SEC at
	1-800-SEC-0330
	for further information on the Public Reference Room. We also
	provide copies of our
	Forms 8-K,
	10-K,
	10-Q,
	Proxy
	and Annual Report at no charge to investors upon request and
	make electronic copies of our most recently filed reports
	available through our website at www.suptech.com as soon as
	reasonably practicable after filing such material with the SEC.
	1
 
	 
	PART I
	 
	ITEM 1.  
	BUSINESS
	 
	Our
	Company
	 
	We develop, manufacture and market high performance
	infrastructure products for wireless voice and data
	applications. Wireless carriers face many challenges in
	todays competitive marketplace. Minutes of use are
	skyrocketing, and wireless users now expect the same quality of
	service from their mobile devices as from their landline phones.
	We help wireless carriers meet these challenges by doing
	more with less.
	 
	Our products help maximize the performance of wireless
	telecommunications networks by improving the quality of uplink
	signals from mobile wireless devices. Our products increase
	capacity utilization, lower dropped and blocked calls, extend
	coverage, and enable higher wireless data throughput 
	all while reducing capital and operating costs. SuperLink
	incorporates patented high-temperature superconductor (HTS)
	technology to create a receiver front-end that enhances network
	performance. Today, we are leveraging our expertise and
	proprietary technology in radio frequency (RF) engineering to
	expand our product line beyond HTS technology. We believe our RF
	engineering expertise provides us with a significant competitive
	advantage in the development of high performance, cost-effective
	solutions for the front end of wireless telecommunications
	networks.
	 
	We currently sell most of our commercial products directly to
	wireless network operators in the United States. Our customers
	to date include ALLTEL, Cingular, Sprint Nextel,
	T-Mobile,
	U.S. Cellular and Verizon Wireless. We have a concentrated
	customer base. Verizon Wireless, ALLTEL and
	T-Mobile
	each accounted for more than 10% of our commercial revenues in
	2006 and 2005. We plan to expand our customer base by selling
	directly to other wireless network operators and manufacturers
	of base station equipment, including internationally, but we
	cannot assure that this effort will be successful.
	 
	Industry Background.
	  The ability to provide
	high quality service to subscribers is becoming increasingly
	difficult for wireless operators as the number of users grows,
	minutes of use increase and the market for wireless data
	services expands. Wireless service providers in both rural and
	urban areas are encountering radio frequency interference due to
	greater subscriber density and a larger number of users on
	adjacent channels. This reduced signal quality and higher
	percentage of dropped calls can lead to lower system
	utilization, decreased revenue and, ultimately, higher rates of
	customer churn. Service providers are also facing network
	capacity constraints.
	 
	As a result, wireless carriers are seeking to cost-effectively
	reduce interference, increase capacity, expand coverage to
	improve the quality of their systems, and, where possible,
	utilize their spectrum in the most efficient manner possible.
	 
	Our Solution.
	  We leverage our expertise in RF
	technology to cost effectively deliver interference protection
	and increased sensitivity to our wireless carrier customers. Our
	solutions provide the following
	quality-of-service
	improvements:
	 
| 
 | 
 | 
 | 
| 
	 
 | 
	 
 | 
	reduction of dropped calls and network access failures;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	elimination of interference from other sources such as
	specialized mobile radio handsets and other base stations;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	increased in-building penetration;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	reduction in base station noise figure; and
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	improves handset power consumption
 | 
	 
	Our Products.
	  Our solutions consist of the
	following three product lines:
	 
| 
 | 
 | 
 | 
| 
	 
 | 
	 
 | 
	SuperLink
	combines HTS filters with a proprietary
	cryogenic cooler and an ultra low-noise amplifier to create a
	highly compact and reliable receiver front-end that can
	simultaneously deliver both high selectivity (interference
	rejection) and high sensitivity (detection of low level signals).
 | 
	2
 
	 
| 
 | 
 | 
 | 
| 
	 
 | 
	 
 | 
	AmpLink
	is a ground-mounted unit which includes a
	high-performance amplifier that provides increased sensitivity.
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	SuperPlex
	is a line of multiplexers that provides
	extremely low insertion loss and excellent cross-band isolation.
 | 
	 
	Our Strategy.
	  Our objective is to provide a
	full range of performance improvement solutions to wireless
	carriers by offering our field-proven solutions, innovative
	duplexer designs for antenna sharing and network overlays,
	ground-based sensitivity improvement solutions and
	high-performance multiplexers. The primary elements of our
	strategy include:
	 
| 
 | 
 | 
 | 
| 
	 
 | 
	 
 | 
	diversifying our customer base,
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	expanding our current product offerings,
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	enhancing our productivity and lowering our costs,
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	maintaining our focus on technical excellence and
	innovation, and
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	pursuing strategic partnerships, alliances and acquisitions.
 | 
	 
	Government Contracts.
	  We also generate
	significant revenues from government contracts. We primarily
	pursue government research and development contracts which
	complement our commercial product development, but we also
	pursue government product opportunities. We undertake government
	contract work which has the potential to add to or improve our
	commercial product line. These contracts often yield valuable
	intellectual property relevant to our commercial business. We
	typically own the intellectual property developed under these
	contracts, and the Federal Government receives a royalty-free,
	non-exclusive and nontransferable license to use the
	intellectual property for the United States.
	 
	Corporate Information.
	  Our facilities and
	executive offices are located at 460 Ward Drive,
	Santa Barbara, California 93111, and our telephone number
	is
	(805) 690-4500.
	We were incorporated in Delaware on May 11, 1987.
	Additional information about us is available on our website at
	www.suptech.com. The information on our web site is not
	incorporated herein by reference.
	 
	Our
	Wireless Products
	 
	Wireless service providers can use our solutions to keep pace
	with the growing demand for wireless communications. Wireless
	providers may deploy our products in connection with the
	installation of additional base stations in a network, as well
	as with the installation of an entirely new network. Wireless
	service providers can also improve the performance of existing
	base stations and networks by retrofitting their equipment with
	our link enhancement products.
	 
	Our performance improvement solutions fit into three product
	families: SuperLink, AmpLink and SuperPlex.
	 
| 
 | 
 | 
 | 
| 
	 
 | 
	 
 | 
	SuperLink.
	  In order to receive uplink signals
	from wireless handsets, base stations require a filter system to
	eliminate
	out-of-band
	interference, and amplification to enhance the base
	stations sensitivity. To address this need, we offer the
	SuperLink product line for the receiver front-end of base
	stations. These products combine specialized filters using HTS
	technology with a proprietary cryogenic cooler and ultra
	low-noise amplifiers. The result is a highly compact and
	reliable receiver front-end that can simultaneously deliver both
	high selectivity (interference rejection) and high sensitivity
	(detection of low level signals). SuperLink products offer
	significant performance advantages over conventional filter and
	amplifier systems.
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	AmpLink.
	  AmpLink is designed to address the
	sensitivity requirements of wireless base stations. AmpLink is a
	ground-mounted unit which utilizes a high-performance. The
	enhanced uplink performance provided by AmpLink improves network
	coverage immediately and avoids the installation and maintenance
	costs associated with tower mounted alternatives.
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	SuperPlex.
	  SuperPlex is our line of
	multiplexers that provides extremely low insertion loss and
	excellent cross-band isolation. Products in our SuperPlex family
	of high-performance multiplexers are designed to facilitate base
	station antenna sharing and reduce infrastructure costs.
	SuperPlex can be used in conjunction
 | 
	3
 
| 
 | 
 | 
 | 
| 
	 
 | 
 | 
	with AmpLink and SuperLink products to optimize performance in
	networks where 1900 MHz EV-DO capabilities are added to
	existing 850 MHz networks. Relative to competing
	technologies, this portfolio of STI solutions offers increased
	transmit power delivered to the base station antenna, higher
	sensitivity to subscriber handset signals, interference
	rejection and fast and cost-effective network overlays.
 | 
	 
	Marketing
	and Sales
	 
	We sell solutions to wireless communication service providers in
	the United States and pursue selected international
	opportunities.
	 
	We have a concentrated customer base. Verizon Wireless, ALLTEL
	and
	T-Mobile
	each accounted for more than 10% of our commercial revenues in
	2006 and 2005; Verizon Wireless and ALLTEL each accounted for
	more than 10% of our commercial revenues in 2004.
	 
	We sell using a direct sales force in the U.S. to focus on
	the Tier I wireless carriers. We use indirect channels to
	market our products to select customers internationally.
	 
	We demonstrate our products at trade shows, and participate in
	industry conferences. Advertising, email campaigns, direct
	mailings, and contribution of technical and application reports
	to recognized trade journals, are all employed to communicate
	our solutions to potential customers. We also advertise our
	products through our website, brochures, data sheets,
	application notes, trade journal reports and press releases.
	 
	Our sales and marketing efforts are complemented by a team of
	sales applications engineers who manage field trials and initial
	installations, as well as provide ongoing pre- and post-sales
	support.
	 
	Our marketing efforts are focused on establishing and developing
	long-term relationships with potential customers. The initial
	sales cycle for our solutions can be lengthy, typically ranging
	from six months to twelve months. Our customers typically
	conduct significant technical evaluations of products before
	making purchase commitments. We typically negotiate general
	purchase agreements with our customers. These agreements specify
	the terms and conditions for the business relationship with our
	customers. Standard purchase orders are subject to cancellation,
	postponement or other types of delays.
	 
	We purchase inventory components and manufacture inventory based
	on sales forecasts.
	 
	Backlog
	 
	Our commercial backlog consists of accepted product purchase
	orders with scheduled delivery dates during the next twelve
	months. We had commercial backlog of $75,000 at
	December 31, 2006, as compared to $250,000 at
	December 31, 2005.
	 
	How We
	Use Government Contracts to Fund Technology
	Development
	 
	Our strategy is to continue to pursue government research and
	development contract awards which complement our commercial
	product and technology development and allow for
	commercialization of the underlying technology. Since our
	inception in 1987, a substantial part of our revenues have been
	from research and development contracts with the
	U.S. government or as a subcontractor to a supplier to the
	U.S. government. Nearly all of these revenues were paid
	under contracts with the U.S. Department of Defense. We
	interact with various government agencies to identify
	opportunities and actively solicit partners for product
	development proposals. Since 1988, we have successfully obtained
	a number of classified and
	non-classified
	government contracts for superconductor research, including one
	of the largest
	non-classified
	HTS awards from DARPA through the Office of Naval Research. In
	addition to actively soliciting government contracts, we have
	participated in the Small Business Innovative Research, (SBIR)
	and Small Business Technology Transfer (STTR) programs. We have
	been awarded 34 Phase I SBIR/STTR contracts, each of which
	typically generates up to $100,000 in revenues. We have been
	successful in converting eight of these Phase I contracts
	into Phase II programs, each of which typically generates
	up to $750,000 in revenues, and we converted one of these
	contracts into a Phase III program valued at
	$2.2 million. Since our formation, government contracts
	have provided us approximately $93 million of revenue and
	remain a significant source of revenue today. We also develop
	and sell RF transceiver front-end
	4
 
	products that utilize our unique HTS filter and cryogenics
	technologies to the US Government and we intend to grow this
	government products business.
	 
	Our
	Manufacturing Capabilities
	 
	Our manufacturing process involves the assembly of numerous
	individual components and precision tuning by production
	technicians. The parts and materials used by us and our contract
	manufacturers consist primarily of printed circuit boards,
	specialized subassemblies, fabricated housing, relays and small
	electric circuit components, such as integrated circuits,
	semiconductors, resistors and capacitors. Principal components
	of our AmpLink and SuperPlex products are manufactured by
	foreign manufacturers. We currently manufacture our SuperLink
	systems at our facilities in Santa Barbara, California.
	 
	In 1998, we opened a
	state-of-the-art
	manufacturing facility in Santa Barbara. We renovated these
	manufacturing areas in early 2003, the first in a series of
	moves that have enabled us to produce larger quantities of our
	SuperLink products. In 2003 and 2004, we expanded our controlled
	clean rooms, continued to develop and introduce new,
	state-of-the-art
	production and test equipment and processes, and implemented a
	continuous flow manufacturing strategy. In addition, performance
	testing and systems screening methods, along with optimized
	quality improvement techniques, have been instrumental in
	enabling our SuperLink units to reach Mean Time Between Failure
	(MTBF) levels of more than 500,000 hours.
	 
	We have the physical infrastructure to manufacture up to 2,800
	SuperLink units per year. This capacity is unchanged from the
	prior year. We are holding physical capacity and staffing at
	their current levels to conserve cash resources. We could expand
	manufacturing capacity to approximately 5,000 units per
	year in our current facility with minor additional equipment
	purchases and staffing increases.
	 
	Our internal capabilities include a proprietary manufacturing
	process for thin-film materials that is scaleable for high
	volume production. In addition, we have established a production
	operation that we use to produce thin films on wafers for
	wireless applications. Our radio frequency circuitry is
	designed, modeled and tested by internal engineering resources.
	We have in-house capabilities to pattern the superconducting
	material and all other aspects of radio frequency component
	production, including packaging the filters. We also have
	in-house capabilities to manufacture our cryogenic coolers. We
	have refined our supplier base to improve the quality of
	received parts, while lowering the cost and decreasing
	lead-times.
	 
	In early 2006, STI launched its high volume AmpLink assembly and
	distribution center within the existing Santa Barbara site.
	The 3,200 square foot production facility has the capacity
	to produce 10,000 AmpLink units annually which can be increased
	to 20,000 units with no additional capital expenditure. The
	production line is supported by a newly refurbished
	8,000 square foot warehouse and distribution center. The
	manufacturing and distributions centers are tightly linked to
	provide the most efficient and rapid order fulfillment
	capabilities for up to 200 AmpLink units per week.
	 
	A number of the parts used in our products are available from
	only one or a limited number of outside suppliers due to unique
	component designs as well as certain quality and performance
	requirements.
	 
	Intellectual
	Property
	 
	We rely upon trade secrets and patents to protect our
	intellectual property. We execute confidentiality and
	non-disclosure agreements with our employees and suppliers and
	limit access to, and distribution of, our proprietary
	information. We have an on-going program to identify and file
	applications for both U.S. and international patents for various
	aspects of our technology. We regard our product designs, design
	tools, fabrication equipment and manufacturing processes as
	proprietary and seek to protect our rights in them through a
	combination of patent, trademark, trade secret and copyright law
	and internal procedures and non-disclosure agreements. We also
	seek licenses from third parties for HTS materials and processes
	used by us, which have been patented by other parties. We
	believe that our success will depend, in part, on the protection
	of our proprietary information, patents and the licensing of key
	technologies from third parties.
	5
 
	 
	We have an extensive patent portfolio for the technology
	relevant to our SuperLink products, government products and
	related business. As of December 31, 2006, we held 49
	U.S. patents in the following categories which are
	currently relevant to this business:
	 
| 
 | 
 | 
 | 
| 
	 
 | 
	 
 | 
	6 patents for technologies directed toward producing thin-film
	materials and structures expiring in 2010 to 2024;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	23 patents for cryogenic and non-microwave circuit designs
	expiring in 2010 to 2023;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	15 patents covering cryogenics, packaging and systems expiring
	in 2013 to 2024; and
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	5 patents covering other superconducting technologies expiring
	in 2013 to 2015.
 | 
	 
	We also had 25 U.S. patent applications pending as of
	December 31, 2006 which are currently relevant to this
	business. As of that date, we held 13 foreign issued patents and
	22 foreign patents pending.
	 
	We have trade secrets and unpatented technology and proprietary
	knowledge about the sale, promotion, operation, development and
	manufacturing of our products. We have confidentiality
	agreements with our employees and consultants to protect these
	rights.
	 
	We own federally registered trademarks to Superconductor
	Technologies, Conductus and Improving the Quality of Wireless
	and have several other trademark registrations pending. We own
	other registered and unregistered trademarks, and have certain
	trademark rights in foreign jurisdictions.
	 
	From time to time we grant licenses for our technology to other
	companies for fields of use that are not relevant to our
	business. Specifically, we have granted licenses to, among
	others, (1) Bruker for Nuclear Magnetic Resonance
	application, (2) General Dynamics for government
	applications and (3) Star Cryoelectronics for
	Superconducting Quantum Interference Device applications, among
	others.
	 
	We use superconducting technology in our SuperLink solution to
	improve both the selectivity (rejection of adjacent band
	interference) and the sensitivity (ability to hear
	signals better) of a base station receiver. Superconducting
	materials have the ability to conduct electrical energy with
	little or no resistance when cooled to critical
	temperatures. In contrast, electric currents that flow through
	conventional conductors encounter resistance that requires power
	to overcome and generates heat. Substantial improvement in the
	performance characteristics of electrical systems can be made
	with superconductors, including reduced power loss, lower heat
	generation and decreased electrical noise. As these properties
	have been applied to radio and microwave frequency applications,
	new products, such as wireless filters, have been developed that
	are extremely small, highly sensitive and highly frequency
	selective.
	 
	The discovery of superconductors was made in 1911. However, a
	fundamental understanding of the phenomenon of superconductivity
	eluded physicists until J. Robert Schrieffer (a former director
	and Chairman of our Technical Advisory Board), John Bardeen
	(co-inventor of the transistor) and Leon Cooper proposed a
	theory explaining superconductivity, for which they were awarded
	the Nobel Prize in Physics in 1972. Until 1986, all
	superconductor utilization was done at extremely low
	temperatures, below 23K (-250ºC). Superconductors were not
	widely used in commercial applications because of the high cost
	and complexities associated with reaching and maintaining such
	low temperatures. In 1986, high temperature superconductors with
	critical temperatures greater than 30K (-243ºC) were
	discovered. In early 1987, YBCO was discovered, which has a
	critical temperature of 93K (-180ºC). Shortly thereafter,
	TBCCO was discovered, which has a critical temperature of 125K
	(-148ºC). These discoveries were important because these
	high temperature superconductors allowed for operating
	temperatures higher than 77K (-196ºC), or the point at
	which nitrogen liquefies at atmospheric pressure. These high
	critical temperatures allow superconductors to be cooled using
	less expensive and more efficient refrigeration processes. We
	were formed following this discovery for the initial purpose of
	developing and commercializing high temperature superconductors.
	 
	We have historically utilized thallium barium calcium copper
	oxide (TBCCO) as the primary HTS material in our
	SuperLink product line. In the fourth quarter of 2004, we
	shifted all of our production from TBCCO to yttrium barium
	copper oxide (YBCO) to lower the product
	manufacturing cost of the SuperLink. We have a non-exclusive
	license in the U.S. and selected foreign countries to the
	primary patents on YBCO from Lucent and
	6
 
	TBCCO from the University of Arkansas. We use HTS materials as
	the base material to produce thin film
	microelectronics, primarily RF filters, in our SuperLink product
	line. We manufacture YBCO using proprietary processes, including
	proprietary manufacturing techniques. We believe that the
	process technology we have developed produces state of the art
	HTS thin-films of the highest quality using YBCO.
	 
	As part of our strategy to maintain our technological
	leadership, we have focused our research and development
	activities on HTS materials, RF circuitry, cryogenic design and
	product application. We utilize a proprietary manufacturing
	process for HTS thin-film production, the base material for our
	filtering products. An in-house design team develops the
	filters, which are packaged into a vacuum-sealed container for
	thermal insulation. The filter package is integrated with our
	cryogenic cooler and the necessary control electronics into a
	complete system that is deployed in conjunction with new or
	existing wireless base stations.
	 
	We have devoted a significant portion of our engineering
	resources to design and model the complex RF circuitry that is
	basic to our products. The expertise of this highly qualified
	team has allowed us to design and fabricate very precise
	individual components, such as RF signal filters. We have
	developed computer simulation systems to design our products and
	this RF circuitry design capability has allowed us to produce
	extremely small, high-performance circuits. Some of our design
	and engineering innovations have been patented; others are the
	subjects of pending patent applications. We believe that our RF
	engineering expertise provides us with a unique competitive
	advantage.
	 
	The availability of a low-cost, highly reliable, compact cooling
	technology is critical to the successful commercialization of
	our superconducting products. Prior to the Companys
	efforts, no such cryogenic cooler had been commercially
	available. In response to this lack of availability, we
	developed a low-cost, highly reliable low-power cooler designed
	to cool to 77K (-196ºC) with sufficient cooling
	capacity for our superconducting applications. Our SuperLink
	systems have logged in excess of 158 million hours of
	cumulative operation. The cryogenic coolers in our current
	models have demonstrated a mean time between failure
	(the industry standard measurement) of greater than one million
	hours. The design was based in part on patents licensed by us
	from Sunpower, Inc. We believe our internally developed cooler,
	which is both compact enough and reliable enough to meet the
	most demanding wireless industry standards, provides us with a
	significant and unique competitive advantage.
	 
	Cooling to cryogenic temperatures requires proper thermal
	isolation and packaging. Any superconducting or other
	cryogenically cooled device must be maintained at its optimal
	operating temperature, and its interaction with higher
	temperature components must be controlled. We have developed a
	variety of proprietary and patented cryogenic packaging
	innovations to satisfy this requirement.
	 
	Competition
	 
	The wireless communication market is intensely competitive. We
	face competition in various aspects of our technology and
	product development and in each of our target markets. Our
	products compete on the basis of performance, functionality,
	reliability, pricing, quality, and compliance with industry
	standards. Our current and potential competitors include
	conventional RF filter manufacturers and both established and
	newly emerging companies developing similar or competing HTS
	technologies. We also compete with companies that design,
	manufacture and sell antenna-optimizing multiplexers and
	companies that seek to enhance base station range and
	selectivity by means other than a superconducting filter. The
	primary competitors use tower mounted and ground mounted
	amplifiers, conventional filters, repeaters or smart
	antenna technologies. Tower mounted and ground mounted
	amplifiers pass an RF signal received by an antenna through a
	broad filter, followed by a low noise amplifier. These units are
	produced by a number of companies, which include most of the
	base station original equipment manufacturers (OEMs) such as
	Ericsson and Nokia. Filter manufacturers, including Andrew,
	Powerwave, and Radio Frequency Systems, also produce these
	units. Smart antennas allow base stations to focus energy more
	directly on individual wireless devices in order to improve
	capacity. Some competitors have significantly greater financial,
	technical, manufacturing, sales, marketing and other resources.
	Some competitors have achieved greater name recognition for
	their products and technologies.
	 
	In addition, we currently supply components and license
	technology to several companies that may eventually decide to
	manufacture or design their own HTS components, rather than
	purchasing or licensing our technology. With respect to our HTS
	materials, we compete with THEVA among others. In the government
	sector, we compete
	7
 
	with universities, national laboratories and both large and
	small companies for research and development contracts, and with
	larger defense contractors, such as Raytheon and Northrop
	Grumman for government products.
	 
	Employees
	 
	We employed a total of 115 people as of December 31,
	2006: 50 in manufacturing, 31 in research and development, 20 in
	sales and marketing and 14 in administration. Nine of our
	employees have Ph.D.s, and thirteen others hold advanced degrees
	in physics, materials science, electrical engineering and other
	fields. Our employees are not represented by a labor union and
	we believe that our employee relations are good.
	 
	Environmental
	Issues
	 
	We use certain hazardous materials in our research, development
	and manufacturing operations. As a result, we are subject to
	stringent federal, state and local regulations governing the
	storage, use and disposal of such materials. Current or future
	laws and regulations could require substantial expenditures for
	preventative or remedial action, reduction of chemical exposure,
	waste treatment or disposal. Although we believe that our safety
	procedures for the handling and disposing of hazardous materials
	comply with the standards prescribed by state and federal
	regulations, there is always the risk of accidental
	contamination or injury from these materials. To date, we have
	not incurred substantial expenditures for preventive action with
	respect to hazardous materials or for remedial action with
	respect to any hazardous materials accident, but the use and
	disposal of hazardous materials involves the risk that we could
	incur substantial expenditures for such preventive or remedial
	actions. If such an accident occurred, we could be held liable
	for resulting damages. The liability in the event of an accident
	or the costs of such remedial actions could exceed our resources
	or otherwise have a material adverse effect on our financial
	condition, results of operations or cash flows.
	 
	 
	The following section includes some of the material factors that
	may adversely affect our business and operations. This is not an
	exhaustive list, and additional factors could adversely affect
	our business and financial performance. Moreover, we operate in
	a very competitive and rapidly changing environment. New risk
	factors emerge from time to time and it is not possible for us
	to predict all such risk factors, nor can we assess the impact
	of all such risk factors on our business or the extent to which
	any factor, or combination of factors, may cause actual results
	to differ materially from those contained in any forward-looking
	statements. This discussion of risk factors includes many
	forward-looking statements. For cautions about relying on such
	forward looking statements, please refer to the section entitled
	Forward Looking Statements at the beginning of this
	Report immediately prior to Item 1.
	 
	Risks
	Related to Our Business
	 
	We
	have a history of losses and may never become
	profitable.
	 
	In each of our last five years, we have experienced significant
	net losses and negative cash flows from operations. If we fail
	to increase our revenues, we may not achieve and maintain
	profitability and may not meet our expectations or the
	expectations of financial analysts who report on our stock.
	 
	We may
	need to raise additional capital, and if we are unable to raise
	capital our ability to implement our current business plan and
	ultimately our viability as a company could be adversely
	affected.
	 
	During 2006, we incurred a net loss of $29.6 million and
	negative cash flows from operations of $7.3 million. In
	addition, our independent registered public accounting firm,
	Stonefield Josephson Inc, has included in their report for 2006
	an explanatory paragraph expressing doubt about our ability to
	continue as a going concern due to past losses and negative cash
	flows. Our independent registered public accounting firm,
	PricewaterhouseCoopers, LLC, included a similar explanatory
	paragraph in audit reports for 2003, 2004 and 2005.
	 
	Our principal sources of liquidity consist of existing cash
	balances and funds expected to be generated from future
	operations. Based on our current forecasts, our cash resources
	may not be sufficient to fund our planned
	8
 
	operations for the remainder of 2007. We believe the key factors
	to our liquidity in 2007 will be our ability to successfully
	execute on our plans to increase sales levels. Our cash
	requirements will also depend on numerous other variable
	factors, including the rate of growth of sales, the timing and
	levels of products purchased, payment terms and credit limits
	from manufacturers, and the timing and level of accounts
	receivable collections. Because of the uncertainty of these many
	factors, the Company intends to raise funds in the next six
	months to meet its working capital needs.
	 
	We cannot ensure you that additional financing (public or
	private) will be available on acceptable terms or at all. If we
	issue additional equity securities to raise funds, the ownership
	percentage of our existing stockholders would be reduced, and we
	could deplete our reserve of authorized but unissued common
	stock. New investors may demand rights, preferences or
	privileges senior to those of existing holders of common stock.
	If we cannot raise needed funds, we would also be forced to make
	further substantial reductions in our operating expenses, which
	could adversely affect our ability to implement our current
	business plan and ultimately our viability as a company.
	 
	We
	rely on a small number of customers for the majority of our
	commercial revenues and the loss of any one of these customers,
	or a significant loss, reduction or rescheduling of orders from
	any of these customers, could have a material adverse effect on
	our business, results of operations and financial
	condition.
	 
	We sell most of our products to a small number of wireless
	carriers. We derived 96% of our commercial product revenues from
	ALLTEL, Verizon Wireless and
	T-Mobile
	in
	2006 and 95% of our commercial product revenues from ALLTEL,
	Verizon Wireless and
	T-Mobile
	in
	2005. Our future success depends upon the wireless carriers
	continuing to purchase our products, and fluctuations in demand
	from such customers could negatively impact our results.
	Unanticipated demand fluctuations can have a negative impact on
	our revenues and business and an adverse effect on our results
	of operations and financial condition.
	 
	In addition, our dependence on a small number of major customers
	exposes us to numerous other risks, including:
	 
| 
 | 
 | 
 | 
| 
	 
 | 
	 
 | 
	a slowdown or delay in the deployment, upgrading or improvement
	of wireless networks by any one customer could significantly
	reduce demand for our products;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	reductions in a single customers forecasts and demand
	could result in excess inventories;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	each of our customers have significant purchasing leverage over
	us to require changes in sales terms including pricing, payment
	terms and product delivery schedules; and
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	concentration of accounts receivable credit risk, which could
	have a material adverse effect on our liquidity and financial
	condition if one of our major customers declared bankruptcy or
	delayed payment of their receivables.
 | 
	 
	Many of our customers also provide minimal lead-time prior to
	the release of their purchase orders and have non-binding
	commitments to purchase from us. If we fail to forecast our
	customers demands accurately, we could experience delays
	in manufacturing which could result in customer dissatisfaction.
	Additionally, these factors further impact our ability to
	forecast future revenue.
	 
	The
	wireless communication industry is highly concentrated, which
	limits the number of potential customers, and further industry
	consolidation could result in the loss of key
	customers.
	 
	The wireless communication industry is highly concentrated in
	nature and may become more concentrated due to anticipated
	industry consolidation. As a result, we believe that the number
	of potential customers for our products may be limited. We also
	face significant risks in the event any of our key customers is
	acquired by a company that has not adopted our technology or not
	adopted it to the same extent. In that event, we could face a
	significant decline in our sales to the acquired customer.
	9
 
	 
	We
	experience significant fluctuations in sales and operating
	results from quarter to quarter.
	 
	Our quarterly results fluctuate due to a number of factors,
	including:
	 
| 
 | 
 | 
 | 
| 
	 
 | 
	 
 | 
	the lack of any contractual obligation by our customers to
	purchase their forecasted demand for our products;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	variations in the timing, cancellation, or rescheduling of
	customer orders and shipments; and
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	high fixed expenses that may disproportionately impact operating
	expenses, especially during a quarter with a sales shortfall.
 | 
	 
	The nature of our business requires that we promptly ship
	products after we receive orders. This means that we typically
	do not have a significant backlog of unfilled orders at the
	start of each quarter. We have also regularly generated a large
	percentage of our revenues in the last month of a quarter. Our
	major customers generally have no contractual obligation to
	purchase forecasted amounts and may cancel orders, change
	delivery schedules or change the mix of products ordered with
	minimal notice and minimal penalty. As a result of these
	factors, we may not be able to accurately predict our quarterly
	sales. Any shortfall in sales relative to our quarterly
	expectations or any delay of customer orders would adversely
	affect our revenues and results of operations.
	 
	Order deferrals and cancellations by our customers, declining
	average sales prices, changes in the mix of products sold,
	increases in inventory and finished goods, delays in the
	introduction of new products and longer than anticipated sales
	cycles for our products have, in the past, adversely affected
	our results of operations. Despite these factors, we maintain
	significant finished goods,
	work-in-progress
	and raw materials inventory to meet estimated order forecasts.
	If our customers purchase less than the forecasted amounts or
	cancel or delay existing purchase orders, there will be higher
	levels of inventory that face a greater risk of obsolescence. If
	our customers desire to purchase products in excess of the
	forecasted amounts or in a different product mix, there may not
	be enough inventory or manufacturing capacity to fill their
	orders.
	 
	Due to these and other factors, our past results may not be
	reliable indicators of our future performance. Future revenues
	and operating results may not meet the expectations of stock
	analysts and investors. In either case, the price of our common
	stock could be materially adversely affected.
	 
	Our
	sales cycles are unpredictable, making future performance
	uncertain.
	 
	The sales cycle for telecommunications products includes
	identification of decision makers within the customers
	organizations, development of an understanding of
	customer-specific performance and economic issues, convincing
	the customer through field trial reports of the benefits of
	systems offered, negotiation of purchase orders and deployment.
	Customers who purchase our systems must commit a significant
	amount of capital and other resources. Our customers must
	consider budgetary constraints, comply with internal procedures
	for approving large expenditures and complete whatever testing
	is necessary for them to integrate new technologies that will
	impact their key operations. Customer delays can lengthen the
	sales cycles and have a material adverse effect on our business.
	 
	We
	depend on the capital spending patterns of wireless network
	operators, and if capital spending is decreased or delayed, our
	business may be harmed.
	 
	Because we rely on wireless network operators for product
	purchases, any substantial decrease or delay in capital spending
	patterns in the wireless communication industry may harm our
	business. Demand from customers for our products depends to a
	significant degree upon the amount and timing of capital
	spending by these customers for constructing, rebuilding or
	upgrading their systems. The capital spending patterns of
	wireless network operators depend on a variety of factors,
	including access to financing, the status of federal, local and
	foreign government regulation and deregulation, changing
	standards for wireless technology, overall demand for wireless
	services, competitive pressures and general economic conditions.
	In addition, capital spending patterns in the wireless industry
	can be subject to some degree of seasonality, with lower levels
	of spending in the first and third calendar quarters, based on
	annual budget cycles.
	10
 
	 
	Our
	reliance on a limited number of suppliers and the long lead time
	of components for our products could impair our ability to
	manufacture and deliver our systems on a timely
	basis.
	 
	A number of components used in our products are available from
	only one or a limited number of outside suppliers due to unique
	designs as well as certain quality and performance requirements.
	We currently purchase substrates for growth of high-temperature
	superconductor thin-films from a single supplier because of the
	quality of their substrates. A thin film is a thin layer of
	high-temperature superconductor material. There are additional
	components that we source from a single vendor due to the
	present volume. Key components of our conventional products are
	manufactured by sole foreign manufacturer. Our reliance on sole
	or limited source suppliers involves certain risks and
	uncertainties, many of which are beyond our control. These
	include the possibility of a shortage or the discontinuation of
	certain key components. Any reduced availability of these parts
	or components when required could impair our ability to
	manufacture and deliver our systems on a timely basis and result
	in the delay or cancellation of orders, which could harm our
	business.
	 
	In addition, the purchase of some of our key components involves
	long lead times and, in the event of unanticipated increases in
	demand for our solutions, we may be unable to obtain these
	components in sufficient quantities to meet our customers
	requirements. We do not have guaranteed supply arrangements with
	any of these suppliers, do not maintain an extensive inventory
	of parts or components and customarily purchase sole or limited
	source parts and components pursuant to purchase orders.
	Business disruptions, quality issues, production shortfalls or
	financial difficulties of a sole or limited source supplier
	could materially and adversely affect us by increasing product
	costs, or eliminating or delaying the availability of such parts
	or components. In such events, our inability to develop
	alternative sources of supply quickly and on a cost-effective
	basis could impair our ability to manufacture and deliver our
	systems on a timely basis and could harm our business.
	 
	Our
	reliance on a limited number of suppliers exposes us to quality
	control issues.
	 
	Our reliance on certain single-source and limited-source
	components exposes us to quality control issues if these
	suppliers experience a failure in their production process or
	otherwise fail to meet our quality requirements. A failure in
	single-source or limited-source components or products could
	force us to repair or replace a product utilizing replacement
	components. If we cannot obtain comparable replacements or
	effectively return or redesign our products, we could lose
	customer orders or incur additional costs, which could have a
	material adverse effect on our gross margins and results of
	operations.
	 
	We
	expect decreases in average selling prices, requiring us to
	reduce product costs in order to achieve and maintain
	profitability.
	 
	The average selling price of our products has decreased over the
	years. We anticipate customer pressure on our product pricing
	will continue for the foreseeable future. We have plans to
	further reduce the manufacturing cost of our products, but there
	is no assurance that our future cost reduction efforts will keep
	pace with price erosion. We will need to further reduce our
	manufacturing costs through engineering improvements and
	economies of scale in production and purchasing in order to
	achieve adequate gross margins. We may not be able to achieve
	the required product cost savings at a rate needed to keep pace
	with competitive pricing pressure. Additionally, we may be
	forced to discount future orders. If we fail to reach our cost
	saving objectives or we are required to offer future discounts,
	our business may be harmed.
	 
	Our
	ability to protect our patents and other proprietary rights is
	uncertain, exposing us to possible losses of competitive
	advantage.
	 
	Our efforts to protect our proprietary rights may not succeed in
	preventing infringement by others or ensure that these rights
	will provide us with a competitive advantage. Pending patent
	applications may not result in issued patents and the validity
	of issued patents may be subject to challenge. Third parties may
	also be able to design around the patented aspects of the
	products. Additionally, certain of the issued patents and patent
	applications are owned jointly with third parties. Because any
	owner or co-owner of a patent can license its rights under
	jointly-owned patents or applications, inventions made by us
	jointly with others are not subject to our exclusive control.
	Any of these possible events could result in losses of
	competitive advantage.
	11
 
	 
	We
	depend on specific patents and licenses to technologies, and we
	will likely need additional technologies in the future that we
	may not be able to obtain.
	 
	We utilize technologies under licenses of patents from others
	for our products. These patents may be subject to challenge,
	which may result in significant litigation expense (which may or
	may not be recoverable against future royalty obligations).
	Additionally, we continually try to develop new products, and,
	in the course of doing so, we may be required to utilize
	intellectual property rights owned by others and may seek
	licenses to do so. Such licenses may not be obtainable on
	commercially reasonable terms, or at all. It is also possible
	that we may inadvertently utilize intellectual property rights
	held by others, which could result in substantial claims.
	 
	Intellectual
	property infringement claims against us could materially harm
	results of operations.
	 
	Our products incorporate a number of technologies, including
	high-temperature superconductor technology, technology related
	to other materials, and electronics technologies. Our patent
	positions, and that of other companies using high-temperature
	superconductor technology, is uncertain and there is significant
	risk that others, including our competitors or potential
	competitors, have obtained or will obtain patents relating to
	our products or technologies or products or technologies planned
	to be introduced by us.
	 
	We believe that patents may be or have been issued, or
	applications may be pending, claiming various compositions of
	matter used in our products. We may need to secure one or more
	licenses of these patents. There can be no assurances that such
	licenses could be obtained on commercially reasonable terms, or
	at all. We may be required to expend significant resources to
	develop alternatives that would not infringe such patents or to
	obtain licenses to the related technology. We may not be able to
	successfully design around these patents or obtain licenses to
	them and may have to defend ourselves at substantial cost
	against allegations of infringement of third party patents or
	other rights to intellectual property. In those circumstances,
	we could face significant liabilities and also be forced to
	cease the use of key technology.
	 
	We were engaged in a patent dispute with ISCO International,
	Inc. from July 2001 to May 2005 relating to U.S. Patent
	No. 6,263,215 entitled Cryoelectronically Cooled
	Receiver Front End for Mobile Radio Systems. ISCO alleged
	that some of our HTS products infringed the ISCO patent. We
	prevailed at trial. The jury returned a unanimous verdict that
	our products did not infringe the ISCO patent and that the ISCO
	patent is invalid and unenforceable. The jurys verdict was
	upheld on appeal, and we do not expect any further legal action
	related to this matter.
	 
	We
	currently rely on specific technologies and may not successfully
	adapt to the rapidly changing wireless telecommunications
	equipment market.
	 
	Wireless telecommunication equipment is characterized by rapidly
	advancing technology. Our success depends upon our ability to
	keep pace with advancing wireless technology, including
	materials, processes and industry standards. For example, we had
	to redesign our SuperLink product to convert from thallium
	barium calcium copper oxide to yttrium barium copper oxide in
	order to reduce the product cost and compete with other
	technologies. However, even with the lower cost HTS material,
	SuperLink may not ultimately prove commercially competitive
	against other current technologies or those that may be
	discovered in the future.
	 
	We will have to continue to develop and integrate advances to
	our core technologies. We will also need to continue to develop
	and integrate advances in complementary technologies. We cannot
	guarantee that our development efforts will not be rendered
	obsolete by research efforts and technological advances made by
	others.
	 
	Other
	parties may have the right to utilize technology important to
	our business.
	 
	We utilize certain intellectual property rights under
	non-exclusive licenses or have granted to others the right to
	utilize certain intellectual property rights licensed from a
	third party. Because we may not have the exclusive rights to
	utilize such intellectual property, other parties may be able to
	compete with us, which may harm our business.
	12
 
	 
	Our
	failure to anticipate and respond to developments in the
	wireless telecommunications market could substantially harm our
	business.
	 
	Our efforts are focused on the wireless telecommunications
	market, including the 2G, 2.5G and 3G markets. The dedication of
	our resources to the wireless telecommunications market makes us
	potentially vulnerable to changes in this market, such as new
	technologies like WIMAX, future competition, changes in
	availability of capital resources or regulatory changes that
	could affect the competitive position and rate of growth of the
	wireless industry.
	 
	We may
	not be able to compete effectively against alternative
	technologies.
	 
	Our products compete with a number of alternative approaches and
	technologies that increase the capacity and improve the quality
	of wireless networks. Some of these alternatives may be more
	cost effective or offer better performance than our products.
	Wireless network operators may opt to increase the number of
	transmission stations, increase tower heights, install filters
	and amplifiers at the top of towers or use advanced antenna
	technology in lieu of purchasing our products. We may not
	succeed in competing against these alternatives.
	 
	We
	depend upon government contracts for a substantial amount of
	revenue, and our business may suffer if significant contracts
	are terminated, adversely modified, or we are unable to win new
	contracts.
	 
	We derive a portion of our revenue from a few large contracts
	with the U.S. government. As a result, a reduction in, or
	discontinuance of, the governments commitment to current
	or future programs could materially reduce government contract
	revenue.
	 
	Contracts involving the U.S. government may include various
	risks, including:
	 
| 
 | 
 | 
 | 
| 
	 
 | 
	 
 | 
	termination by the government;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	reduction or modification in the event of changes in the
	governments requirements or budgetary constraints;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	increased or unexpected costs causing losses or reduced profits
	under contracts where prices are fixed or unallowable costs
	under contracts where the government reimburses for costs and
	pays an additional premium;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	risks of potential disclosure of confidential information to
	third parties;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	the failure or inability of the main contractor to perform its
	contract in circumstances where STI is a subcontractor;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	the failure of the government to exercise options for additional
	work provided for in the contracts; and
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	the governments right in certain circumstances to freely
	use technology developed under these contracts.
 | 
	 
	The programs in which we participate may extend for several
	years, but are normally funded on an annual basis. The
	U.S. government may not continue to fund programs under
	which we have entered into contracts. Even if funding is
	continued, we may fail to compete successfully to obtain funding
	within such programs.
	 
	All costs for services under government contracts are subject to
	audit, and the acceptance of such costs as allowable and
	allocable is subject to federal regulatory guidelines. We record
	contract revenues in amounts which we expect to be realized upon
	final audit settlement. Any disallowance of costs by the
	government could have an adverse effect on our business,
	operating results and financial condition. Audits and
	adjustments may result in decreased revenues and net income for
	those years. Additionally, because of our participation in
	government contracts, we are subject to audit from time to time
	for our compliance with government regulations by various
	agencies. Government agencies may conduct inquiries or
	investigations that may cover a broad range of activity.
	Responding to any such audits, inquiries or investigations may
	involve significant expense and divert managements
	attention. In addition, an adverse finding in any such audit,
	inquiry or investigation could involve penalties that may harm
	our business.
	13
 
	 
	Because
	competition for target employees is intense, we may be subject
	to claims of unfair hiring practices, trade secret
	misappropriation or other related claims.
	 
	Companies in the wireless telecommunications industry whose
	employees accept positions with competitors frequently claim
	that competitors have engaged in unfair hiring practices, trade
	secret misappropriation or other related claims. We may be
	subject to such claims in the future as we seek to hire
	qualified personnel, and such claims may result in material
	litigation. If this should occur, we could incur substantial
	costs in defending against these claims, regardless of their
	merits.
	 
	If we
	are unable to forecast our inventory needs accurately, we may be
	unable to obtain sufficient manufacturing capacity or may incur
	unnecessary costs and produce excess inventory.
	 
	We forecast our inventory needs based on anticipated purchase
	orders to determine manufacturing requirements. If we
	overestimate demand, we may have excess inventory, and our
	suppliers may as well, which could increase our costs. If we
	underestimate our requirements, our suppliers may have
	inadequate inventory, which could interrupt manufacturing and
	result in delays in shipments and recognition of revenues. In
	addition, lead times for ordering materials and components vary
	significantly and depend on factors such as the specific
	supplier, contract terms and demand for any component at a given
	time. Accordingly, if we inaccurately forecast demand, we may be
	unable to obtain adequate manufacturing capacity from our
	suppliers to meet customers delivery requirements, which
	would harm our business.
	 
	Our
	success depends on the attraction and retention of senior
	management and technical personnel with relevant
	expertise.
	 
	As a competitor in a highly technical market, we depend heavily
	upon the efforts of our existing senior management and technical
	teams. The loss of the services of one or more members of these
	teams could slow product development and commercialization
	objectives. Due to the specialized nature of our products, we
	also depend upon our ability to attract and retain qualified
	technical personnel with substantial industry knowledge and
	expertise. Competition for qualified personnel is intense and we
	may not be able to continue to attract and retain qualified
	personnel necessary for the development of our business.
	 
	We have experienced difficulty recruiting senior management due
	to the high cost of living in the Santa Barbara area. We
	have a limited pool of qualified executives in
	Santa Barbara and may attempt to recruit qualified
	candidates from across the country. Some candidates have cited
	the high cost of housing in Santa Barbara as a significant
	negative factor when considering our employment offers. We have
	mitigated this problem to a limited extent by allowing some
	executives to maintain their existing residences in other parts
	of the country and effectively commute to our
	corporate headquarters in Santa Barbara as needed to perform
	their duties. Regardless, we expect the cost of housing in our
	area will continue to present a significant obstacle to
	recruiting senior executives.
	 
	Regulatory
	changes negatively affecting wireless communications companies
	could substantially harm our business.
	 
	The Federal Communications Commission strictly regulates the
	operation of wireless base stations in the United States. Other
	countries also regulate the operation of base stations within
	their territories. Base stations and equipment marketed for use
	in base stations must meet specific technical standards. Our
	ability to sell our high-temperature superconductor filter
	subsystems will depend upon the rate of deployment of other new
	wireless digital services, the ability of base station equipment
	manufacturers and of base station operators to obtain and retain
	the necessary approvals and licenses, and changes in regulations
	that may impact the product requirements. Any failure or delay
	of base station manufacturers or operators in obtaining
	necessary approvals could harm our business.
	 
	We may
	acquire or make investments in companies or technologies that
	could cause loss of value to stockholders and disruption of
	business.
	 
	We may explore opportunities to acquire companies or
	technologies in the future. Other than the acquisition of
	Conductus, Inc. in 2002, we have not made any such acquisitions
	or investments to date and, therefore, our ability as
	14
 
	an organization to make acquisitions or investments is unproven.
	Entering into an acquisition entails many risks, any of which
	could adversely affect our business, including:
	 
| 
 | 
 | 
 | 
| 
	 
 | 
	 
 | 
	failure to integrate operations, services and personnel;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	the price paid may exceed the value eventually realized;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	loss of share value to existing stockholders as a result of
	issuing equity securities to finance an acquisition;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	potential loss of key employees from either our then current
	business or any acquired business;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	entering into markets in which we have little or no prior
	experience;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	diversion of financial resources and managements attention
	from other business concerns;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	assumption of unanticipated liabilities related to the acquired
	assets; and
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	the business or technologies acquired or invested in may have
	limited operating histories and may be subjected to many of the
	same risks to which we are exposed.
 | 
	 
	In addition, future acquisitions may result in potentially
	dilutive issuances of equity securities, or the incurrence of
	debt, contingent liabilities or amortization expenses or charges
	related to goodwill or other intangible assets, any of which
	could harm our business. As a result, if we fail to properly
	evaluate and execute acquisitions or investments, our business
	and prospects may be seriously harmed.
	 
	If we
	are unable to implement appropriate controls and procedures to
	manage our expected growth, we may not be able to successfully
	offer our products and implement our business
	plan.
	 
	Our ability to successfully offer our products and implement our
	business plan in a rapidly evolving market requires an effective
	planning and management process. Anticipated growth in future
	operations will continue to place a significant strain on
	management systems and resources. We expect that we will need to
	continue to improve our financial and managerial controls,
	reporting systems and procedures, and will need to continue to
	expand, train and manage our work force worldwide. Furthermore,
	we expect that we will be required to manage multiple
	relationships with various customers and other third parties.
	 
	Compliance
	with environmental regulations could be especially costly due to
	the hazardous materials used in the manufacturing
	process.
	 
	We are subject to a number of federal, state and local
	governmental regulations related to the use, storage, discharge
	and disposal of toxic, volatile or otherwise hazardous chemicals
	used in our business. Any failure to comply with present or
	future regulations could result in fines being imposed,
	suspension of production or interruption of operations. In
	addition, these regulations could restrict our ability to expand
	or could require us to acquire costly equipment or incur other
	significant expense to comply with environmental regulations or
	to clean up prior discharges.
	 
	The
	reliability of market data included in our public filings is
	uncertain.
	 
	Since we operate in a rapidly changing market, we have in the
	past, and may from time to time in the future, include market
	data from industry publications and our own internal estimates
	in some of the documents we file with the Securities Exchange
	Commission. The reliability of this data cannot be assured.
	Industry publications generally state that the information
	contained in these publications has been obtained from sources
	believed to be reliable, but that its accuracy and completeness
	is not guaranteed. Although we believe that the market data used
	in our SEC filings is and will be reliable, it has not been
	independently verified. Similarly, internal company estimates,
	while believed by us to be reliable, have not been verified by
	any independent sources.
	15
 
	 
	Our
	international operations expose us to certain
	risks.
	 
	We are looking to expand into international markets. To the
	extent that we are successful, our financial results may be
	adversely affected by other international risks, such as:
	 
| 
 | 
 | 
 | 
| 
	 
 | 
	 
 | 
	changes in exchange rates;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	international political and economic conditions;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	changes in government regulation in various countries;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	trade barriers;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	adverse tax consequences; and
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	costs associated with expansion into new territories.
 | 
	 
	Risks
	Related to Our Common Stock
	 
	Our
	stock price is volatile.
	 
	The market price of our common stock has been, and we expect
	will continue to be, subject to significant volatility. The
	value of our common stock may decline regardless of our
	operating performance or prospects. Factors affecting our market
	price include:
	 
| 
 | 
 | 
 | 
| 
	 
 | 
	 
 | 
	our perceived prospects;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	variations in our operating results and whether we have achieved
	key business targets;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	changes in, or our failure to meet, earnings estimates;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	changes in securities analysts buy/sell recommendations;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	differences between our reported results and those expected by
	investors and securities analysts;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	announcements of new contracts by us or our competitors;
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	market reaction to any acquisitions, joint ventures or strategic
	investments announced by us or our competitors; and
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	general economic, political or stock market conditions.
 | 
	 
	Recent events have caused stock prices for many companies,
	including ours, to fluctuate in ways unrelated or
	disproportionate to their operating performance. The general
	economic, political and stock market conditions that may affect
	the market price of our common stock are beyond our control. The
	market price of our common stock at any particular time may not
	remain the market price in the future.
	 
	We
	have a significant number of outstanding warrants and options,
	and future sales of these shares could adversely affect the
	market price of our common stock.
	 
	As of December 31, 2006, we had outstanding warrants and
	options exercisable for an aggregate of 1,983,779 shares of
	common stock at a weighted average exercise price of
	$30.99 per share. We have registered the issuance of all
	these shares, and they will be freely tradable by the exercising
	party upon issuance. The holders may sell these shares in the
	public markets from time to time, without limitations on the
	timing, amount or method of sale. As our stock price rises, the
	holders may exercise their warrants and options and sell a large
	number of shares. This could cause the market price of our
	common stock to decline.
	 
	Our
	corporate governance structure may prevent our acquisition by
	another company at a premium over the public trading price of
	STI shares.
	 
	It is possible that the acquisition of a majority of our
	outstanding voting stock by another company could result in our
	stockholders receiving a premium over the public trading price
	for our shares. Provisions of our restated certificate of
	incorporation and bylaws and of Delaware corporate law could
	delay or make more difficult an
	16
 
	acquisition of our company by merger, tender offer or proxy
	contest, even if it would create an immediate benefit to our
	stockholders. For example, our restated certificate of
	incorporation does not permit stockholders to act by written
	consent and our bylaws generally require ninety days advance
	notice of any matters to be brought before the stockholders at
	an annual or special meeting.
	 
	In addition, our board of directors has the authority to issue
	up to 2,000,000 shares of preferred stock and to determine
	the terms, rights and preferences of this preferred stock,
	including voting rights of those shares, without any further
	vote or action by the stockholders. The rights of the holders of
	common stock may be subordinate to, and adversely affected by,
	the rights of holders of preferred sock that may be issued in
	the future. The issuance of preferred stock could also make it
	more difficult for a third party to acquire a majority of our
	outstanding voting stock, even at a premium over our public
	trading price.
	 
	Further, our certificate of incorporation also provides for a
	classified board of directors with directors divided into three
	classes serving staggered terms. These provisions may have the
	effect of delaying or preventing a change in control of STI
	without action by our stockholders and, therefore, could
	adversely affect the price of our stock or the possibility of
	sale of shares to an acquiring person.
	 
	We do
	not anticipate declaring any cash dividends on our common
	stock.
	 
	We have never declared or paid cash dividends on our common
	stock and do not plan to pay any cash dividends in the near
	future. Our current policy is to retain all funds and earnings
	for use in the operation and expansion of our business. In
	addition, our debt agreements prohibit the payment of cash
	dividends or other distributions on any of our capital stock
	except dividends payable in additional shares of capital stock.
	 
| 
 | 
 | 
| 
	ITEM 1B.
	  
 | 
	UNRESOLVED
	STAFF COMMENTS
 | 
	 
	Not applicable.
	 
	 
	We lease all of our properties. All of our operations, including
	our manufacturing facility, are located in an industrial complex
	in Santa Barbara, California. We occupy approximately
	71,000 square feet in this complex. We have a long-term
	lease for 60,000 square feet that expires in 2011, and we
	rent the remaining 11,000 square feet on a
	year-to-year
	basis. We believe that our Santa Barbara facilities are
	adequate to meet current and reasonably anticipated needs for
	approximately the next two years.
	 
| 
 | 
 | 
| 
	ITEM 3.
	  
 | 
	LEGAL
	PROCEEDINGS
 | 
	 
	Settlement
	of Shalvoy Litigation
	 
	Mr. Shalvoy, a director and stockholder, executed two notes
	aggregating $820,244 in principal in connection with the
	exercise in December 2000 of two options to purchase Conductus,
	Inc. common stock prior our acquisition of Conductus, Inc. in
	December 2002. Through the third quarter of, 2005, we carried
	the principal (as Notes Receivable from
	Stockholder) and accrued interest (as Prepaid
	Expenses and Other Current Assets) for both notes as
	assets on our balance sheet.
	 
	We filed a lawsuit against Mr. Shalvoy on December 21,
	2005 in the California Superior Court (Case
	No. 1186812) to collect both notes. In that same
	quarter, due to Mr. Shalvoys refusal to pay the notes
	voluntarily we recorded a reserve for the value of the notes
	(principal plus accrued interest) in excess of the market value
	of the collateral securing the notes.
	 
	On March 2, 2007, we entered into a Settlement Agreement
	and Mutual Release of All Claims with Mr. Shalvoy to settle
	the lawsuit. The agreement provides for a payment of $610,000 to
	us on or before April 2, 2007 in payment of one note,
	including interest and attorneys fees, and the rescission
	of Mr. Shalvoys second purported option exercise
	including cancellation of the related note.
	17
 
	 
	Routine
	Litigation
	 
	We may be involved in routine litigation arising in the ordinary
	course of our business, and, while the results of the
	proceedings cannot be predicted with certainty, we believe that
	the final outcome of such matters will not have a material
	adverse effect on our financial position, operating results or
	cash flow.
	 
| 
 | 
 | 
| 
	ITEM 4.
	  
 | 
	SUBMISSION
	OF MATTERS TO A VOTE OF SECURITY HOLDERS
 | 
	 
	No matters were submitted to security holders during the last
	quarter of the year.
	 
	PART II
	 
| 
 | 
 | 
| 
	ITEM 5.
	  
 | 
	MARKET
	FOR REGISTRANTS COMMON EQUITY, RELATED STOCKHOLDER MATTERS
	AND ISSUER PURCHASES OF EQUITY SECURITIES
 | 
	 
	Market
	for Common Stock
	 
	Our common stock is traded on the NASDAQ Capital Market under
	the symbol SCON. The following table shows the high
	and low intraday sales prices for our common stock as reported
	by NASDAQ for each calendar quarter in the last two fiscal years:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	High
 | 
	 
 | 
	 
 | 
	Low
 | 
	 
 | 
| 
	 
 | 
| 
 
	2005
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Quarter ended April 2, 2005
 
 | 
	 
 | 
	$
 | 
	14.30
 | 
	 
 | 
	 
 | 
	$
 | 
	6.50
 | 
	 
 | 
| 
 
	Quarter ended July 2, 2005
 
 | 
	 
 | 
	$
 | 
	8.70
 | 
	 
 | 
	 
 | 
	$
 | 
	3.73
 | 
	 
 | 
| 
 
	Quarter ended October 1, 2005
 
 | 
	 
 | 
	$
 | 
	11.10
 | 
	 
 | 
	 
 | 
	$
 | 
	5.80
 | 
	 
 | 
| 
 
	Quarter ended December 31,
	2005
 
 | 
	 
 | 
	$
 | 
	7.40
 | 
	 
 | 
	 
 | 
	$
 | 
	4.10
 | 
	 
 | 
| 
 
	2006
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Quarter ended April 1, 2006
 
 | 
	 
 | 
	$
 | 
	6.70
 | 
	 
 | 
	 
 | 
	$
 | 
	3.21
 | 
	 
 | 
| 
 
	Quarter ended July 1, 2006
 
 | 
	 
 | 
	$
 | 
	4.54
 | 
	 
 | 
	 
 | 
	$
 | 
	1.90
 | 
	 
 | 
| 
 
	Quarter ended September 30,
	2006
 
 | 
	 
 | 
	$
 | 
	2.10
 | 
	 
 | 
	 
 | 
	$
 | 
	1.30
 | 
	 
 | 
| 
 
	Quarter ended December 31,
	2006
 
 | 
	 
 | 
	$
 | 
	3.24
 | 
	 
 | 
	 
 | 
	$
 | 
	1.43
 | 
	 
 | 
	 
	Holders
	of Record
	 
	We had 129 holders of record of our common stock on
	February 28, 2007. This number does not include
	stockholders for whom shares were held in a nominee
	or street name. We estimate that there are more than
	20,000 round lot beneficial owners of our common stock.
	 
	Dividends
	 
	We have never paid cash dividends and intend to employ all
	available funds in the development of our business. We have no
	plans to pay cash dividends in the near future, and our line of
	credit does not allow the payment of dividends
	 
	Sales of
	Unregistered Securities
	 
	We did not conduct any offerings of equity securities during the
	fourth quarter of 2006 that were not registered under the
	Securities Act of 1933.
	 
	Repurchases
	of Equity Securities
	 
	We did not repurchase any shares of our common stock during the
	fourth quarter of 2006.
	18
 
	 
	Securities
	Authorized for Issuance Under Equity Compensation
	Plans
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	Number of Securities
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	Weighted-average
 
 | 
	 
 | 
	 
 | 
	Remaining Available for
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Number of Securities to
 
 | 
	 
 | 
	 
 | 
	Exercise Price of
 
 | 
	 
 | 
	 
 | 
	Future Issuance Under Equity
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	be Issued Upon Exercise
 
 | 
	 
 | 
	 
 | 
	Outstanding
 
 | 
	 
 | 
	 
 | 
	Compensation Plans
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	of Outstanding Options,
 
 | 
	 
 | 
	 
 | 
	Options, Warrants
 
 | 
	 
 | 
	 
 | 
	(Excluding Securities Reflected in
 
 | 
	 
 | 
| 
 
	Plan Category
 
 | 
	 
 | 
	Warrants and Rights
 | 
	 
 | 
	 
 | 
	and Rights
 | 
	 
 | 
	 
 | 
	Column (a))
 | 
	 
 | 
| 
	 
 | 
| 
 
	Equity compensation plans approved
	by security holders
 
 | 
	 
 | 
	 
 | 
	1,154,941
 | 
	 
 | 
	 
 | 
	$
 | 
	38.33
 | 
	 
 | 
	 
 | 
	 
 | 
	44,413
 | 
	 
 | 
| 
 
	Equity compensation plans not
	approved by security holders
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Total
 
 | 
	 
 | 
	 
 | 
	1,154,941
 | 
	 
 | 
	 
 | 
	$
 | 
	38.33
 | 
	 
 | 
	 
 | 
	 
 | 
	44,413
 | 
	 
 | 
	 
	Stock
	Performance Graph
	 
	The graph and table below compare the cumulative total
	stockholders return on the Companys common stock
	since December 31, 2001 with the Nasdaq Composite Index,
	and the Nasdaq Telecommunications Index over the same period
	(assuming the investment of $100 in the Companys common
	stock and in the two other indices, and reinvestment of all
	dividends).
	 
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	31-Dec-01
 | 
	 
 | 
	 
 | 
	31-Dec-02
 | 
	 
 | 
	 
 | 
	31-Dec-03
 | 
	 
 | 
	 
 | 
	31-Dec-04
 | 
	 
 | 
	 
 | 
	31-Dec-05
 | 
	 
 | 
	 
 | 
	31-Dec-06
 | 
| 
 
	Superconductor Technologies
 
 | 
	 
 | 
	 
 | 
	$
 | 
	100.00
 | 
	 
 | 
	 
 | 
	 
 | 
	$
 | 
	14.46
 | 
	 
 | 
	 
 | 
	 
 | 
	$
 | 
	85.54
 | 
	 
 | 
	 
 | 
	 
 | 
	$
 | 
	21.38
 | 
	 
 | 
	 
 | 
	 
 | 
	$
 | 
	6.62
 | 
	 
 | 
	 
 | 
	 
 | 
	$
 | 
	2.72
 | 
	 
 | 
| 
 
	Nasdaq Composite
 
 | 
	 
 | 
	 
 | 
	 
 | 
	100.00
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	68.47
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	102.72
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	111.54
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	113.07
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	123.84
 | 
	 
 | 
| 
 
	Nasdaq-Telecommunications
 
 | 
	 
 | 
	 
 | 
	 
 | 
	100.00
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	45.97
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	77.58
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	83.78
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	77.74
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	99.32
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	19
 
	 
| 
 | 
 | 
| 
	ITEM 6.
	  
 | 
	SELECTED
	FINANCIAL DATA
 | 
	 
	The information set forth below is not necessarily indicative of
	results of future operations and should be read in conjunction
	with the Companys Financial Statements and Notes thereto
	appearing in Item 15 of Part IV of this Report and
	Managements Discussion and Analysis of Financial
	Condition and Results of Operations. We acquired
	Conductus, Inc. on December 18, 2002. The results of
	Conductus, Inc. are included in the consolidated financial
	statement starting for 13 days in 2002 following its
	acquisition and all periods thereafter.
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Year Ended December 31,
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	2002
 | 
	 
 | 
	 
 | 
	2003
 | 
	 
 | 
	 
 | 
	2004
 | 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	(In thousands, except per share data)
 | 
	 
 | 
| 
	 
 | 
| 
 
	Statement of Operations
	Data:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Net revenues:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Net commercial product revenues
 
 | 
	 
 | 
	$
 | 
	17,601
 | 
	 
 | 
	 
 | 
	$
 | 
	38,577
 | 
	 
 | 
	 
 | 
	$
 | 
	16,787
 | 
	 
 | 
	 
 | 
	$
 | 
	21,080
 | 
	 
 | 
	 
 | 
	$
 | 
	17,697
 | 
	 
 | 
| 
 
	Government contract revenues
 
 | 
	 
 | 
	 
 | 
	4,785
 | 
	 
 | 
	 
 | 
	 
 | 
	10,759
 | 
	 
 | 
	 
 | 
	 
 | 
	6,189
 | 
	 
 | 
	 
 | 
	 
 | 
	3,107
 | 
	 
 | 
	 
 | 
	 
 | 
	3,361
 | 
	 
 | 
| 
 
	Sub license royalties
 
 | 
	 
 | 
	 
 | 
	10
 | 
	 
 | 
	 
 | 
	 
 | 
	58
 | 
	 
 | 
	 
 | 
	 
 | 
	28
 | 
	 
 | 
	 
 | 
	 
 | 
	22
 | 
	 
 | 
	 
 | 
	 
 | 
	20
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Total net revenues
 
 | 
	 
 | 
	 
 | 
	22,396
 | 
	 
 | 
	 
 | 
	 
 | 
	49,394
 | 
	 
 | 
	 
 | 
	 
 | 
	23,004
 | 
	 
 | 
	 
 | 
	 
 | 
	24,209
 | 
	 
 | 
	 
 | 
	 
 | 
	21,078
 | 
	 
 | 
| 
 
	Costs and expenses:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Cost of commercial product revenues
 
 | 
	 
 | 
	 
 | 
	19,286
 | 
	 
 | 
	 
 | 
	 
 | 
	28,249
 | 
	 
 | 
	 
 | 
	 
 | 
	23,421
 | 
	 
 | 
	 
 | 
	 
 | 
	18,989
 | 
	 
 | 
	 
 | 
	 
 | 
	15,922
 | 
	 
 | 
| 
 
	Contract research and development
 
 | 
	 
 | 
	 
 | 
	2,531
 | 
	 
 | 
	 
 | 
	 
 | 
	6,899
 | 
	 
 | 
	 
 | 
	 
 | 
	4,465
 | 
	 
 | 
	 
 | 
	 
 | 
	2,806
 | 
	 
 | 
	 
 | 
	 
 | 
	2,407
 | 
	 
 | 
| 
 
	Other research and development
 
 | 
	 
 | 
	 
 | 
	4,489
 | 
	 
 | 
	 
 | 
	 
 | 
	4,697
 | 
	 
 | 
	 
 | 
	 
 | 
	5,036
 | 
	 
 | 
	 
 | 
	 
 | 
	4,214
 | 
	 
 | 
	 
 | 
	 
 | 
	3,488
 | 
	 
 | 
| 
 
	Selling, general and administrative
 
 | 
	 
 | 
	 
 | 
	14,976
 | 
	 
 | 
	 
 | 
	 
 | 
	20,567
 | 
	 
 | 
	 
 | 
	 
 | 
	16,051
 | 
	 
 | 
	 
 | 
	 
 | 
	11,442
 | 
	 
 | 
	 
 | 
	 
 | 
	9,086
 | 
	 
 | 
| 
 
	Restructuring expenses and
	impairment charges
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	4,128
 | 
	 
 | 
	 
 | 
	 
 | 
	1,197
 | 
	 
 | 
	 
 | 
	 
 | 
	38
 | 
	 
 | 
| 
 
	Write off of Goodwill
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	20,107
 | 
	 
 | 
| 
 
	Write off of in-process research
	and development
 
 | 
	 
 | 
	 
 | 
	700
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Total costs and expenses
 
 | 
	 
 | 
	 
 | 
	41,982
 | 
	 
 | 
	 
 | 
	 
 | 
	60,412
 | 
	 
 | 
	 
 | 
	 
 | 
	53,101
 | 
	 
 | 
	 
 | 
	 
 | 
	38,648
 | 
	 
 | 
	 
 | 
	 
 | 
	51,048
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Loss from operations
 
 | 
	 
 | 
	 
 | 
	(19,586
 | 
	)
 | 
	 
 | 
	 
 | 
	(11,018
 | 
	)
 | 
	 
 | 
	 
 | 
	(30,097
 | 
	)
 | 
	 
 | 
	 
 | 
	(14,439
 | 
	)
 | 
	 
 | 
	 
 | 
	(29,970
 | 
	)
 | 
| 
 
	Other income (expense), net
 
 | 
	 
 | 
	 
 | 
	73
 | 
	 
 | 
	 
 | 
	 
 | 
	(327
 | 
	)
 | 
	 
 | 
	 
 | 
	(1,120
 | 
	)
 | 
	 
 | 
	 
 | 
	226
 | 
	 
 | 
	 
 | 
	 
 | 
	346
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Net loss
 
 | 
	 
 | 
	 
 | 
	(19,513
 | 
	)
 | 
	 
 | 
	 
 | 
	(11,345
 | 
	)
 | 
	 
 | 
	 
 | 
	(31,217
 | 
	)
 | 
	 
 | 
	 
 | 
	(14,213
 | 
	)
 | 
	 
 | 
	 
 | 
	(29,624
 | 
	)
 | 
| 
 
	Less deemed and cumulative
	preferred stock Dividends
 
 | 
	 
 | 
	 
 | 
	(1,756
 | 
	)
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Net loss available to common
	stockholders
 
 | 
	 
 | 
	$
 | 
	(21,269
 | 
	)
 | 
	 
 | 
	$
 | 
	(11,345
 | 
	)
 | 
	 
 | 
	$
 | 
	(31,217
 | 
	)
 | 
	 
 | 
	$
 | 
	(14,213
 | 
	)
 | 
	 
 | 
	$
 | 
	(29,624
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Basic and diluted net loss per
	share:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Net loss per common share
 
 | 
	 
 | 
	$
 | 
	(8.85
 | 
	)
 | 
	 
 | 
	$
 | 
	(1.81
 | 
	)
 | 
	 
 | 
	$
 | 
	(3.71
 | 
	)
 | 
	 
 | 
	$
 | 
	(1.24
 | 
	)
 | 
	 
 | 
	$
 | 
	(2.37
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Weighted average number of shares
	Outstanding
 
 | 
	 
 | 
	 
 | 
	2,402
 | 
	 
 | 
	 
 | 
	 
 | 
	6,269
 | 
	 
 | 
	 
 | 
	 
 | 
	8,424
 | 
	 
 | 
	 
 | 
	 
 | 
	11,419
 | 
	 
 | 
	 
 | 
	 
 | 
	12,483
 | 
	 
 | 
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	December 31,
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	2002
 | 
	 
 | 
	 
 | 
	2003
 | 
	 
 | 
	 
 | 
	2004
 | 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
| 
	 
 | 
| 
 
	Balance Sheet Data:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Cash and cash equivalents
 
 | 
	 
 | 
	$
 | 
	18,191
 | 
	 
 | 
	 
 | 
	$
 | 
	11,144
 | 
	 
 | 
	 
 | 
	$
 | 
	12,802
 | 
	 
 | 
	 
 | 
	$
 | 
	13,018
 | 
	 
 | 
	 
 | 
	$
 | 
	5,487
 | 
	 
 | 
| 
 
	Working capital
 
 | 
	 
 | 
	 
 | 
	16,503
 | 
	 
 | 
	 
 | 
	 
 | 
	15,576
 | 
	 
 | 
	 
 | 
	 
 | 
	16,146
 | 
	 
 | 
	 
 | 
	 
 | 
	17,218
 | 
	 
 | 
	 
 | 
	 
 | 
	9,958
 | 
	 
 | 
| 
 
	Total assets
 
 | 
	 
 | 
	 
 | 
	65,326
 | 
	 
 | 
	 
 | 
	 
 | 
	68,123
 | 
	 
 | 
	 
 | 
	 
 | 
	62,358
 | 
	 
 | 
	 
 | 
	 
 | 
	52,045
 | 
	 
 | 
	 
 | 
	 
 | 
	21,904
 | 
	 
 | 
| 
 
	Long-term debt, including current
	portion
 
 | 
	 
 | 
	 
 | 
	2,123
 | 
	 
 | 
	 
 | 
	 
 | 
	721
 | 
	 
 | 
	 
 | 
	 
 | 
	76
 | 
	 
 | 
	 
 | 
	 
 | 
	33
 | 
	 
 | 
	 
 | 
	 
 | 
	14
 | 
	 
 | 
| 
 
	Total stockholders equity
 
 | 
	 
 | 
	 
 | 
	49,524
 | 
	 
 | 
	 
 | 
	 
 | 
	52,220
 | 
	 
 | 
	 
 | 
	 
 | 
	49,249
 | 
	 
 | 
	 
 | 
	 
 | 
	47,257
 | 
	 
 | 
	 
 | 
	 
 | 
	17,951
 | 
	 
 | 
	20
 
	 
| 
 | 
 | 
| 
	ITEM 7.
	  
 | 
	MANAGEMENTS
	DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
	OPERATIONS
 | 
	 
	This Managements Discussion and Analysis of Financial
	Condition and Results of Operations includes many
	forward-looking statements. For cautions about relying on such
	forward looking statements, please refer to the section entitled
	Forward Looking Statements at the beginning of this
	Report immediately prior to Item 1.
	 
	General
	 
	We develop, manufacture and market high performance
	infrastructure products for wireless voice and data
	applications. Wireless carriers face many challenges in
	todays competitive marketplace. Minutes of use are
	skyrocketing, and wireless users now expect the same quality of
	service from their mobile devices as from their landline phones.
	We help wireless carriers meet these challenges by doing
	more with less.
	 
	Our products help maximize the performance of wireless
	telecommunications networks by improving the quality of uplink
	signals from mobile wireless devices. Our products increase
	capacity utilization, lower dropped and blocked calls, extend
	coverage, and enable higher wireless data throughput 
	all while reducing capital and operating costs. SuperLink
	incorporates patented high-temperature superconductor (HTS)
	technology to create a receiver front-end that enhances network
	performance. Today, we are leveraging our expertise and
	proprietary technology in radio frequency (RF) engineering to
	expand our product line beyond HTS technology. We believe our RF
	engineering expertise provides us with a significant competitive
	advantage in the development of high performance, cost-effective
	solutions for the front end of wireless telecommunications
	networks.
	 
	We have three product offerings:
	 
| 
 | 
 | 
 | 
| 
	 
 | 
	 
 | 
	SuperLink
	.
	  In order to receive uplink
	signals from wireless handsets, base stations require a wireless
	filter system to eliminate
	out-of-band
	interference. SuperLink combines HTS filters with a proprietary
	cryogenic cooler and an ultra low-noise amplifier. The result is
	a highly compact and reliable receiver front-end that can
	simultaneously deliver both high selectivity (interference
	rejection) and high sensitivity (detection of low level
	signals). SuperLink delivers significant performance advantages
	over conventional filter systems.
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	AmpLink
	.
	  AmpLink is designed to address
	the sensitivity requirements of wireless base stations. AmpLink
	is a ground-mounted unit which utilizes a high-performance
	amplifier. The enhanced uplink performance provided by AmpLink
	improves network coverage immediately and avoids the
	installation and maintenance costs associated with tower mounted
	alternatives.
 | 
| 
	 
 | 
| 
	 
 | 
	 
 | 
	SuperPlex
	.
	  SuperPlex is our line of
	multiplexers that provides extremely low insertion loss and
	excellent cross-band isolation. SuperPlex high-performance
	multiplexers are designed to eliminate the need for additional
	base station antennas and reduce infrastructure costs. Relative
	to competing technologies, these products offer increased
	transmit power delivered to the base station antenna, higher
	sensitivity to subscriber handset signals, and fast and
	cost-effective network overlays.
 | 
	 
	We currently sell most of our commercial products directly to
	wireless network operators in the United States. Our customers
	to date include ALLTEL, Cingular, Sprint Nextel,
	T-Mobile,
	U.S. Cellular and Verizon Wireless. We have a concentrated
	customer base. Verizon Wireless, ALLTEL and
	T-Mobile
	each accounted for more than 10% of our commercial revenues in
	2006 and 2005. We plan to expand our customer base by selling
	directly to other wireless network operators and manufacturers
	of base station equipment, but we cannot assure that this effort
	will be successful.
	 
	We also generate significant revenues from government contracts.
	We primarily pursue government research and development
	contracts which compliment our commercial product development.
	We undertake government contract work which has the potential to
	improve our commercial product offering. These contracts often
	yield valuable intellectual property relevant to our commercial
	business. We typically own the intellectual property developed
	under these contracts, and the Federal Government receives a
	royalty-free, non-exclusive and nontransferable license to use
	the intellectual property for the United States.
	21
 
	We sell most of our products to a small number of wireless
	carriers, and their demand for wireless communications equipment
	fluctuates dramatically and unpredictably. We expect these
	trends to continue and may cause significant fluctuations in our
	quarterly and annual revenues.
	 
	The wireless communications infrastructure equipment market is
	extremely competitive and is characterized by rapid
	technological change, new product development, product
	obsolescence, evolving industry standards and price erosion over
	the life of a product. We face constant pressures to reduce
	prices. Consequently, we expect the average selling prices of
	our products will continue decreasing over time. We have
	responded in the past by successfully reducing our product
	costs, and expect further cost reductions over the next twelve
	months. However, we cannot predict whether our costs will
	decline at a rate sufficient to keep pace with the competitive
	pricing pressures.
	 
	Recent
	Developments
	 
	Settlement
	of Shalvoy Litigation
	 
	On March 2, 2007, we entered into a Settlement Agreement
	and Mutual Release of All Claims with Charles Shalvoy, a
	director and shareholder. The agreement settles a lawsuit we
	filed against Mr. Shalvoy in December 2005 to collect
	payment of amounts due under two promissory notes executed by
	Mr. Shalvoy in connection with his exercise of two options
	to purchase common stock of Conductus, Inc. prior to our
	acquisition of Conductus. The agreement provides for a payment
	of $610,000 to us on or before April 2, 2007 in payment of
	one note, including interest and attorneys fees, and the
	rescission of Mr. Shalvoys second purported option
	exercise including cancellation of the related note. See
	Item 3  Legal Proceedings 
	Settlement of Shalvoy Litigation.
	 
	Change of
	Independent Registered Public Accounting Firm
	 
	On October 3, 2006, we changed our independent registered
	public accounting firm from PricewaterhouseCoopers LLP to
	Stonefield Josephson, Inc. Our Audit Committee made the decision
	to change independent registered public accounting firms, and
	the decision was ratified by the Executive Committee of our
	Board of Directors. Stonefield Josephson, Inc. was engaged as
	our independent registered public accounting firm for the fiscal
	year ending December 31, 2006, and to perform procedures
	related to the financial statements included in our quarterly
	reports on
	Form 10-Q,
	beginning with, and including, the quarter ended
	September 30, 2006. In deciding to select SJI, the Audit
	Committee considered the firms experience and expertise
	with publicly traded technology companies and reviewed auditor
	independence issues. The Audit Committee concluded that SJI has
	no commercial relationship that would impair its independence
	and has the appropriate expertise required to audit our current
	operations.
	 
	Cingular
	Master Supplier Agreement
	 
	On September 8, 2006, we entered into a Master Supplier
	Agreement (
	MSA
	) with Cingular Wireless LLC.
	The agreement has a term of 3 years and allows Cingular
	Wireless, its affiliates and regions to purchase any of our
	products at the prices, and on the terms, specified in the MSA.
	The MSA does not contain any minimum purchase commitment, but
	its execution gives each Cingular region direct access to our
	full product line.
	 
	Critical
	Accounting Policies and Estimates
	 
	Our discussion and analysis of our financial condition and
	results of operations are based upon our financial statements,
	which have been prepared in accordance with accounting
	principles generally accepted in the United States. The
	preparation of these financial statements requires us to make
	estimates and judgments that affect the reported amounts of
	assets, liabilities, revenues and expenses, and related
	disclosure of contingent assets and liabilities. We continually
	evaluate our estimates, including those related to bad debts,
	inventories, recovery of long-lived assets, income taxes,
	warranty obligations, contract revenue and contingencies. We
	base our estimates on historical experience and on various other
	assumptions that we believed to be reasonable under the
	circumstances, the results of which form the basis for making
	judgments about the carrying values of assets and liabilities
	that are not readily apparent from other sources. Any future
	changes to these estimates and assumptions could cause a
	22
 
	material change to our reported amounts of revenues, expenses,
	assets and liabilities. Actual results may differ from these
	estimates under different assumptions or conditions.
	 
	We believe the following critical accounting policies affect our
	more significant judgments and estimates used in the preparation
	of the financial statements. We maintain allowances for doubtful
	accounts for estimated losses resulting from the inability of
	our customers to make required payments. If the financial
	condition of our customers were to deteriorate, resulting in an
	impairment of their ability to make payments, additional
	allowances may be required. We write down our inventory for
	estimated obsolescence or unmarketable inventory equal to the
	difference between the cost of inventory and the estimated
	market value based upon assumptions about future demand and
	market conditions. If actual market conditions are less
	favorable than those projected by management, additional
	inventory write-downs may be required.
	 
	Our inventory is valued at the lower of its actual cost or the
	current estimated market value of the inventory. We review
	inventory quantities on hand and on order and record, on a
	quarterly basis, a provision for excess and obsolete inventory
	and/or
	vendor cancellation charges related to purchase commitments. If
	the results of the review determine that a write-down is
	necessary, the Company recognizes a loss in the period in which
	the loss is identified, whether or not the inventory is retained
	or disposed. Our inventory reserves establish a new cost basis
	for inventory and are not reversed until the related inventory
	is sold or otherwise disposed. Such provisions are established
	based on historical usage, adjusted for known changes in demands
	for such products, or the estimated forecast of product demand
	and production requirements. Our business is characterized by
	rapid technological change, frequent new product development and
	rapid product obsolescence that could result in an increase in
	the amount of obsolete inventory quantities on hand. Demand for
	our products can fluctuate significantly. Our estimates of
	future product demand may prove to be inaccurate and we may
	understate or overstate the provision required for excess and
	obsolete inventory.
	 
	Our net sales consist of revenue from sales of products net of
	trade discounts and allowances. We recognize revenue when
	evidence of an arrangement exists, contractual obligations have
	been satisfied, title and risk of loss have been transferred to
	the customer and collection of the resulting receivable is
	reasonably assured. At the time revenue is recognized, we
	provide for the estimated cost of product warranties if allowed
	for under contractual arrangements and return products. Our
	warranty obligation is effected by product failure rates and
	service delivery costs incurred in correcting a product failure.
	Should such failure rates or costs differ from these estimates,
	accrued warranty costs would be adjusted.
	 
	We indemnify, without limit or term, our customers against all
	claims, suits, demands, damages, liabilities, expenses,
	judgments, settlements and penalties arising from actual or
	alleged infringement or misappropriation of any intellectual
	property relating to our products or other claims arising from
	our products. We cannot reasonably develop an estimate of the
	maximum potential amount of payments that might be made under
	our guarantees because of the uncertainty as to whether a claim
	might arise and how much it might total.
	 
	Contract revenues are principally generated under research and
	development contracts. Contract revenues are recognized
	utilizing the
	percentage-of-completion
	method measured by the relationship of costs incurred to total
	estimated contract costs. If the current contract estimate were
	to indicate a loss, utilizing the funded amount of the contract,
	a provision would be made for the total anticipated loss.
	Contract revenues are derived primarily from research contracts
	with agencies of the United States Government. Credit risk
	related to accounts receivable arising from such contracts is
	considered minimal. These contracts include cost-plus, fixed
	price and cost sharing arrangements and are generally short-term
	in nature.
	 
	All payments to us for work performed on contracts with agencies
	of the U.S. Government are subject to adjustment upon audit
	by the Defense Contract Audit Agency. Based on historical
	experience and review of current projects in process, we believe
	that the audits will not have a significant effect on our
	financial position, results of operations or cash flows. The
	Defense Contract Audit Agency has audited us through 2002.
	 
	In connection with the acquisition of Conductus we recognized
	$20 million of goodwill. Goodwill is tested for impairment
	annually in the fourth quarter after the annual planning
	process, or earlier if events occur which require an impairment
	analysis to be performed. We operate in a single business
	segment as a single reporting unit. The first step of the
	impairment test, used to identify potential impairment, compares
	the fair value based on market
	23
 
	capitalization of the entire organization with the book value of
	its net assets, including goodwill. (Our market capitalization
	is based the closing price of our common stock as traded on
	NASDAQ multiplied by our outstanding common shares.) If the fair
	value of our company exceeds the book value of our net assets,
	our goodwill is not considered impaired. If the book value of
	our net assets exceeds our fair value, the second step of the
	goodwill impairment test shall be performed to measure the
	amount of impairment loss. The second step of the goodwill
	impairment test, used to measure the amount of impairment loss,
	compares the implied fair value of the goodwill with the book
	value of that goodwill. If the carrying amount of the reporting
	unit goodwill exceeds the implied fair value of that goodwill,
	an impairment loss shall be recognized in an amount equal to
	that excess. At July 1, 2006, the Companys market
	capitalization had declined to $25.5 million, an amount
	less than the total book value of the Company. We concluded that
	our declining stock price constituted an event under
	FAS 142 and required us to test for goodwill impairment as
	of July 1, 2006. We then proceeded with step two of the
	impairment analysis  determining the fair values of
	all the tangible and intangible assets of the Company and then
	aggregating and subtracting these values from the fair value of
	the Company. Our analysis was not complete at the time we filed
	our quarterly report for the second quarter, but our preliminary
	analysis led us to reasonably estimate at that time that the
	Companys fair market value was less than its net assets
	excluding goodwill. Accordingly, we recorded a full write-down
	of the goodwill ($20.1 million) in the second quarter. We
	completed this exercise in the third quarter and confirmed that
	an impairment loss had occurred. Our final analysis confirmed
	that the Companys fair market value at July 1 was
	less than its net assets excluding goodwill.
	 
	We periodically evaluate the realizability of long-lived assets
	as events or circumstances indicate a possible inability to
	recover the carrying amount. Long-lived assets that will no
	longer be used in business are written off in the period
	identified since they will no longer generate any positive cash
	flows for the Company. Periodically, long-lived assets that will
	continue to be used by the Company need to be evaluated for
	recoverability. Such evaluation is based on various analyses,
	including cash flow and profitability projections. The analyses
	necessarily involve significant management judgment. In the
	event the projected undiscounted cash flows are less than net
	book value of the assets, the carrying value of the assets will
	be written down to their estimated fair value. Our future cash
	flows may vary from estimates.
	 
	Effective January 1, 2006, we adopted the provisions of
	Statement of Financial Accounting Standards (SFAS)
	No. 123(revised 2004), Share-Based Payment
	(SFAS No. 123(R)). Under this provision,
	the share-based compensation cost recognized beginning
	January 1, 2006 includes compensation cost for (i) all
	share-based payments granted prior to, but not vested as of
	January 1, 2006, based on the grant date fair value
	originally estimated in accordance with the provisions of
	SFAS No. 123, Accounting for Stock-Based
	Compensation, (SFAS No. 123) and
	(ii) all share-based payments granted subsequent to
	January 1, 2006, based on the grant date fair value
	estimated in accordance with the provisions of
	SFAS No. 123(R). Compensation cost under
	SFAS No. 123(R) is recognized ratably using the
	straight-line attribution method over the expected vesting
	period. Prior periods are not restated under this transition
	method.
	 
	Prior to 2006, as permitted under Statement of Financial
	Accounting Standards No. 123 (SFAS 123),
	Accounting for Stock-Based Compensation, we elected
	to follow Accounting Principles Board Opinion No. 25,
	Accounting for Stock Issued to Employees in
	accounting for stock options and other stock-based employee
	awards. Pro forma information regarding net loss and loss per
	share, as calculated under the provisions of SFAS 123, are
	disclosed in the notes to the financial statements. We accounted
	for equity securities issued to non-employees in accordance with
	the provision of SFAS 123 and Emerging Issues Task Force
	96-18.
	 
	Prior to 2006, we did not recognize compensation expense for
	issuance of stock options to employees. If we had elected to
	recognize compensation expense for employee awards prior to 2006
	based upon the fair value at the
	24
 
	grant date consistent with the methodology prescribed by
	SFAS 123, our net loss and net loss per share would have
	been increased to the pro forma amounts indicated below:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	For the Years Ended December 31,
 | 
	 
 | 
| 
 
	Net loss:
 
 | 
	 
 | 
	2004
 | 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	(In thousands, except per share data)
 | 
	 
 | 
| 
	 
 | 
| 
 
	As reported
 
 | 
	 
 | 
	$
 | 
	(31,217
 | 
	)
 | 
	 
 | 
	$
 | 
	(14,213
 | 
	)
 | 
| 
 
	Stock-based employee compensation
	included in net loss
 
 | 
	 
 | 
	 
 | 
	48
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Stock-based compensation expense
	determined under fair value method
 
 | 
	 
 | 
	 
 | 
	(5,543
 | 
	)
 | 
	 
 | 
	 
 | 
	(6,459
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Pro forma
 
 | 
	 
 | 
	 
 | 
	(36,712
 | 
	)
 | 
	 
 | 
	 
 | 
	(20,672
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Basic and Diluted Loss per
	Share:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	As reported
 
 | 
	 
 | 
	$
 | 
	(3.71
 | 
	)
 | 
	 
 | 
	$
 | 
	(1.24
 | 
	)
 | 
| 
 
	Stock-based compensation expense
	determined under fair value method
 
 | 
	 
 | 
	 
 | 
	(0.66
 | 
	)
 | 
	 
 | 
	 
 | 
	(0.57
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Pro forma
 
 | 
	 
 | 
	$
 | 
	(4.37
 | 
	)
 | 
	 
 | 
	$
 | 
	(1.81
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
	On December 1, 2005, the Compensation Committee of the
	Companys Board of Directors approved the accelerated
	vesting of all time-vested outstanding
	out-of-the-money
	stock options held by current employees or consultants. For this
	purpose, the Compensation Committee defined
	out-of-the-money
	options as options having an exercise price equal to or
	greater than $5.80 per share (the market price on the date
	of the committees decision to accelerate the vesting). If
	the Company had elected to recognize compensation expense for
	employee awards, the pro forma cost impact of these accelerated
	options in 2005 would have been $3.7m.
	 
	Our valuation allowance against the deferred tax assets is based
	on our assessments of historical losses and projected operating
	results in future periods. If and when we generate future
	taxable income in the U.S. against which these tax assets
	may be applied, some portion or all of the valuation allowance
	would be reversed and an increase in net income would
	consequently be reported in future years.
	 
	We have a contract to deliver several custom products to a
	government contractor. We are unable to manufacture the products
	for technical reasons. We have discussed the problem with the
	contractor and its government customer. They are considering the
	problem, and we expect further discussions. We do not believe
	that a loss is reasonably estimable at this time and therefore
	have not recorded any liability relating to this matter. We will
	periodically reassess our potential liability as additional
	information becomes available. If we later determine that a loss
	is probable and the amount reasonably estimable, we would record
	a liability for the potential loss.
	 
	Backlog
	 
	Our commercial backlog consists of accepted product purchase
	orders with scheduled delivery dates during the next twelve
	months. We had commercial backlog of $75,000 at
	December 31, 2006, as compared to $250,000 at
	December 31, 2005.
	 
	Results
	of Operations
	 
	2006
	Compared to 2005
	 
	Net revenues decreased by $3.1 million, or 13%, from
	$24.2 million in 2005 to $21.1 million in 2006. Net
	revenues consist primarily of commercial product revenues and
	government contract revenues. We also generate some additional
	revenues from sublicensing our technology.
	 
	Net commercial product revenues decreased by $3.4 million,
	or 16%, to $17.7 million in 2006 from $21.1 million in
	2005. The decrease is primarily the result of lower sales and
	lower average sale prices of our products. Our three largest
	customers accounted for 96% of our net commercial revenues in
	2006, as compared to 95% in 2005. These customers generally
	purchase products through non-binding commitments with minimal
	lead-
	25
 
	times. Consequently, our commercial product revenues can
	fluctuate dramatically from quarter to quarter based on changes
	in our customers capital spending patterns.
	 
	Government contract revenues increased to $3.4 million in
	2006 from $3.1 million in 2005, an increase of
	$.3 million, or 8%. This increase is primarily attributable
	to the addition of new or amended contracts in 2006.
	 
	Cost of commercial product revenues includes all direct costs,
	manufacturing overhead, provision for excess and obsolete
	inventories. The cost of commercial product revenues totaled
	$15.9 million for 2006 as compared to $19.0 million
	for 2005, a decrease of $3.1 million, or 16%. The lower
	costs resulted from no restructuring expenses in 2006 and a
	lower provision for obsolete inventory. Restructuring and
	impairment expenses from severance and fixed assets write
	off included in cost of goods sold were zero in 2006 as
	compared to $109,000 in 2005. Our provision for obsolete
	inventories totaled $360,000 in 2006 as compared to
	$1.0 million in 2005.
	 
	Our cost of sales includes both variable and fixed cost
	components. The variable component consists primarily of
	materials, assembly and test labor, overhead, which includes
	equipment and facility depreciation, transportation costs and
	warranty costs. The fixed component includes test equipment and
	facility depreciation, purchasing and procurement expenses and
	quality assurance costs. Given the fixed nature of such costs,
	the absorption of our production overhead costs into inventory
	decreases and the amount of production overhead variances
	expensed to cost of sales increases as production volumes
	decline since we have fewer units to absorb our overhead costs
	against. Conversely, the absorption of our production overhead
	costs into inventory increases and the amount of production
	overhead variances expensed to cost of sales decreases as
	production volumes increase since we have more units to absorb
	our overhead costs against. As a result, our gross profit
	margins generally decrease as revenue and production volumes
	decline due to lower sales volume and higher amounts of
	production overhead variances expensed to cost of sales; and our
	gross profit margins generally increase as our revenue and
	production volumes increase due to higher sales volume and lower
	amounts of production overhead variances expensed to cost of
	sales. Our inventory is valued at the lower of its actual cost
	or the current estimated market value of the inventory. We
	review inventory quantities on hand and on order and record, on
	a quarterly basis, a provision for excess and obsolete inventory
	and/or
	vendor cancellation charges related to purchase commitments. If
	the results of the review determine that a write-down is
	necessary, the Company recognizes a loss in the period in which
	the loss is identified, whether or not the inventory is retained
	or disposed.
	 
	The following is an analysis of our commercial product gross
	profit margins for 2005 and 2006:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	For the Years Ended December 31,
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	(Dollars in thousands)
 | 
	 
 | 
| 
	 
 | 
| 
 
	Net commercial product sales
 
 | 
	 
 | 
	$
 | 
	21,080
 | 
	 
 | 
	 
 | 
	 
 | 
	100.0
 | 
	%
 | 
	 
 | 
	$
 | 
	17,697
 | 
	 
 | 
	 
 | 
	 
 | 
	100.0
 | 
	%
 | 
| 
 
	Cost of commercial product sales
 
 | 
	 
 | 
	 
 | 
	18,989
 | 
	 
 | 
	 
 | 
	 
 | 
	90.1
 | 
	%
 | 
	 
 | 
	 
 | 
	15,922
 | 
	 
 | 
	 
 | 
	 
 | 
	90
 | 
	%
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Gross profit
 
 | 
	 
 | 
	$
 | 
	2,091
 | 
	 
 | 
	 
 | 
	 
 | 
	9.9
 | 
	%
 | 
	 
 | 
	$
 | 
	1,775
 | 
	 
 | 
	 
 | 
	 
 | 
	10
 | 
	%
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
	We had a positive gross margin of $1.8 million in 2006 from
	the sale of our commercial products as compared to a positive
	gross margin of $2.1 million in 2005. The gross margin
	percentage improved slightly on lower sales volumes primarily
	due to lower restructuring expenses, a lower provision for
	obsolete inventory and the positive results of our cost
	reduction efforts. Gross margin was also favorably impacted
	$.7 million by the sale of previously written-off
	inventory. We regularly review inventory quantities on hand and
	provide an allowance for excess and obsolete inventory based on
	numerous factors including sales backlog, historical inventory
	usage, forecasted product demand and production requirements for
	the next twelve months.
	 
	Contract research and development expenses totaled
	$2.4 million in 2006 as compared to $2.8 million in
	2005, a decrease of $399,000 or 14%. The decrease was primarily
	the result of 2005 expenses totaling $759,000 on a contract for
	which no revenue was recognized. See
	Contractual
	Contingency
	under the Contractual Guarantees and
	Indemnities Note to the Financial Statements for a description
	of the non-revenue generating contract.
	 
	Other research and development expenses relate to development of
	new wireless commercial products. We also incur design expenses
	associated with reducing the cost and improving the
	manufacturability of our existing products. These expenses
	totaled $3.5 million in 2006 as compared to
	$4.2 million in 2005, a decrease of $726,000,
	26
 
	or 17%. The decrease is due to lower expenses associated with
	commercial products development and the result of our cost
	reduction efforts.
	 
	Selling, general and administrative expenses totaled
	$9.1 million in 2006 as compared to $11.4 million in
	2005, a decrease of $2.3 million, or 20%. The lower
	expenses resulted primarily from lower auditor fees, lower
	insurance premiums, lower legal expenses for other matters, no
	restructuring activities in 2006 and the payment in 2005 of
	retirement benefits for our previous Chief Executive Officer.
	 
	We implemented several restructuring programs since 2004. These
	activities were completed in 2005. In connection with the
	acquisition of Conductus in December 2002 we recognized
	$20.1 million of goodwill. At July 1, 2006, we
	concluded that our declining stock price constituted an event
	under FAS 142 and required us to test for goodwill
	impairment. Our analysis led us to reasonably estimate at that
	time that the Companys fair market value was less than its
	net assets excluding goodwill. Accordingly, we recorded a full
	write-down of the goodwill ($20.1 million) in the second
	quarter. We also recorded an impairment charge of $38,000
	related to a note receivable from a Board member.
	 
	The following table summarizes our restructuring and impairment
	charges for 2005 and 2006:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	For the Year Ended December 31,
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Restructuring
 
 | 
	 
 | 
	 
 | 
	Impairment
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	Restructuring
 
 | 
	 
 | 
	 
 | 
	Impairment
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Charges for
 
 | 
	 
 | 
	 
 | 
	Charges for
 
 | 
	 
 | 
	 
 | 
	Total for
 
 | 
	 
 | 
	 
 | 
	Charges for
 
 | 
	 
 | 
	 
 | 
	Charges for
 
 | 
	 
 | 
	 
 | 
	Total for
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
 
	2005
 
 | 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
| 
	 
 | 
| 
 
	Severance costs
 
 | 
	 
 | 
	$
 | 
	178,000
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
	 
 | 
	$
 | 
	178,000
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
| 
 
	Fixed assets write offs
 
 | 
	 
 | 
	 
 | 
	137,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	137,000
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Facility consolidation costs
 
 | 
	 
 | 
	 
 | 
	6,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	6,000
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Employee relocation cost
 
 | 
	 
 | 
	 
 | 
	16,000
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	16,000
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Goodwill Write-off
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	20,107,000
 | 
	 
 | 
	 
 | 
	 
 | 
	20,107,000
 | 
	 
 | 
| 
 
	Impairment charge for notes
	receivable from shareholder and board member
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	969,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	38,000
 | 
	 
 | 
	 
 | 
	 
 | 
	38,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Total
 
 | 
	 
 | 
	$
 | 
	337,000
 | 
	 
 | 
	 
 | 
	$
 | 
	969,000
 | 
	 
 | 
	 
 | 
	$
 | 
	1,306,000
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	20,145,000
 | 
	 
 | 
	 
 | 
	 
 | 
	20,145,000
 | 
	 
 | 
| 
 
	Fixed Asset write off and
	severance costs included in cost of goods sold
 
 | 
	 
 | 
	 
 | 
	(109,000
 | 
	)
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	(109,000
 | 
	)
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Expense included in operating
	expenses
 
 | 
	 
 | 
	$
 | 
	228,000
 | 
	 
 | 
	 
 | 
	$
 | 
	969,000
 | 
	 
 | 
	 
 | 
	$
 | 
	1,197,000
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
	 
 | 
	$
 | 
	20,145,000
 | 
	 
 | 
	 
 | 
	$
 | 
	20,145,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
	Interest income increased to $391,000 in 2006, as compared to
	$342,000 in 2005, primarily because of increased interest rates.
	 
	Interest expense in 2006 amounted to $45,000, as compared to
	$116,000 in 2005, as a result of lower borrowing levels.
	 
	Our loss totaled $29.6 million in 2006 as compared to $14.2
	in 2005.
	 
	The net loss available to common shareholders totaled
	$2.37 per common share in 2006, as compared to
	$1.24 per common share in 2005.
	 
	2005
	Compared to 2004
	 
	Net revenues increased by $1.2 million, or 5%, from
	$23.0 million in 2004 to $24.2 million in 2005. Net
	revenues consist primarily of commercial product revenues and
	government contract revenues. We also generate some additional
	revenues from sublicensing our technology.
	 
	Net commercial product revenues increased by $4.3 million,
	or 26%, to $21.1 million in 2005 from $16.8 million in
	2004. The increase is primarily the result of higher sales of
	our SuperPlex and AmpLink products, partially offset by lower
	sales and average sale prices of our SuperLink product. Our
	three largest customers
	27
 
	accounted for 95% of our net commercial revenues in 2005, as
	compared to 92% in 2004. These customers generally purchase
	products through non-binding commitments with minimal
	lead-times. Consequently, our commercial product revenues can
	fluctuate dramatically from quarter to quarter based on changes
	in our customers capital spending patterns.
	 
	Government contract revenues decreased to $3.1 million in
	2005 from $6.2 million in 2004, a decrease of
	$3.1 million, or 50%. This decrease is primarily
	attributable to the completion of contracts in 2004 and 2005
	that have not been replaced.
	 
	The cost of commercial product revenues totaled
	$19.0 million for 2005 as compared to $23.4 million
	for 2004, a decrease of $4.4 million, or 19%. The lower
	costs resulted from lower restructuring expenses and a lower
	provision for obsolete inventory. Restructuring and impairment
	expenses from severance and fixed assets write off
	included in cost of goods sold totaled $109,000 in 2005 as
	compared to $1.1 million in 2004. The provision for
	obsolete inventories totaled $1.0 million in 2005 as
	compared to $4.8 million in 2004.
	 
	The following is an analysis of our commercial product gross
	profit margins for 2004 and 2005:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	For the Years Ended December 31,
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	2004
 | 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	(Dollars in thousands)
 | 
	 
 | 
| 
	 
 | 
| 
 
	Net commercial product sales
 
 | 
	 
 | 
	$
 | 
	16,787
 | 
	 
 | 
	 
 | 
	 
 | 
	100.0
 | 
	%
 | 
	 
 | 
	$
 | 
	21,080
 | 
	 
 | 
	 
 | 
	 
 | 
	100.0
 | 
	%
 | 
| 
 
	Cost of commercial product sales
 
 | 
	 
 | 
	 
 | 
	23,421
 | 
	 
 | 
	 
 | 
	 
 | 
	139.5
 | 
	%
 | 
	 
 | 
	 
 | 
	18,989
 | 
	 
 | 
	 
 | 
	 
 | 
	90.1
 | 
	%
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Gross profit
 
 | 
	 
 | 
	$
 | 
	(6,634
 | 
	)
 | 
	 
 | 
	 
 | 
	(39.5
 | 
	)%
 | 
	 
 | 
	$
 | 
	2,091
 | 
	 
 | 
	 
 | 
	 
 | 
	9.9
 | 
	%
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
	We had a positive gross margin of $2.1 million in 2005 from
	the sale of our commercial products as compared to a negative
	gross margin of $6.6 million in 2004. The gross margin
	improvement was primarily due to higher sales volumes, lower
	restructuring expenses, a lower provision for obsolete inventory
	and the positive results of our cost reduction efforts. Gross
	margin was also favorably impacted by $1.1 million as a
	result of the sale of previously written-off inventory. We
	regularly review inventory quantities on hand and provide an
	allowance for excess and obsolete inventory based on numerous
	factors including sales backlog, historical inventory usage,
	forecasted product demand and production requirements for the
	next twelve months.
	 
	Contract research and development expenses totaled
	$2.8 million in 2005 as compared to $4.5 million in
	2004, a decrease of $1.7 million, or 37%. The decrease was
	the result of lower expenses associated with performing a fewer
	number of government contracts, offset by expenses totaling
	$759,000 on a contract for which no revenue was recognized. See
	Contractual Contingency
	under the Contractual
	Guarantees and Indemnities Note to the Financial Statements for
	a description of the non-revenue generating contract.
	 
	Other research and development expenses relate to development of
	new wireless commercial products. We also incur design expenses
	associated with reducing the cost and improving the
	manufacturability of our existing products. These expenses
	totaled $4.2 million in 2005 as compared to
	$5.0 million in 2004, a decrease of $800,000, or 16%. The
	decrease is due to lower expenses associated with commercial
	products development and the result of our cost reduction
	efforts.
	 
	Selling, general and administrative expenses totaled
	$11.4 million in 2005 as compared to $16.1 million in
	2004, a decrease of $4.6 million, or 29%. The lower
	expenses resulted primarily from lower insurance premiums, the
	cessation of ISCO related litigation expenses, lower legal
	expenses for other matters, the closure of our Sunnyvale
	facility and overall lower expense levels resulting from our
	restructuring activities in 2004 and 2005. These reductions were
	partially offset by retirement benefits for our previous Chief
	Executive Officer.
	28
 
	 
	We implemented several restructuring programs and wrote off
	certain assets in 2004. These activities continued in 2005, when
	we implemented another restructuring program, further reduced
	our workforce and vacated a portion of our leased facility in
	Santa Barbara. We also recorded an impairment charge of
	$969,000 related to a shareholder note receivable in 2005. See
	Item 3  Legal Proceedings 
	Settlement of Shalvoy Litigation.
	The following table
	summarizes our restructuring and impairment charges for 2004 and
	2005:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	For the Year Ended December 31,
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Restructuring
 
 | 
	 
 | 
	 
 | 
	Impairment
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	Restructuring
 
 | 
	 
 | 
	 
 | 
	Impairment
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Charges for
 
 | 
	 
 | 
	 
 | 
	Charges for
 
 | 
	 
 | 
	 
 | 
	Total for
 
 | 
	 
 | 
	 
 | 
	Charges for
 
 | 
	 
 | 
	 
 | 
	Charges for
 
 | 
	 
 | 
	 
 | 
	Total for
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	2004
 | 
	 
 | 
	 
 | 
	2004
 | 
	 
 | 
	 
 | 
	2004
 | 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
| 
	 
 | 
| 
 
	Severance costs
 
 | 
	 
 | 
	$
 | 
	826,000
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
	 
 | 
	$
 | 
	826,000
 | 
	 
 | 
	 
 | 
	$
 | 
	178,000
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
	 
 | 
	$
 | 
	178,000
 | 
	 
 | 
| 
 
	Fixed assets write offs
 
 | 
	 
 | 
	 
 | 
	803,000
 | 
	 
 | 
	 
 | 
	 
 | 
	403,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,206,000
 | 
	 
 | 
	 
 | 
	 
 | 
	137,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	137,000
 | 
	 
 | 
| 
 
	Patents, licenses and purchased
	technology write-off
 
 | 
	 
 | 
	 
 | 
	1,051,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,171,000
 | 
	 
 | 
	 
 | 
	 
 | 
	2,222,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Lease abandonment costs
 
 | 
	 
 | 
	 
 | 
	279,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	279,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Facility consolidation costs
 
 | 
	 
 | 
	 
 | 
	268,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	268,000
 | 
	 
 | 
	 
 | 
	 
 | 
	6,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	6,000
 | 
	 
 | 
| 
 
	Employee relocation cost
 
 | 
	 
 | 
	 
 | 
	382,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	382,000
 | 
	 
 | 
	 
 | 
	 
 | 
	16,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	16,000
 | 
	 
 | 
| 
 
	Impairment charge for notes
	receivable from shareholder and board member
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	969,000
 | 
	 
 | 
	 
 | 
	 
 | 
	969,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Total
 
 | 
	 
 | 
	$
 | 
	3,609,000
 | 
	 
 | 
	 
 | 
	$
 | 
	1,574,000
 | 
	 
 | 
	 
 | 
	$
 | 
	5,183,000
 | 
	 
 | 
	 
 | 
	 
 | 
	337,000
 | 
	 
 | 
	 
 | 
	 
 | 
	969,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,306,000
 | 
	 
 | 
| 
 
	Fixed Asset write off and
	severance costs included in cost of goods sold
 
 | 
	 
 | 
	 
 | 
	669,000
 | 
	 
 | 
	 
 | 
	 
 | 
	386,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,055,000
 | 
	 
 | 
	 
 | 
	 
 | 
	109,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	109,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Expense included in operating
	expenses
 
 | 
	 
 | 
	$
 | 
	2,940,000
 | 
	 
 | 
	 
 | 
	$
 | 
	1,188,000
 | 
	 
 | 
	 
 | 
	$
 | 
	4,128,000
 | 
	 
 | 
	 
 | 
	$
 | 
	228,000
 | 
	 
 | 
	 
 | 
	$
 | 
	969,000
 | 
	 
 | 
	 
 | 
	$
 | 
	1,197,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
	Interest income increased to $342,000 in 2005, as compared to
	$125,000 in 2004, primarily because we had more cash available
	for investment and increased interest rates.
	 
	Interest expense in 2005 amounted to $116,000, as compared to
	$1.2 million in 2004, because of higher borrowing levels
	and a non-cash charge of $802,000 for warrants issued to the
	lenders in connection with a bridge loan in April 2004.
	 
	Our loss totaled $14.2 million in 2005 as compared to $31.2
	in 2004.
	 
	The net loss available to common shareholders totaled
	$1.24 per common share in 2005, as compared to
	$3.71 per common share in 2004.
	 
	Liquidity
	and Capital Resources
	 
	Cash
	Flow Analysis
	 
	As of December 31, 2006, we had working capital of
	$9.9 million, including $5.5 million in cash and cash
	equivalents, as compared to working capital of
	$17.2 million at December 31, 2005, which included
	$13.0 million in cash and cash equivalents. We currently
	invest our excess cash in short-term, investment-grade,
	money-market instruments with maturities of three months or
	less. We believe that all of our cash investments would be
	readily available to us should the need arise.
	 
	Cash and cash equivalents decreased by $7.5 million from
	$13.0 million at December 31, 2005 to
	$5.5 million at December 31, 2006. Cash was used in
	operations, for the purchase of property and equipment and for
	the payment
	29
 
	of short and long-term borrowings. Cash and cash equivalents
	increased by $216,000 from $12.8 million at
	December 31, 2004 to $13.0 million at
	December 31, 2005. Cash was used in operations, for the
	purchase of property and equipment, for the payment of short and
	long-term borrowings and for the payment of common stock
	offering expenses. These uses were offset by gross cash proceeds
	of $12.5 million received from the sale of common stock in
	a public offering during the third quarter of 2005.
	 
	Cash used in operations totaled $7.3 million in 2006. We
	used $6.2 million to fund the cash portion of our net loss.
	We also used cash to fund a $1.8 million increase in
	accounts payable payments and inventory. These uses were offset
	by cash generated from lower accounts receivable and prepaid
	balances totaling $746,000. Cash used in operations totaled
	$9.4 million in 2005. We used $9.0 million to fund the
	cash portion of our net loss. We also used cash to fund a
	$3.5 million increase in accounts receivable, patents and
	other assets and accounts payable payments. These uses were
	offset by cash generated from lower inventory and prepaid
	balances totaling $3.1 million.
	 
	Net cash used in investing activities totaled $229,000 in 2006,
	$45,000 in 2005 and $1.8 million in 2004. In 2005, sales of
	fixed assets generated $216,000 and essentially offset purchases
	of property and equipment totaling $261,000. In 2004, our
	investing activities consisted primarily of purchases of
	manufacturing equipment and facilities improvements to increase
	our production capacity.
	 
	Net cash used in financing activities totaled $19,000 in 2006.
	Cash was used to pay long term debt. Net cash provided by
	financing activities totaled $9.7 million in 2005. In 2005
	gross cash received from the sale of common stock totaled
	$12.5 million and borrowings against our line of credit
	totaled $662,000, offset by cash used to pay down our line of
	credit and long term debt of $1.6 million. Cash was also
	used to pay $1.9 million of offering expenses related to
	the sale of common stock in November 2004 and August 2005.
	 
	Financing
	Activities
	 
	We have historically financed our operations through a
	combination of cash on hand, equipment lease financings,
	available borrowings under bank lines of credit and both private
	and public equity offerings. We have effective registration
	statements on file with the SEC covering the public resale by
	investors of all the common stock issued in our private
	placements, as well as any common stock acquired upon exercise
	of their warrants.
	 
	We have an existing line of credit from a bank. It is a material
	source of funds for our business. The line of credit expires
	June 15, 2007. The loan agreement is structured as a sale
	of our accounts receivable and provides for the sale of up to
	$5.0 million of eligible accounts receivable, with advances
	to us totaling 80% of the receivables sold. Advances bear
	interest at the prime rate (8.25% at December 31,
	2006) plus 2.50% subject to a minimum monthly charge.
	There was no amount outstanding under this borrowing facility at
	December 31, 2006. Advances are collateralized by a lien on
	all of our assets. Under the terms of the agreement, we continue
	to service the sold receivables and are subject to recourse
	provisions.
	 
	We completed one financing transaction in 2005 and none in 2006.
	In August 2005, we raised net proceeds of $11.4 million in
	a registered direct public sale of 1,712,329 shares of
	common stock at $7.30 per share and
	5-year
	warrants to purchase an additional 342,466 shares of common
	stock exercisable at $11.10 per share. The warrants became
	exercisable on February 16, 2006. The warrant agreement
	also contains the following significant terms: (i) in the
	event of changes in the outstanding Common Stock of the Company,
	the number of shares and their price under the warrant shall be
	correspondingly adjusted and (ii) if, at any time while the
	warrants are outstanding, the Company issues additional shares
	at an effective price less than the warrant price the number of
	shares and their price will be adjusted.
	 
	Contractual
	Obligations and Commercial Commitments
	 
	We incur various contractual obligations and commercial
	commitments in our normal course of business. They consist of
	the following:
	 
| 
 | 
 | 
 | 
| 
	 
 | 
	 
 | 
	Capital Lease Obligations
 | 
	 
	Our capital lease obligations are for property and equipment and
	total $15,000.
	 
| 
 | 
 | 
 | 
| 
	 
 | 
	 
 | 
	Operating Lease Obligations
 | 
	30
 
	 
	Our operating lease obligations consist of a facility lease in
	Santa Barbara, California and several copier leases.
	 
	 
	We have entered into various licensing agreements requiring
	royalty payments ranging from 0.13% to 2.5% of specified product
	sales. Some of these agreements contain provisions for the
	payment of guaranteed or minimum royalty amounts. Typically, the
	licensor can terminate our license if we fail to pay minimum
	annual royalties.
	 
	 
	In the normal course of business, we incur purchase obligations
	with vendors and suppliers for the purchase of inventory, as
	well as other goods and services. These obligations are
	generally evidenced by purchase orders that contain the terms
	and conditions associated with the purchase arrangements. We are
	committed to accept delivery of such material pursuant to the
	purchase orders subject to various contract provisions which
	allow us to delay receipt of such orders or cancel orders beyond
	certain agreed upon lead times. Cancellations may result in
	cancellation costs payable by us.
	 
| 
 | 
 | 
 | 
| 
	 
 | 
	 
 | 
	Quantitative Summary of Contractual Obligations and
	Commercial Commitments
 | 
	 
	At December 31, 2006, we had the following contractual
	obligations and commercial commitments:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Payments Due by Period
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Contractual Obligations
 
 | 
	 
 | 
	Total
 | 
	 
 | 
	 
 | 
	Less Than 1 Year
 | 
	 
 | 
	 
 | 
	2-3 Years
 | 
	 
 | 
	 
 | 
	4-5 Years
 | 
	 
 | 
	 
 | 
	After 5 Years
 | 
	 
 | 
| 
	 
 | 
| 
 
	Capital lease obligations
 
 | 
	 
 | 
	$
 | 
	15,000
 | 
	 
 | 
	 
 | 
	$
 | 
	15,000
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
| 
 
	Operating leases
 
 | 
	 
 | 
	 
 | 
	6,665,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,303,000
 | 
	 
 | 
	 
 | 
	 
 | 
	2,653,000
 | 
	 
 | 
	 
 | 
	 
 | 
	2,709,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Minimum license commitment
 
 | 
	 
 | 
	 
 | 
	1,950,000
 | 
	 
 | 
	 
 | 
	 
 | 
	150,000
 | 
	 
 | 
	 
 | 
	 
 | 
	300,000
 | 
	 
 | 
	 
 | 
	 
 | 
	300,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,200,000
 | 
	 
 | 
| 
 
	Fixed asset and inventory purchase
	commitments
 
 | 
	 
 | 
	 
 | 
	1,414,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,414,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Total contractual cash obligations
 
 | 
	 
 | 
	$
 | 
	10,044,000
 | 
	 
 | 
	 
 | 
	$
 | 
	2,882,000
 | 
	 
 | 
	 
 | 
	$
 | 
	2,953,000
 | 
	 
 | 
	 
 | 
	$
 | 
	3,009,000
 | 
	 
 | 
	 
 | 
	$
 | 
	1,200,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
	Capital
	Expenditures
	 
	We plan to invest approximately $900,000 in fixed assets during
	2007.
	 
	Future
	Liquidity
	 
	Our principal sources of liquidity consist of existing cash
	balances and funds expected to be generated from future
	operations. Based on our current forecasts, our cash resources
	may not be sufficient to fund our planned operations for the
	remainder of 2007. We believe one of the key factors to our
	liquidity in 2007 will be our ability to successfully execute on
	our plans to increase sales levels. Our cash requirements will
	also depend on numerous other variable factors, including the
	rate of growth of sales, the timing and levels of products
	purchased, payment terms and credit limits from manufacturers,
	and the timing and level of accounts receivable collections.
	Because of the uncertainty of these many factors, the Company
	intends to raise funds in the next six months to meet its
	working capital needs.
	 
	We cannot assure you that additional financing (public or
	private) will be available on acceptable terms or at all. If we
	issue additional equity securities to raise funds, the ownership
	percentage of our existing stockholders would be reduced. New
	investors may demand rights, preferences or privileges senior to
	those of existing holders of common stock. If we cannot raise
	any needed funds, we might be forced to make further substantial
	reductions in our operating expenses, which could adversely
	affect our ability to implement our current business plan and
	ultimately our viability as a company.
	 
	Our financial statements have been prepared assuming that the
	Company will continue as a going concern.
	 
	In 2006, we incurred a net loss of $29.6 million and had
	negative cash flows from operations of $7.3 million. Our
	independent registered public accounting firm has included in
	their audit report for fiscal 2006 an explanatory paragraph
	expressing doubt about our ability to continue as a going
	concern. They included a similar explanatory
	31
 
	paragraph in their audit report for
	2002-2005.
	The factors described above raise substantial doubt about our
	ability to continue as a going concern. Our financial statements
	do not include any adjustments that might result from this
	uncertainty. In response to these issues, we reduced direct and
	indirect labor and continued to cut fixed costs. We also
	consolidated our Sunnyvale operations into our
	Santa Barbara facility and accelerated the reduction of our
	production costs. We have also taken several steps to increase
	our commercial sales. We have introduced new products and are
	aggressively taking steps to add new customers.
	 
	Net
	Operating Loss Carryforward
	 
	As of December 31, 2006, we had net operating loss
	carryforwards for federal and state income tax purposes of
	approximately $275.1 million and $143.4 million,
	respectively, which expire in the years 2007 through 2026. Of
	these amounts $91.2 million and $23.5 million,
	respectively resulted from the acquisition of Conductus.
	Included in the net operating loss carryforwards are deductions
	related to stock options of approximately $24.1 million and
	$13.1 million for federal and California income tax
	purposes, respectively. To the extent net operating loss
	carryforwards are recognized for accounting purposes the
	resulting benefits related to the stock options will be credited
	to stockholders equity. In addition, we have research and
	development and other tax credits for federal and state income
	tax purposes of approximately $2.4 million and $983,000,
	respectively, which expire in the years 2007 through 2026. Of
	these amounts $661,000 and $736,000, respectively resulted from
	the acquisition of Conductus.
	 
	Due to the uncertainty surrounding their realization, we have
	recorded a full valuation allowance against our net deferred tax
	assets. Accordingly, no deferred tax asset has been recorded in
	the accompanying balance sheet.
	 
	Section 382 of the Internal Revenue Code imposes an annual
	limitation on the utilization of net operating loss
	carryforwards based on a statutory rate of return (usually the
	applicable federal funds rate, as defined in the
	Internal Revenue Code) and the value of the corporation at the
	time of a change of ownership as defined by
	Section 382. We completed an analysis of our equity
	transactions and determined that we had a change in ownership in
	August 1999 and December 2002. Therefore, the ability to utilize
	net operating loss carryforwards incurred prior to the change of
	ownership totaling $98.0 million will be subject in future
	periods to an annual limitation of $1.3 million. In
	addition, we acquired the right to Conductus net operating
	losses, which are also subject to the limitations imposed by
	Section 382. Conductus underwent three ownership changes,
	which occurred in February 1999, February 2001 and December
	2002. Therefore, the ability to utilize Conductus net
	operating loss carryforwards of $91.2 million incurred
	prior to the ownership changes will be subject in future periods
	to annual limitation of $700,000. Net operating losses incurred
	by us subsequent to the ownership changes totaled
	$86.4 million and are not subject to this limitation.
	 
	Future
	Accounting Requirements
	 
	In February 2007, the FASB issued SFAS No. 159,
	The Fair Value Option for Financial Assets and Financial
	Liabilities (SFAS 159). Under the provisions of
	SFAS 159, Companies may choose to account for eligible
	financial instruments, warranties and insurance contracts at
	fair value on a
	contract-by-contract
	basis. Changes in fair value will be recognized in earnings each
	reporting period. SFAS 159 is effective for financial
	statements issued for fiscal years beginning after
	November 15, 2007, and interim periods within those fiscal
	years. The Company is currently evaluating the requirements of
	SFAS 159 and have not yet determined the impact on the
	financial statements.
	 
	In September 2006, the FASB issued SFAS No. 157,
	Fair Value Measurements, which defines fair value,
	establishes a framework for using fair value to measure assets
	and liabilities, and expands disclosures about fair value
	measurements. The Statement applies whenever other statements
	require or permit assets or liabilities to be measured at fair
	value. SFAS No. 157 is effective for fiscal years
	beginning after November 15, 2007. We are currently
	evaluating the impact this Statement will have on our
	consolidated financial statements.
	 
	In September 2006, the SEC issued Staff Accounting Bulletin
	(SAB) No. 108, Considering the Effects of
	Prior Year Misstatements when Quantifying Misstatements in
	Current Year Financial Statements, which provides
	interpretive guidance regarding the consideration given to prior
	year misstatements when determining materiality in current year
	financial statements. SAB No. 108 is effective for
	fiscal years ending after November 15, 2006 and had no
	impact on our consolidated financial statements.
	32
 
	 
	In June 2006, the Financial Accounting Standards Board (FASB)
	issued FASB Interpretation Number 48 (FIN 48),
	Accounting for Uncertainty in Income Taxes  an
	interpretation of FASB Statement No. 109. The
	interpretation contains a two step approach to recognizing and
	measuring uncertain tax positions accounted for in accordance
	with SFAS No. 109. The first step is to evaluate the
	tax position for recognition by determining if the weight of
	available evidence indicates it is more likely than not that the
	position will be sustained on audit, including resolution of
	related appeals or litigation processes, if any. The second step
	is to measure the tax benefit as the largest amount which is
	more than 50% likely of being realized upon ultimate settlement.
	The provisions are effective for the company beginning in the
	first quarter of 2007. We are evaluating the impact this
	statement will have on our financial statements.
	 
	In March 2006, the Emerging Issues Task Force (EITF)
	issued EITF Issue
	06-03,
	How Taxes Collected from Customers and Remitted to
	Governmental Authorities Should Be Presented in the Income
	Statement (That Is, Gross versus Net Presentation). A
	consensus was reached that entities may adopt a policy of
	presenting sales taxes in the income statement on either a gross
	or net basis. If taxes are significant, an entity should
	disclose its policy of presenting taxes and the amounts of
	taxes. The guidance is effective for periods beginning after
	December 15, 2006. We present revenues net of sales taxes.
	This issue has not impacted our method for presenting these
	sales taxes in our consolidated financial statements.
	 
	Market
	Risk
	 
	We are exposed to various market risks, including changes in
	interest rates. Market risk is the potential loss arising from
	adverse changes in market rates and prices. We do not enter into
	derivatives or other financial instruments for trading or
	speculation purposes.
	 
	At December 31, 2006, we had approximately
	$5.2 million invested in a money market account yielding
	approximately 5.125%. Assuming a 1% decrease in the yield on
	this money market account and no liquidation of principal for
	the year, our total interest income would decrease by
	approximately $52,000 per annum. Also, at December 31,
	2006, we had no amounts outstanding under a $5.0 million
	bank borrowing arrangement bearing interest at the prime rate
	(8.25% at December 31, 2006) plus 2.50%. Assuming a 1%
	increase in the prime rate interest and that the entire line was
	used for the entire year, interest expense would increase
	approximately $40,000 per annum.
	 
	Inflation
	 
	We do not foresee any material impact on our operations from
	inflation.
	 
| 
 | 
 | 
| 
	ITEM 7A.
	  
 | 
	QUANTITATIVE
	AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 | 
	 
	See
	Managements Discussion and Analysis of
	Financial Condition and Results of Operations  Market
	Risk.
	 
| 
 | 
 | 
| 
	ITEM 8.
	  
 | 
	FINANCIAL
	STATEMENTS AND SUPPLEMENTARY DATA
 | 
	 
	All information required by this item is listed in the Index to
	Financial Statements in Part IV, Item 15(a)1.
	 
| 
 | 
 | 
| 
	ITEM 9.
	  
 | 
	CHANGES
	IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING
	AND
	FINANCIAL DISCLOSURE
 | 
	 
	On October 3, 2006, we changed our independent registered
	public accounting firm from PricewaterhouseCoopers LLP to
	Stonefield Josephson, Inc. Our Audit Committee made the decision
	to change independent registered public accounting firms, and
	the decision was ratified by the Executive Committee of our
	Board of Directors. Stonefield Josephson, Inc. was engaged as
	our independent registered public accounting firm for the fiscal
	year ending December 31, 2006, and to perform procedures
	related to the financial statements included in our quarterly
	reports on
	Form 10-Q,
	beginning with, and including, the quarter ended
	September 30, 2006.
	33
 
	 
| 
 | 
 | 
| 
	ITEM 9A.
	  
 | 
	CONTROLS
	AND PROCEDURES
 | 
	 
	Evaluation
	of Disclosure Controls and Procedures
	 
	Disclosure controls and procedures are designed to provide
	reasonable assurance that information required to be disclosed
	by us in the reports that we file or submit, is recorded,
	processed, summarized and reported, within the time periods
	specified in the U.S. Securities and Exchange
	Commissions rules and forms, and such information is
	accumulated and communicated to management as appropriate to
	allow timely decisions regarding required disclosures.
	 
	Our Chief Executive Officer and Principal Financial Officer have
	evaluated our disclosure controls and procedures and have
	concluded, as of December 31, 2006, that they are effective
	as described above.
	 
	Changes
	in Internal Control over Financial Reporting
	 
	There have been no changes in our internal control over
	financial reporting during the year ended December 31, 2006
	that have materially affected or are reasonably likely to
	materially affect our internal control over financial reporting.
	 
	Because of its inherent limitations, internal control over
	financial reporting may not prevent or detect misstatements.
	Also, projections of any evaluation of effectiveness to future
	periods are subject to risk that controls may become inadequate
	because of changes in conditions, or that the degree of
	compliance with the policies or procedures may deteriorate.
	 
| 
 | 
 | 
| 
	ITEM 9B.
	  
 | 
	OTHER
	INFORMATION
 | 
	 
	We disclosed all the information required to be disclosed
	pursuant to
	Form 8-K
	during the fourth quarter of 2006.
	 
	PART III
	 
| 
 | 
 | 
| 
	ITEM 10.
	  
 | 
	DIRECTORS,
	EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
 | 
	 
	Information regarding our executive officers and directors is
	incorporated by reference to the information set forth under the
	caption
	Directors and Executive Officers
	in
	our Proxy Statement for the Annual Meeting of Stockholders to be
	filed with the Commission within 120 days after the end of
	our year ended December 31, 2006.
	 
	We have a Code of Business Conduct and Ethics for all of our
	employees, including our Chief Executive Officer, Chief
	Financial Officer and Principal Accounting Officer. The purpose
	of the code is to ensure that our business is conducted in a
	consistently legal and ethical matter. We have posted the text
	of the code on our website at www.suptech.com. We will post any
	material amendments or waivers to the code on our website. We
	will provide a copy of our code free of charge to any person
	upon request by writing to us at the following address:
	Superconductor Technologies Inc., 460 Ward Drive, Santa Barbara,
	California
	93111-2310,
	Attn: Corporate Secretary.
	 
| 
 | 
 | 
| 
	ITEM 11.
	  
 | 
	EXECUTIVE
	COMPENSATION
 | 
	 
	Information regarding executive compensation is incorporated by
	reference to the information set forth under the caption
	Executive Compensation
	in our Proxy Statement
	for the Annual Meeting of Stockholders to be filed with the
	Commission within 120 days after the end of our year ended
	December 31, 2006.
	 
| 
 | 
 | 
| 
	ITEM 12.
	  
 | 
	SECURITY
	OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND
	RELATED STOCKHOLDER MATTERS
 | 
	 
	Information regarding security ownership of certain beneficial
	owners and management is incorporated by reference to the
	information set forth under the caption Voting Securities
	and Principal Shareholders 
	Security Ownership of
	Certain Beneficial Owners and Management
	in our Proxy
	Statement for the Annual Meeting of Stockholders to be filed
	with the Commission within 120 days after the end of our
	year ended December 31, 2006.
	34
 
	 
| 
 | 
 | 
| 
	ITEM 13.
	  
 | 
	CERTAIN
	RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
	INDEPENDENCE
 | 
	 
	Information regarding certain relationships and related
	transactions is incorporated by reference to the information set
	forth under the caption
	Transactions With Related
	Persons
	and
	Corporate Governance 
	Director Independence
	in our Proxy Statement for the
	Annual Meeting of Stockholders to be filed with the Commission
	within 120 days after the end of our year ended
	December 31, 2006.
	 
| 
 | 
 | 
| 
	ITEM 14.
	  
 | 
	PRINCIPAL
	ACCOUNTING FEES AND DISCLOSURES
 | 
	 
	Information regarding accounting fees and disclosures is
	incorporated by reference to the information set forth under the
	caption
	Fees Paid to Independent Auditors
	in
	our Proxy Statement for the Annual Meeting of Stockholders to be
	filed with the Commission within 120 days after the end of
	our year ended December 31, 2006.
	35
 
	 
	 
	PART IV
	 
	ITEM 15.  
	EXHIBITS AND
	FINANCIAL STATEMENT SCHEDULES
	 
	(a) The following documents are filed as part of this
	Report:
	 
	1. 
	Index to Financial
	Statements.
	  The following financial
	statements of the Company and the Reports of Stonefield
	Josephson, Inc., Independent Registered Public Accounting Firm
	and PricewaterhouseCoopers LLP, Independent Registered Public
	Accounting Firm , are included in Part IV of this Report on
	the pages indicated:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
 
	Page
 
 | 
	 
 | 
| 
	 
 | 
| 
 
	Reports of Independent Registered
	Public Accounting Firms
 
 | 
	 
 | 
	 
 | 
	F-1
 | 
	 
 | 
| 
 
	Consolidated Balance Sheet as of
	December 31, 2005 and 2006
 
 | 
	 
 | 
	 
 | 
	F-3
 | 
	 
 | 
| 
 
	Consolidated Statement of
	Operations for the years ended December 31, 2004, 2005 and
	2006
 
 | 
	 
 | 
	 
 | 
	F-4
 | 
	 
 | 
| 
 
	Consolidated Statement of
	Stockholders Equity for the years ended December 31,
	2004, 2005 and 2006
 
 | 
	 
 | 
	 
 | 
	F-5
 | 
	 
 | 
| 
 
	Consolidated Statement of Cash
	Flows for the years ended December 31, 2004, 2005 and 2006
 
 | 
	 
 | 
	 
 | 
	F-6
 | 
	 
 | 
| 
 
	Notes to Consolidated Financial
	Statements
 
 | 
	 
 | 
	 
 | 
	F-7
 | 
	 
 | 
	 
	2. 
	Financial Statement Schedule Covered by the
	Foregoing Report of Independent Registered Public Accounting
	Firms.
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Schedule II 
	Valuation and Qualifying Accounts
 
 | 
	 
 | 
	 
 | 
	F-29
 | 
	 
 | 
	 
	All other schedules are omitted because they are not applicable
	or the required information is shown in the financial statements
	or the notes thereto.
	 
	3. 
	Exhibits.
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Number
 
 | 
	 
 | 
 
	Description of Document
 
 | 
| 
	 
 | 
| 
	 
 | 
	3
 | 
	.1
 | 
	 
 | 
	Amended and Restated Certificate
	of Incorporation of the Company(1)
 | 
| 
	 
 | 
	3
 | 
	.2
 | 
	 
 | 
	Certificate of Amendment of
	Restated Certificate of Incorporation(2)
 | 
| 
	 
 | 
	3
 | 
	.3
 | 
	 
 | 
	Certificate of Amendment of
	Restated Certificate of Incorporation(3)
 | 
| 
	 
 | 
	3
 | 
	.4
 | 
	 
 | 
	Amended and Restated Bylaws of the
	Registrant(4)
 | 
| 
	 
 | 
	4
 | 
	.1
 | 
	 
 | 
	Form of Common Stock Certificate(5)
 | 
| 
	 
 | 
	4
 | 
	.2
 | 
	 
 | 
	Third Amended and Restated
	Stockholders Rights Agreement(6)
 | 
| 
	 
 | 
	4
 | 
	.3
 | 
	 
 | 
	Warrant Issued to PNC Bank,
	National Association in connection with Credit Agreement(6)
 | 
| 
	 
 | 
	4
 | 
	.4
 | 
	 
 | 
	Warrant Purchase Agreement dated
	December 1, 1999 with PNC Bank(7)
 | 
| 
	 
 | 
	4
 | 
	.5
 | 
	 
 | 
	Warrant Purchase Agreement dated
	January 12, 2000 with PNC Bank(7)
 | 
| 
	 
 | 
	4
 | 
	.6
 | 
	 
 | 
	Certificate of Designations,
	Preferences and Rights of Series E Convertible Stock(8)
 | 
| 
	 
 | 
	4
 | 
	.7
 | 
	 
 | 
	Securities Purchase Agreement
	dated as of September 29, 2000 between the Company and RGC
	International Investors, LDC. (Exhibits and Schedules Omitted)(8)
 | 
| 
	 
 | 
	4
 | 
	.8
 | 
	 
 | 
	Registration Rights Agreement
	dated as of September 29, 2000 between the Company and RGC
	International Investors, LDC.(8)
 | 
| 
	 
 | 
	4
 | 
	.9
 | 
	 
 | 
	Initial Stock Purchase Warrant
	dated as of September 29, 2000 between the Company and RGC
	International Investors, LDC.(8)
 | 
| 
	 
 | 
	4
 | 
	.10
 | 
	 
 | 
	Incentive Stock Purchase Warrant
	dated as of September 29, 2000 between the Company and RGC
	International Investors, LDC.(8)
 | 
| 
	 
 | 
	4
 | 
	.11
 | 
	 
 | 
	Registration Rights Agreement,
	dated March 6, 2002(9)
 | 
| 
	 
 | 
	4
 | 
	.12
 | 
	 
 | 
	Warrants to Purchase Shares of
	Common Stock, dated March 11, 2002(9)
 | 
| 
	 
 | 
	4
 | 
	.13
 | 
	 
 | 
	Registration Rights Agreement
	dated October 10, 2002(10)
 | 
| 
	 
 | 
	4
 | 
	.14
 | 
	 
 | 
	Warrants to Purchase Common Stock
	dated October 10, 2002(10)
 | 
| 
	 
 | 
	4
 | 
	.15
 | 
	 
 | 
	Common Stock Purchase Agreement,
	dated March 8, 2002 between Conductus, Inc. and the
	investors signatory thereto(11)
 | 
	36
 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Number
 
 | 
	 
 | 
 
	Description of Document
 
 | 
| 
	 
 | 
| 
	 
 | 
	4
 | 
	.16
 | 
	 
 | 
	Warrant to Purchase Common Stock,
	dated March 8, 2002 by Conductus, Inc. to certain
	investors(12)
 | 
| 
	 
 | 
	4
 | 
	.17
 | 
	 
 | 
	Registration Rights Agreement,
	dated March 26, 2002, between Conductus, Inc. and certain
	investors(12)
 | 
| 
	 
 | 
	4
 | 
	.18
 | 
	 
 | 
	Warrant to Purchase Common Stock,
	dated August 7, 2000, issued by Conductus to Dobson
	Communications Corporation(13)
 | 
| 
	 
 | 
	4
 | 
	.19
 | 
	 
 | 
	Form of Series B Preferred
	Stock and Warrant Purchase Agreement dated September 11, 1998
	and September 22, 1998 between Conductus and Series B
	Investors(14)
 | 
| 
	 
 | 
	4
 | 
	.20
 | 
	 
 | 
	Form of Warrant to Purchase Common
	Stock between Conductus and Series B investors, dated
	September 28, 1998, issued by Conductus in a private
	placement(14)
 | 
| 
	 
 | 
	4
 | 
	.21
 | 
	 
 | 
	Form of Series C Preferred
	Stock and Warrant Purchase Agreement, dated December 10, 1999,
	between Conductus and Series C Investors(15)
 | 
| 
	 
 | 
	4
 | 
	.22
 | 
	 
 | 
	Form of Warrant Purchase Common
	Stock between Conductus and Series C investors, dated
	December 10, 1999, issued by Conductus in a private
	placement(15)
 | 
| 
	 
 | 
	4
 | 
	.23
 | 
	 
 | 
	Form of Warrant to Purchase Common
	Stock dated March 28, 2003, issued to Silicon Valley
	Bank(16)
 | 
| 
	 
 | 
	4
 | 
	.24
 | 
	 
 | 
	Form of Warrant(17)
 | 
| 
	 
 | 
	4
 | 
	.25
 | 
	 
 | 
	Form of Registration Rights
	Agreement(17)
 | 
| 
	 
 | 
	4
 | 
	.26
 | 
	 
 | 
	Agility Capital Warrant dated May
	2004(18)
 | 
| 
	 
 | 
	4
 | 
	.27
 | 
	 
 | 
	Silicon Valley Bank Warrant dated
	May 2004(18)
 | 
| 
	 
 | 
	4
 | 
	.28
 | 
	 
 | 
	Form of Warrant dated August
	2005(19)
 | 
| 
	 
 | 
	10
 | 
	.1
 | 
	 
 | 
	1992 Director Option Plan(20)
 | 
| 
	 
 | 
	10
 | 
	.2
 | 
	 
 | 
	1992 Stock Option Plan(20)
 | 
| 
	 
 | 
	10
 | 
	.3
 | 
	 
 | 
	Joint Venture Company (JDC)
	Agreement between the Registrant and Sunpower Incorporated dated
	April 2, 1992(20)
 | 
| 
	 
 | 
	10
 | 
	.4
 | 
	 
 | 
	Government Contract issued to
	Registrant by the Defense Advanced Research Projects Agency
	through the Office of Naval Research dated September 4,
	1991(20)
 | 
| 
	 
 | 
	10
 | 
	.5
 | 
	 
 | 
	License Agreement between the
	Registrant and E.I. DuPont de Nemours and Company dated December
	1992(20)
 | 
| 
	 
 | 
	10
 | 
	.6
 | 
	 
 | 
	Amended and Restated 1988 Stock
	Option Plan, as amended, with form of stock option agreement(21)
 | 
| 
	 
 | 
	10
 | 
	.7
 | 
	 
 | 
	1999 Stock Option Agreement(7)
 | 
| 
	 
 | 
	10
 | 
	.8
 | 
	 
 | 
	1998 Stock Option Plan(22)
 | 
| 
	 
 | 
	10
 | 
	.10(a)
 | 
	 
 | 
	Promissory Note between Charles E.
	Shalvoy and Conductus dated December 28, 2000(23)
 | 
| 
	 
 | 
	10
 | 
	.10(b)
 | 
	 
 | 
	Security Agreement between Charles
	E. Shalvoy and Conductus dated December 28, 2000(23)
 | 
| 
	 
 | 
	10
 | 
	.10(c)
 | 
	 
 | 
	Promissory Note Agreement
	between Charles E. Shalvoy and Conductus dated August 21,2001(23)
 | 
| 
	 
 | 
	10
 | 
	.10(d)
 | 
	 
 | 
	Security Agreement between Charles
	E. Shalvoy and Conductus dated August 21, 2000(23)
 | 
| 
	 
 | 
	10
 | 
	.11(a)
 | 
	 
 | 
	Form of Change of Control
	Agreement dated March 28, 2003(24)
 | 
| 
	 
 | 
	10
 | 
	.11(b)
 | 
	 
 | 
	Form of Amendment to Change of
	Control Agreement dated as of May 24, 2005(30)
 | 
| 
	 
 | 
	10
 | 
	.11(c)
 | 
	 
 | 
	Form of Amendment to Change of
	Control Agreement dated as of December 31, 2006*
 | 
| 
	 
 | 
	10
 | 
	.12(b)
 | 
	 
 | 
	Accounts Receivable Purchase
	Agreement dated March 28, 2003 by and between Registrant
	and Silicon Valley Bank(24)
 | 
| 
	 
 | 
	10
 | 
	.12(c)
 | 
	 
 | 
	Accounts Receivable Purchase
	Modification Agreement with Silicon Valley Bank dated
	March 17, 2004(25)
 | 
| 
	 
 | 
	10
 | 
	.12(d)
 | 
	 
 | 
	Accounts Receivable Purchase
	Modification Agreement with Silicon Valley Bank dated
	March 29, 2005(26)
 | 
| 
	 
 | 
	10
 | 
	.13
 | 
	 
 | 
	Unconditional Guaranty dated
	March 27, 2003 issued by Conductus, Inc. to Silicon Valley
	Bank(24)
 | 
	37
 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Number
 
 | 
	 
 | 
 
	Description of Document
 
 | 
| 
	 
 | 
| 
	 
 | 
	10
 | 
	.13
 | 
	 
 | 
	Patent License Agreement between
	Telcordia Technologies, Inc. and Registrant dated July 13,
	2002(24)
 | 
| 
	 
 | 
	10
 | 
	.14(b)
 | 
	 
 | 
	Securities Purchase Agreement
	dated June 23, 2003(27)
 | 
| 
	 
 | 
	10
 | 
	.14(c)
 | 
	 
 | 
	Form of Investor Warrant(27)
 | 
| 
	 
 | 
	10
 | 
	.15
 | 
	 
 | 
	Form of Registration Rights
	Agreement(27)
 | 
| 
	 
 | 
	10
 | 
	.16
 | 
	 
 | 
	Patent License Agreement by and
	between Lucent Technologies and the Company**(28)
 | 
| 
	 
 | 
	10
 | 
	.17
 | 
	 
 | 
	License Agreement with Charles
	Shalvoy dated November 4, 2004(31)
 | 
| 
	 
 | 
	10
 | 
	.17
 | 
	 
 | 
	License Agreement with
	Sunpower**(31)
 | 
| 
	 
 | 
	10
 | 
	.18(a)
 | 
	 
 | 
	Employment Agreement with Jeffrey
	Quiram(29)
 | 
| 
	 
 | 
	10
 | 
	.18(b)
 | 
	 
 | 
	Option Agreement with Jeffrey
	Quiram(29)
 | 
| 
	 
 | 
	10
 | 
	.18(c)
 | 
	 
 | 
	Amendment to Employment Agreement
	with Jeffrey Quiram dated as of December 31, 2006*
 | 
| 
	 
 | 
	10
 | 
	.19(a)
 | 
	 
 | 
	2003 Equity Management Incentive
	Plan (as amended May 25, 2005)(4)
 | 
| 
	 
 | 
	10
 | 
	.19(b)
 | 
	 
 | 
	Form of Option Agreement for 2003
	Equity Incentive Plan(29)
 | 
| 
	 
 | 
	10
 | 
	.19(c)
 | 
	 
 | 
	Management Incentive Plan(31)
 | 
| 
	 
 | 
	10
 | 
	.20(a)
 | 
	 
 | 
	Employment Agreement with Terry
	White(32)
 | 
| 
	 
 | 
	10
 | 
	.20(b)
 | 
	 
 | 
	Amendment to Employment Agreement
	with Terry White dated as of December 31, 2006 *
 | 
| 
	 
 | 
	10
 | 
	.22
 | 
	 
 | 
	Compensation Policy for
	Non-Employee Directors dated March 18, 2005(32)
 | 
| 
	 
 | 
	10
 | 
	.22
 | 
	 
 | 
	Stipulation of Settlement to
	Class Action dated August 10, 2005(32)
 | 
| 
	 
 | 
	10
 | 
	.23(b)
 | 
	 
 | 
	Placement Agency Agreement for
	August 2005(19)
 | 
| 
	 
 | 
	10
 | 
	.23(b)
 | 
	 
 | 
	Form of Subscription Agreement for
	August 2005 offering(31)
 | 
| 
	 
 | 
	10
 | 
	.24
 | 
	 
 | 
	Form of Director and Officer
	Indemnification Agreement(30)
 | 
| 
	 
 | 
	10
 | 
	.25
 | 
	 
 | 
	Code of Business Conduct and
	Ethics(30)
 | 
| 
	 
 | 
	10
 | 
	.26
 | 
	 
 | 
	Master Services Agreement dated as
	of September 8, 2006 with Cingular Wireless, LLC
 | 
| 
	 
 | 
	10
 | 
	.27
 | 
	 
 | 
	Settlement Agreement and Mutual
	Release of All Claims with Charles Shalvoy and John Lockton*
 | 
| 
	 
 | 
	21
 | 
	 
 | 
	 
 | 
	List of Subsidiaries*
 | 
| 
	 
 | 
	23
 | 
	.1
 | 
	 
 | 
	Consent of Stonefield Josephson
	Inc, Independent Registered Public Accounting Firm
 | 
| 
	 
 | 
	23
 | 
	.2
 | 
	 
 | 
	Consent of PricewaterhouseCoopers
	LLP, Independent Registered Public Accounting Firm
 | 
| 
	 
 | 
	31
 | 
	.1
 | 
	 
 | 
	Statement of CEO Pursuant to 302
	of the Sarbanes-Oxley Act of 2002
 | 
| 
	 
 | 
	31
 | 
	.2
 | 
	 
 | 
	Statement of CFO Pursuant to 302
	of the Sarbanes-Oxley Act of 2002
 | 
| 
	 
 | 
	32
 | 
	.1
 | 
	 
 | 
	Statement of CEO Pursuant to 906
	of the Sarbanes-Oxley Act of 2002
 | 
| 
	 
 | 
	32
 | 
	.2
 | 
	 
 | 
	Statement of CFO Pursuant to 906
	of the Sarbanes-Oxley Act of 2002
 | 
	 
	 
| 
 | 
 | 
 | 
| 
	(1)
 | 
 | 
	Incorporated by reference from the Registrants Quarterly
	Report on Form
	10-Q
	filed
	for the quarter ended April 3, 1999.
 | 
| 
	 
 | 
| 
	(2)
 | 
 | 
	Incorporated by reference from the Registrants Quarterly
	Report on Form
	10-Q
	filed
	for the quarter ended June 30, 2001.
 | 
| 
	 
 | 
| 
	(3)
 | 
 | 
	Incorporated by reference from Registrants
	Form 8-K
	dated March 13, 2006.
 | 
| 
	 
 | 
| 
	(4)
 | 
 | 
	Incorporated by reference from Registrants
	Form 8-K
	dated May 25, 2005.
 | 
| 
	 
 | 
| 
	(5)
 | 
 | 
	Incorporated by reference from the Registrants
	Registration Statement on
	Form S-1
	(Reg.
	No. 33-56714).
 | 
| 
	 
 | 
| 
	(6)
 | 
 | 
	Incorporated by reference from the Registrants Quarterly
	Report on Form
	10-Q
	filed
	for the quarter ended July 3, 1999.
 | 
| 
	 
 | 
| 
	(7)
 | 
 | 
	Incorporated by reference from the Registrants
	Registration Statement on
	Form S-8
	(Reg.
	No. 333-90293).
 | 
| 
	 
 | 
| 
	(8)
 | 
 | 
	Incorporated by reference from the Registrants Annual
	Report on Form
	10-K
	for the
	year ended December 31, 1999.
 | 
	38
 
	 
| 
 | 
 | 
 | 
| 
	(9)
 | 
 | 
	Incorporated by reference from Registrants Annual Report
	on
	Form 10-K
	for the year ended December 31, 2001.
 | 
| 
	 
 | 
| 
	(10)
 | 
 | 
	Incorporated by reference from the Registrants Current
	Report on Form
	8-K,
	filed
	October 2, 2002.
 | 
| 
	 
 | 
| 
	(11)
 | 
 | 
	Incorporated by reference from the Registrants Annual
	Report on Form
	10-K
	filed
	for the year ended December 31, 1997.
 | 
| 
	 
 | 
| 
	(12)
 | 
 | 
	Incorporated by reference from the Conductus, Inc.s
	Registration Statement on
	Form S-3
	(Reg.
	No. 333-85928)
	filed on April 9, 2002.
 | 
| 
	 
 | 
| 
	(13)
 | 
 | 
	Incorporated by reference from Conductus, Inc.s Quarterly
	Report on Form
	10-Q,
	filed
	with the SEC on November 16, 1998.
 | 
| 
	 
 | 
| 
	(14)
 | 
 | 
	Incorporated by reference from Conductus, Inc.s Annual
	Report on Form
	10-K
	for the
	year ended December 31, 1999.
 | 
| 
	 
 | 
| 
	(15)
 | 
 | 
	Incorporated by reference from Conductus, Inc.s Annual
	Report on Form
	10-K
	for the
	year ended December 31, 1999.
 | 
| 
	 
 | 
| 
	(16)
 | 
 | 
	Incorporate by reference from Registrants Quarterly Report
	on
	Form 10-Q
	for the quarter ended March 29, 2003.
 | 
| 
	 
 | 
| 
	(17)
 | 
 | 
	Incorporated by reference from Registrants Current Report
	on
	Form 8-K
	filed June 25, 2003.
 | 
| 
	 
 | 
| 
	(18)
 | 
 | 
	Incorporated by reference from Registrants Registration
	Statement of
	Form S-3
	(Reg.
	333-89184).
 | 
| 
	 
 | 
| 
	(19)
 | 
 | 
	Incorporated by reference from Registrants
	Form 8-K
	dated August 10, 2005.
 | 
| 
	 
 | 
| 
	(20)
 | 
 | 
	Incorporated by reference from Amendment No. 1 to the
	Registrants Registration Statement on
	Form S-1
	(Reg.
	No. 33-56714).
 | 
| 
	 
 | 
| 
	(21)
 | 
 | 
	Incorporated by reference from the Registrants Annual
	Report on Form
	10-K
	filed
	for the year ended December 31, 1994.
 | 
| 
	 
 | 
| 
	(22)
 | 
 | 
	Incorporated by reference from the Registrants
	Registration Statement on
	Form S-8
	(Reg.
	No. 333-56606)
	filed March 6, 2001.
 | 
| 
	 
 | 
| 
	(23)
 | 
 | 
	Incorporated by reference from the Registrants
	Registration Statement on
	Form S-4
	(Reg.
	No. 333-100908).
 | 
| 
	 
 | 
| 
	(24)
 | 
 | 
	Incorporate by reference from Registrants Quarterly Report
	on
	Form 10-Q
	for the quarter ended March 29, 2003.
 | 
| 
	 
 | 
| 
	(25)
 | 
 | 
	Incorporated by reference from Registrants Quarterly
	Report on
	Form 10-Q
	for the quarter ended April 3, 2004.
 | 
| 
	 
 | 
| 
	(26)
 | 
 | 
	Incorporated by reference from Registrants
	Form 8-K
	dated March 29, 2005.
 | 
| 
	 
 | 
| 
	(27)
 | 
 | 
	Incorporated by reference from Registrants
	Form 8-K
	dated June 25, 2003.
 | 
| 
	 
 | 
| 
	(28)
 | 
 | 
	Incorporated by reference from Registrants Annual Report
	on
	Form 10-K
	for the year ended December 31, 2003.
 | 
| 
	 
 | 
| 
	(29)
 | 
 | 
	Incorporated by reference from Registrants Annual Report
	on
	Form 10-K
	for the year ended December 31, 2004.
 | 
| 
	 
 | 
| 
	(30)
 | 
 | 
	Incorporated by reference from Registrants Annual Report
	on
	Form 10-K
	for the year ended December 31, 2005
 | 
| 
	 
 | 
| 
	(31)
 | 
 | 
	Incorporated by reference from Registrants
	Form 8-K
	dated July 27, 2006.
 | 
| 
	 
 | 
| 
	(32)
 | 
 | 
	Incorporated by reference from Registrants Quarterly
	Report on
	Form 10-Q
	for the quarter ended April 2, 2005.
 | 
| 
	 
 | 
| 
	* 
 | 
 | 
	Filed herewith.
 | 
| 
	 
 | 
| 
	**
 | 
 | 
	Confidential treatment has been previously granted for certain
	portions of these exhibits.
 | 
	 
	(b) 
	Exhibits.
	  See Item 15(a) above.
	39
 
	 
	Reports
	of Independent Registered Public Accounting Firms
	 
	Board of Directors and Stockholders
	Superconductor Technologies Inc.:
	 
	We have audited the accompanying consolidated balance sheet of
	Superconductor Technologies, Inc. as of December 31, 2006,
	and the related consolidated statements of operations,
	stockholders equity, and cash flows for the year ended
	December 31, 2006. Our audit also included the financial
	statement schedule listed in the index in Item 15(a). These
	financial statements and schedule are the responsibility of the
	Companys management. Our responsibility is to express an
	opinion on these financial statements and financial statement
	schedule based on our audits.
	 
	We conducted our audit in accordance with the standards of the
	Public Company Accounting Oversight Board (United States). Those
	standards require that we plan and perform the audit to obtain
	reasonable assurance about whether the financial statements are
	free of material misstatement. We were not engaged to perform an
	audit of the Companys internal control over financial
	reporting. Our audit included consideration of internal control
	over financial reporting as a basis for designing audit
	procedures that are appropriate in the circumstances, but not
	for the purpose of expressing an opinion on the effectiveness of
	the Companys internal control over financial reporting.
	Accordingly, we express no such opinion. An audit also includes
	examining, on a test basis, evidence supporting the amounts and
	disclosures in the financial statements, assessing the
	accounting principles used and significant estimates made by
	management, as well as evaluating the overall financial
	statement presentation. We believe that our audit provide a
	reasonable basis for our opinion.
	 
	In our opinion, the financial statements referred to above
	present fairly, in all material respects, the consolidated
	financial position of Superconductor Technologies, Inc. as of
	December 31, 2006, and the results of their operations and
	their cash flows for the year ended December 31, 2006, in
	conformity with accounting principles generally accepted in the
	United States of America. Also in our opinion the financial
	statement schedule when considered in relation to the basic
	consolidated financial statements, taken as a whole, presents
	fairly in all material respects the information set forth
	therein as of and for the year ended December 31, 2006.
	 
	The accompanying consolidated financial statements have been
	prepared assuming that the Company will continue as a going
	concern. As discussed in Note 2 to the consolidated
	financial statements, the Company has incurred substantial net
	losses and had an accumulated deficit of $190,859,000 as of
	December 31, 2006. These matters, and others, raise
	substantial doubt about the Companys ability to continue
	as a going concern. Managements plans concerning these
	matters are described in Note 2. These consolidated
	financial statements do not include any adjustments relating to
	the recoverability and classification of recorded assets, or the
	amounts and classification of liabilities that might be
	necessary in the event the Company cannot continue in existence.
	 
	As discussed in Notes 2 and 7 to the consolidated financial
	statements, in 2006 the Company adopted Statement of Financial
	Accounting Standards No. 123R, Share-Based
	Payment.
	 
	/s/  Stonefield
	Josephson, Inc.
 
	 
	Los Angeles, California
	March 30, 2007
	F-1
 
	To the Board of Directors and Stockholders of
	Superconductor Technologies Inc.:
	 
	In our opinion, the consolidated balance sheet as of
	December 31, 2005 and the related consolidated statements
	of operations, stockholders equity and cash flows present
	fairly, in all material respects, the financial position of
	Superconductor Technologies, Inc. and its subsidiaries at
	December 31, 2005, and the results of their operations and
	their cash flows for each of the two years in the period ended
	December 31, 2005 in conformity with accounting principles
	generally accepted in the United States of America. In addition,
	in our opinion, the financial statement schedule for each of the
	two years in the period ended December 31, 2005 presents
	fairly, in all material respects, the information set forth
	therein when read in conjunction with the related consolidated
	financial statements. These financial statements and financial
	statement schedule are the responsibility of the Companys
	management. Our responsibility is to express an opinion on these
	financial statements and financial statement schedule based on
	our audits. We conducted our audits of these statements in
	accordance with the standards of the Public Company Accounting
	Oversight Board (United States). Those standards require that we
	plan and perform the audit to obtain reasonable assurance about
	whether the financial statements are free of material
	misstatement. An audit includes examining, on a test basis,
	evidence supporting the amounts and disclosures in the financial
	statements, assessing the accounting principles used and
	significant estimates made by management, and evaluating the
	overall financial statement presentation. We believe that our
	audits provide a reasonable basis for our opinion.
	 
	The accompanying consolidated financial statements have been
	prepared assuming that the Company will continue as a going
	concern. As discussed in Note 2 to the consolidated
	financial statements, the Company has had recurring losses and
	used $9.4 million in cash for operations in 2005. These
	matters raise a substantial doubt about the Companys
	ability to continue as a going concern. Managements plans
	in regard to these matters are also described in Note 2.
	The consolidated financial statements do not include any
	adjustments that might result from the outcome of this
	uncertainty.
	 
	PricewaterhouseCoopers LLP
	 
	Los Angeles, California
	March 3, 2006, except for effects of
	the reverse stock split discussed in Note 2,
	as to which the date is March 13, 2006.
	F-2
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	CONSOLIDATED
	BALANCE SHEET
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	December 31,
 
 | 
	 
 | 
	 
 | 
	December 31,
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
| 
	 
 | 
| 
 
	ASSETS
 
 | 
| 
 
	Current
	Assets
	:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Cash and cash equivalents
 
 | 
	 
 | 
	$
 | 
	13,018,000
 | 
	 
 | 
	 
 | 
	$
 | 
	5,487,000
 | 
	 
 | 
| 
 
	Accounts receivable, net
 
 | 
	 
 | 
	 
 | 
	2,166,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,535,000
 | 
	 
 | 
| 
 
	Inventory, net
 
 | 
	 
 | 
	 
 | 
	5,364,000
 | 
	 
 | 
	 
 | 
	 
 | 
	5,978,000
 | 
	 
 | 
| 
 
	Prepaid expenses and other current
	assets
 
 | 
	 
 | 
	 
 | 
	723,000
 | 
	 
 | 
	 
 | 
	 
 | 
	507,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Total Current Assets
 
 | 
	 
 | 
	 
 | 
	21,271,000
 | 
	 
 | 
	 
 | 
	 
 | 
	13,507,000
 | 
	 
 | 
| 
 
	Property and equipment, net of
	accumulated depreciation of $17,295,000 and $18,599,000,
	respectively
 
 | 
	 
 | 
	 
 | 
	7,803,000
 | 
	 
 | 
	 
 | 
	 
 | 
	5,770,000
 | 
	 
 | 
| 
 
	Patents, licenses and purchased
	technology, net of accumulated amortization of $1,065,000 and
	$1,382,000, respectively
 
 | 
	 
 | 
	 
 | 
	2,514,000
 | 
	 
 | 
	 
 | 
	 
 | 
	2,221,000
 | 
	 
 | 
| 
 
	Goodwill
 
 | 
	 
 | 
	 
 | 
	20,107,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Other assets
 
 | 
	 
 | 
	 
 | 
	350,000
 | 
	 
 | 
	 
 | 
	 
 | 
	406,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Total Assets
 
 | 
	 
 | 
	$
 | 
	52,045,000
 | 
	 
 | 
	 
 | 
	$
 | 
	21,904,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	LIABILITIES AND
	STOCKHOLDERS EQUITY
 
 | 
| 
 
	Current
	Liabilities
	:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Accounts payable
 
 | 
	 
 | 
	$
 | 
	2,036,000
 | 
	 
 | 
	 
 | 
	$
 | 
	1,725,000
 | 
	 
 | 
| 
 
	Accrued expenses
 
 | 
	 
 | 
	 
 | 
	1,998,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,610,000
 | 
	 
 | 
| 
 
	Current portion of capitalized
	lease obligations and long term debt
 
 | 
	 
 | 
	 
 | 
	19,000
 | 
	 
 | 
	 
 | 
	 
 | 
	14,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Total Current
	Liabilities
 
 | 
	 
 | 
	 
 | 
	4,053,000
 | 
	 
 | 
	 
 | 
	 
 | 
	3,549,000
 | 
	 
 | 
| 
 
	Capitalized lease obligations and
	long term-debt
 
 | 
	 
 | 
	 
 | 
	14,000
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Other long term liabilities
 
 | 
	 
 | 
	 
 | 
	721,000
 | 
	 
 | 
	 
 | 
	 
 | 
	604,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Total Liabilities
 
 | 
	 
 | 
	 
 | 
	4,788,000
 | 
	 
 | 
	 
 | 
	 
 | 
	3,953,000
 | 
	 
 | 
| 
 
	Commitments and contingencies
	(Notes 9, 10 and 11)
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Stockholders
	Equity:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Preferred stock, $.001 par
	value, 2,000,000 shares authorized, none issued and
	outstanding
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Common stock, $.001 par
	value, 250,000,000 shares authorized, 12,483,431 and
	12,483,367 shares issued and outstanding, respectively
 
 | 
	 
 | 
	 
 | 
	12,000
 | 
	 
 | 
	 
 | 
	 
 | 
	12,000
 | 
	 
 | 
| 
 
	Capital in excess of par value
 
 | 
	 
 | 
	 
 | 
	208,545,000
 | 
	 
 | 
	 
 | 
	 
 | 
	208,825,000
 | 
	 
 | 
| 
 
	Notes receivable from stockholder
	and board member
 
 | 
	 
 | 
	 
 | 
	(65,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(27,000
 | 
	)
 | 
| 
 
	Accumulated deficit
 
 | 
	 
 | 
	 
 | 
	(161,235,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(190,859,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Total Stockholders
	Equity
 
 | 
	 
 | 
	 
 | 
	47,257,000
 | 
	 
 | 
	 
 | 
	 
 | 
	17,951,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Total Liabilities and
	Stockholders Equity
 
 | 
	 
 | 
	$
 | 
	52,045,000
 | 
	 
 | 
	 
 | 
	$
 | 
	21,904,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
	See accompanying notes to the consolidated financial statements
	F-3
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	CONSOLIDATED
	STATEMENT OF OPERATIONS
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	For the Year Ended December 31
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	2004
 | 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
| 
	 
 | 
| 
 
	Net revenues:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Net commercial product revenues
 
 | 
	 
 | 
	$
 | 
	16,787,000
 | 
	 
 | 
	 
 | 
	$
 | 
	21,080,000
 | 
	 
 | 
	 
 | 
	$
 | 
	17,697,000
 | 
	 
 | 
| 
 
	Government and other contract
	revenues
 
 | 
	 
 | 
	 
 | 
	6,189,000
 | 
	 
 | 
	 
 | 
	 
 | 
	3,107,000
 | 
	 
 | 
	 
 | 
	 
 | 
	3,361,000
 | 
	 
 | 
| 
 
	Sub license royalties
 
 | 
	 
 | 
	 
 | 
	28,000
 | 
	 
 | 
	 
 | 
	 
 | 
	22,000
 | 
	 
 | 
	 
 | 
	 
 | 
	20,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Total net revenues
 
 | 
	 
 | 
	 
 | 
	23,004,000
 | 
	 
 | 
	 
 | 
	 
 | 
	24,209,000
 | 
	 
 | 
	 
 | 
	 
 | 
	21,078,000
 | 
	 
 | 
| 
 
	Costs and expenses:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Cost of commercial product revenues
 
 | 
	 
 | 
	 
 | 
	23,421,000
 | 
	 
 | 
	 
 | 
	 
 | 
	18,989,000
 | 
	 
 | 
	 
 | 
	 
 | 
	15,922,000
 | 
	 
 | 
| 
 
	Contract research and development
 
 | 
	 
 | 
	 
 | 
	4,465,000
 | 
	 
 | 
	 
 | 
	 
 | 
	2,806,000
 | 
	 
 | 
	 
 | 
	 
 | 
	2,407,000
 | 
	 
 | 
| 
 
	Other research and development
 
 | 
	 
 | 
	 
 | 
	5,036,000
 | 
	 
 | 
	 
 | 
	 
 | 
	4,214,000
 | 
	 
 | 
	 
 | 
	 
 | 
	3,488,000
 | 
	 
 | 
| 
 
	Selling, general and administrative
 
 | 
	 
 | 
	 
 | 
	16,051,000
 | 
	 
 | 
	 
 | 
	 
 | 
	11,442,000
 | 
	 
 | 
	 
 | 
	 
 | 
	9,086,000
 | 
	 
 | 
| 
 
	Restructuring expenses and
	impairment charges
 
 | 
	 
 | 
	 
 | 
	4,128,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,197,000
 | 
	 
 | 
	 
 | 
	 
 | 
	38,000
 | 
	 
 | 
| 
 
	Write off Goodwill
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	20,107,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Total costs and
	expenses
 
 | 
	 
 | 
	 
 | 
	53,101,000
 | 
	 
 | 
	 
 | 
	 
 | 
	38,648,000
 | 
	 
 | 
	 
 | 
	 
 | 
	51,048,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Loss from operations
 
 | 
	 
 | 
	 
 | 
	(30,097,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(14,439,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(29,970,000
 | 
	)
 | 
| 
 
	Interest income
 
 | 
	 
 | 
	 
 | 
	125,000
 | 
	 
 | 
	 
 | 
	 
 | 
	342,000
 | 
	 
 | 
	 
 | 
	 
 | 
	391,000
 | 
	 
 | 
| 
 
	Interest expense
 
 | 
	 
 | 
	 
 | 
	(1,245,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(116,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(45,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Net loss
 
 | 
	 
 | 
	$
 | 
	(31,217,000
 | 
	)
 | 
	 
 | 
	$
 | 
	(14,213,000
 | 
	)
 | 
	 
 | 
	$
 | 
	(29,624,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Basic and diluted net loss per
	common share
 
 | 
	 
 | 
	$
 | 
	(3.71
 | 
	)
 | 
	 
 | 
	$
 | 
	(1.24
 | 
	)
 | 
	 
 | 
	$
 | 
	(2.37
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Basic and diluted weighted
	average number of common shares outstanding
 
 | 
	 
 | 
	 
 | 
	8,424,145
 | 
	 
 | 
	 
 | 
	 
 | 
	11,418,504
 | 
	 
 | 
	 
 | 
	 
 | 
	12,483,367
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
	See accompanying notes to the consolidated financial statements
	F-4
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	CONSOLIDATED
	STATEMENT OF STOCKHOLDERS EQUITY
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Convertible Preferred
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	Capital in
 
 | 
	 
 | 
	 
 | 
	Receivable
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Stock
 | 
	 
 | 
	 
 | 
	Common Stock
 | 
	 
 | 
	 
 | 
	Excess of
 
 | 
	 
 | 
	 
 | 
	From
 
 | 
	 
 | 
	 
 | 
	Accumulated
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Shares
 | 
	 
 | 
	 
 | 
	Amount
 | 
	 
 | 
	 
 | 
	Shares
 | 
	 
 | 
	 
 | 
	Amount
 | 
	 
 | 
	 
 | 
	Par Value
 | 
	 
 | 
	 
 | 
	Stockholder
 | 
	 
 | 
	 
 | 
	Deficit
 | 
	 
 | 
	 
 | 
	Total
 | 
	 
 | 
| 
	 
 | 
| 
 
	Balance at December 31,
	2003
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	6,890,711
 | 
	 
 | 
	 
 | 
	$
 | 
	7,000
 | 
	 
 | 
	 
 | 
	$
 | 
	168,838,000
 | 
	 
 | 
	 
 | 
	$
 | 
	(820,000
 | 
	)
 | 
	 
 | 
	$
 | 
	(115,805,000
 | 
	)
 | 
	 
 | 
	$
 | 
	52,220,000
 | 
	 
 | 
| 
 
	Exercise of stock options
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	8,975
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	250,000
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	250,000
 | 
	 
 | 
| 
 
	Issuance of common stock and
	warrants for cash
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	3,860,000
 | 
	 
 | 
	 
 | 
	 
 | 
	4,000
 | 
	 
 | 
	 
 | 
	 
 | 
	26,783,000
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	26,787,000
 | 
	 
 | 
| 
 
	Exercise of warrants
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	11,417
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	236,000
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	236,000
 | 
	 
 | 
| 
 
	Issuance of options and warrants
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	973,000
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	973,000
 | 
	 
 | 
| 
 
	Net loss
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	(31,217,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(31,217,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Balance at December 31,
	2004
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	10,771,103
 | 
	 
 | 
	 
 | 
	 
 | 
	11,000
 | 
	 
 | 
	 
 | 
	 
 | 
	197,080,000
 | 
	 
 | 
	 
 | 
	 
 | 
	(820,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(147,022,000
 | 
	)
 | 
	 
 | 
	 
 | 
	49,249,000
 | 
	 
 | 
| 
 
	Exercise of stock options Issuance
	of common stock
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	1,712,329
 | 
	 
 | 
	 
 | 
	 
 | 
	1,000
 | 
	 
 | 
	 
 | 
	 
 | 
	11,440,000
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	11,441,000
 | 
	 
 | 
| 
 
	Issuance of options and warrants
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	25,000
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	25,000
 | 
	 
 | 
| 
 
	Reserve for impairment
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	755,000
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	755,000
 | 
	 
 | 
| 
 
	Net loss
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	(14,213,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(14,213,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Balance at December 31,
	2005
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	12,483,431
 | 
	 
 | 
	 
 | 
	 
 | 
	12,000
 | 
	 
 | 
	 
 | 
	 
 | 
	208,545,000
 | 
	 
 | 
	 
 | 
	 
 | 
	(65,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(161,235,000
 | 
	)
 | 
	 
 | 
	 
 | 
	47,257,000
 | 
	 
 | 
| 
 
	Issuance of common stock and
	warrants
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	(64
 | 
	)
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Issuance of options
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	280,000
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	280,000
 | 
	 
 | 
| 
 
	Reserve for impairment
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	38,000
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	38,000
 | 
	 
 | 
| 
 
	Net loss
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	(29,624,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(29,624,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Balance at December 31,
	2006
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	12,483,367
 | 
	 
 | 
	 
 | 
	$
 | 
	12,000
 | 
	 
 | 
	 
 | 
	$
 | 
	208,825,000
 | 
	 
 | 
	 
 | 
	$
 | 
	(27,000
 | 
	)
 | 
	 
 | 
	$
 | 
	(190,859,000
 | 
	)
 | 
	 
 | 
	$
 | 
	17,951,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
	See accompanying notes to the consolidated financial statements.
	F-5
 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	CONSOLIDATED
	STATEMENT OF CASH FLOWS
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	For the Year Ended December 31
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	2004
 | 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
| 
	 
 | 
| 
 
	CASH FLOWS FROM OPERATING
	ACTIVITIES:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Net loss
 
 | 
	 
 | 
	$
 | 
	(31,217,000
 | 
	)
 | 
	 
 | 
	$
 | 
	(14,213,000
 | 
	)
 | 
	 
 | 
	$
 | 
	(29,624,000
 | 
	)
 | 
| 
 
	Adjustments to reconcile net loss
	to net cash used for operating activities:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Depreciation and amortization
 
 | 
	 
 | 
	 
 | 
	3,463,000
 | 
	 
 | 
	 
 | 
	 
 | 
	3,225,000
 | 
	 
 | 
	 
 | 
	 
 | 
	2,600,000
 | 
	 
 | 
| 
 
	Non-cash restructuring and
	impairment charges
 
 | 
	 
 | 
	 
 | 
	3,659,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Warrants and options charges
 
 | 
	 
 | 
	 
 | 
	973,000
 | 
	 
 | 
	 
 | 
	 
 | 
	25,000
 | 
	 
 | 
	 
 | 
	 
 | 
	280,000
 | 
	 
 | 
| 
 
	Provision for excess and obsolete
	inventories
 
 | 
	 
 | 
	 
 | 
	4,836,000
 | 
	 
 | 
	 
 | 
	 
 | 
	984,000
 | 
	 
 | 
	 
 | 
	 
 | 
	360,000
 | 
	 
 | 
| 
 
	Forgiveness of note receivable
	from former CEO
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	150,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Reserve for impairment of note and
	interest receivable from stockholder
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	924,000
 | 
	 
 | 
	 
 | 
	 
 | 
	38,000
 | 
	 
 | 
| 
 
	Write off Goodwill
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	20,107,000
 | 
	 
 | 
| 
 
	Gain on disposal of property and
	equipment
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	(138,000
 | 
	)
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Changes in assets and liabilities:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Accounts receivable
 
 | 
	 
 | 
	 
 | 
	7,375,000
 | 
	 
 | 
	 
 | 
	 
 | 
	(732,000
 | 
	)
 | 
	 
 | 
	 
 | 
	631,000
 | 
	 
 | 
| 
 
	Inventory
 
 | 
	 
 | 
	 
 | 
	(5,361,000
 | 
	)
 | 
	 
 | 
	 
 | 
	2,979,000
 | 
	 
 | 
	 
 | 
	 
 | 
	(974,000
 | 
	)
 | 
| 
 
	Prepaid expenses and other current
	assets
 
 | 
	 
 | 
	 
 | 
	(146,000
 | 
	)
 | 
	 
 | 
	 
 | 
	112,000
 | 
	 
 | 
	 
 | 
	 
 | 
	115,000
 | 
	 
 | 
| 
 
	Patents and licenses
 
 | 
	 
 | 
	 
 | 
	(546,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(154,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(217,000
 | 
	)
 | 
| 
 
	Other assets
 
 | 
	 
 | 
	 
 | 
	(46,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(23,000
 | 
	)
 | 
	 
 | 
	 
 | 
	128,000
 | 
	 
 | 
| 
 
	Accounts payable and accrued
	expenses
 
 | 
	 
 | 
	 
 | 
	(4,570,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(2,543,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(727,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Net cash used in operating
	activities
 
 | 
	 
 | 
	 
 | 
	(21,580,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(9,404,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(7,283,000
 | 
	)
 | 
| 
 
	CASH FLOWS FROM INVESTING
	ACTIVITIES:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Proceeds from the sale of property
	and equipment
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	216,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Purchase of property and equipment
 
 | 
	 
 | 
	 
 | 
	(1,812,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(261,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(229,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Net cash used in investing
	activities
 
 | 
	 
 | 
	 
 | 
	(1,812,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(45,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(229,000
 | 
	)
 | 
| 
 
	CASH FLOW FROM FINANCING
	ACTIVITIES:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Proceeds from short-term borrowings
 
 | 
	 
 | 
	 
 | 
	5,567,000
 | 
	 
 | 
	 
 | 
	 
 | 
	662,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Payments on short-term borrowings
 
 | 
	 
 | 
	 
 | 
	(7,937,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(1,600,000
 | 
	)
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Payments on long-term obligations
 
 | 
	 
 | 
	 
 | 
	(645,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(43,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(19,000
 | 
	)
 | 
| 
 
	Gross proceeds from sale of common
	stock and exercise of warrants and options
 
 | 
	 
 | 
	 
 | 
	29,829,000
 | 
	 
 | 
	 
 | 
	 
 | 
	12,500,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Payment of common stock issuance
	costs
 
 | 
	 
 | 
	 
 | 
	(1,764,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(1,854,000
 | 
	)
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Net cash provided by (used in)
	financing activities
 
 | 
	 
 | 
	 
 | 
	25,050,000
 | 
	 
 | 
	 
 | 
	 
 | 
	9,665,000
 | 
	 
 | 
	 
 | 
	 
 | 
	(19,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Net increase (decrease) in cash
	and cash equivalents
 
 | 
	 
 | 
	 
 | 
	1,658,000
 | 
	 
 | 
	 
 | 
	 
 | 
	216,000
 | 
	 
 | 
	 
 | 
	 
 | 
	(7,531,000
 | 
	)
 | 
| 
 
	Cash and cash equivalents at
	beginning of year
 
 | 
	 
 | 
	 
 | 
	11,144,000
 | 
	 
 | 
	 
 | 
	 
 | 
	12,802,000
 | 
	 
 | 
	 
 | 
	 
 | 
	13,018,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Cash and cash equivalents at end
	of year
 
 | 
	 
 | 
	$
 | 
	12,802,000
 | 
	 
 | 
	 
 | 
	$
 | 
	13,018,000
 | 
	 
 | 
	 
 | 
	$
 | 
	5,487,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
	See accompanying notes to the consolidated financial statements.
	F-6
 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	 
	Note 1 
	The Company
	 
	Superconductor Technologies Inc. (together with its
	subsidiaries, the Company) was incorporated in
	Delaware on May 11, 1987 and maintains its headquarters in
	Santa Barbara, California. The Company operates in a single
	industry segment, the research, development, manufacture and
	marketing of high-performance infrastructure products for
	wireless voice and data applications. The Companys
	commercial products are divided into three product offerings:
	SuperLink (high-temperature superconducting filters), AmpLink
	(high performance, ground-mounted amplifiers) and SuperPlex
	(high performance multiplexers). The Companys research and
	development contracts are used as a source of funds for its
	commercial technology development. From 1987 to 1997, the
	Company was engaged primarily in research and development and
	generated revenues primarily from government research contracts.
	 
	The Company continues to be involved as either contractor or
	subcontractor on a number of contracts with the United States
	government. These contracts have been and continue to provide a
	significant source of revenues for the Company. For the years
	ended December 31, 2004, 2005, and 2006, government related
	contracts account for 27%, 22% and 16%, respectively, of the
	Companys net revenues.
	 
	Note 2 
	Summary of Significant Accounting Policies
	 
	Basis
	of Presentation
	 
	In 2006, the Company incurred a net loss of $29.6 million
	and negative cash flows from operations of $7.3 million and
	in 2005 the Company incurred a net loss of $14.2 million
	and negative cash flows from operations of $9.4 million.
	 
	The Companys principal sources of liquidity consist of
	existing cash balances and funds expected to be generated from
	future operations. Based on our current forecasts, our cash
	resources may not be sufficient to fund our planned operations
	for the remainder of 2007. We believe one of the key factors to
	our liquidity in 2007 will be our ability to successfully
	execute on our plans to increase sales levels. Our cash
	requirements will also depend on numerous other variable
	factors, including the rate of growth of sales, the timing and
	levels of products purchased, payment terms and credit limits
	from manufacturers, and the timing and level of accounts
	receivable collections. Because of the uncertainty of these many
	factors, the Company may raise funds in the next six months to
	meet its working capital needs.
	 
	There is no assurance that additional financing (public or
	private) will be available on acceptable terms or at all. If the
	Company issues additional equity securities to raise funds, the
	ownership percentage of its existing stockholders would be
	reduced. New investors may demand rights, preferences or
	privileges senior to those of existing holders of common stock.
	If the Company cannot raise any needed funds, it might be forced
	to make further substantial reductions in its operating
	expenses, which could adversely affect its ability to implement
	its current business plan and ultimately its viability as a
	company.
	 
	The Companys financial statements have been prepared
	assuming that it will continue as a going concern. The factors
	described above raise substantial doubt about its ability to
	continue as a going concern. These financial statements do not
	include any adjustments that might result from this uncertainty.
	 
	Principles
	of Consolidation
	 
	The consolidated financial statements include the accounts of
	Superconductor Technologies Inc. and its wholly owned
	subsidiaries (the Company). All significant
	intercompany transactions have been eliminated from the
	consolidated financial statements.
	F-7
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
	 
	Cash
	and Cash Equivalents
	 
	Cash and cash equivalents consist of highly liquid investments
	with original maturities of three months or less. Cash and cash
	equivalents are maintained with quality financial institutions
	and from time to time exceed FDIC limits. Historically, the
	Company has not experienced any losses due to such concentration
	of credit risk.
	 
	Accounts
	Receivable
	 
	The Company sells predominantly to entities in the wireless
	communications industry and to entities of the United States
	government. The Company grants uncollateralized credit to its
	customers. The Company performs usual and customary credit
	evaluations of its customers before granting credit. Trade
	accounts receivable are recorded at the invoiced amount and do
	not bear interest. The allowance for doubtful accounts is our
	best estimate of the amount of probable credit losses in our
	existing accounts receivable. The Company determines the
	allowance based on historical write-off experience. Past due
	balances are reviewed for collectibility. Accounts balances are
	charged off against the allowance when the Company deems it is
	probable the receivable will not be recovered. The Company does
	not have any off balance sheet credit exposure related to its
	customers.
	 
	Revenue
	Recognition
	 
	Commercial revenues are principally derived from the sale of the
	Companys SuperLink, AmpLink and SuperPlex family of
	products and are recognized once all of the following conditions
	have been met: a) an authorized purchase order has been
	received in writing, b) customers credit worthiness
	has been established, c) shipment of the product has
	occurred, d) title has transferred, and e) if
	stipulated by the contract, customer acceptance has occurred and
	all significant vendor obligations, if any, have been satisfied.
	 
	Contract revenues are principally generated under research and
	development contracts. Contract revenues are recognized
	utilizing the
	percentage-of-completion
	method measured by the relationship of costs incurred to total
	estimated contract costs. If the current contract estimate were
	to indicate a loss, utilizing the funded amount of the contract,
	a provision would be made for the total anticipated loss.
	Revenues from research related activities are derived primarily
	from contracts with agencies of the United States Government.
	Credit risk related to accounts receivable arising from such
	contracts is considered minimal. These contracts include
	cost-plus, fixed price and cost sharing arrangements and are
	generally short-term in nature.
	 
	All payments to the Company for work performed on contracts with
	agencies of the U.S. Government are subject to adjustment
	upon audit by the Defense Contract Audit Agency. Contract audits
	through 2002 are closed. Based on historical experience and
	review of current projects in process, management believes that
	the audits will not have a significant effect on the financial
	position, results of operations or cash flows of the Company.
	 
	Shipping
	and Handling Fees and Costs
	 
	Shipping and handling fees billed to customers are included in
	net commercial product revenues. Shipping and handling fees
	associated with freight are generally included in cost of
	commercial product revenues.
	 
	Warranties
	 
	The Company offers warranties generally ranging from one to five
	years, depending on the product and negotiated terms of purchase
	agreements with its customers. Such warranties require the
	Company to repair or replace defective product returned to the
	Company during such warranty period at no cost to the customer.
	An estimate by the Company for warranty related costs is
	recorded by the Company at the time of sale based on its actual
	historical product return rates and expected repair costs. Such
	costs have been within managements expectations.
	F-8
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
	 
	Guarantees
	 
	In connection with the sales and manufacturing of its commercial
	products, the Company indemnifies, without limit or term, its
	customers and contract manufactures against all claims, suits,
	demands, damages, liabilities, expenses, judgments, settlements
	and penalties arising from actual or alleged infringement or
	misappropriation of any intellectual property relating to its
	products or other claims arising from its products. The Company
	cannot reasonably develop an estimate of the maximum potential
	amount of payments that might be made under its guarantee
	because of the uncertainty as to whether a claim might arise and
	how much it might total. Historically, the Company has not
	incurred any expenses related to these guarantees.
	 
	Research
	and Development Costs
	 
	Research and development costs are expensed as incurred and
	include salary, facility, depreciation and material expenses.
	Research and development costs incurred solely in connection
	with research and development contracts are charged to contract
	research and development expense. Other research and development
	costs are charged to other research and development expense.
	 
	Inventories
	 
	Inventories are stated at the lower of cost or market, with
	costs primarily determined using standard costs, which
	approximate actual costs utilizing the
	first-in,
	first-out method. We review inventory quantities on hand and on
	order and record, on a quarterly basis, a provision for excess
	and obsolete inventory
	and/or
	vendor cancellation charges related to purchase commitments. If
	the results of the review determine that a write-down is
	necessary, the Company recognizes a loss in the period in which
	the loss is identified, whether or not the inventory is retained
	or disposed. Our inventory reserves establish a new cost basis
	for inventory and are not reversed until the related inventory
	is sold or otherwise disposed. Such provisions are established
	based on historical usage, adjusted for known changes in demands
	for such products, or the estimated forecast of product demand
	and production requirements. Costs associated with idle capacity
	are expensed immediately.
	 
	Property
	and Equipment
	 
	Property and equipment are recorded at cost. Equipment is
	depreciated using the straight-line method over their estimated
	useful lives ranging from three to five years. Leasehold
	improvements and assets financed under capital leases are
	amortized over the shorter of their useful lives or the lease
	term. Furniture and fixtures are depreciated over seven years.
	Expenditures for additions and major improvements are
	capitalized. Expenditures for minor tooling, repairs and
	maintenance and minor improvements are charged to expense as
	incurred. When property or equipment is retired or otherwise
	disposed of, the related cost and accumulated depreciation are
	removed from the accounts. Gains or losses from retirements and
	disposals are recorded in selling, general and administration
	expenses.
	 
	Patents,
	Licenses and Purchased Technology
	 
	Patents and licenses are recorded at cost and are amortized
	using the straight-line method over the shorter of their
	estimated useful lives or approximately seventeen years.
	Purchased technology acquired through the acquisition of
	Conductus, Inc. in 2002 is recorded at its estimated fair value
	and is amortized using the straight-line method over seven years.
	 
	Goodwill
	 
	Goodwill represents the excess of purchase price over fair value
	of net assets acquired in connection with the acquisition of
	Conductus in December 2002. Conductus was acquired primarily for
	the synergies the acquisition
	F-9
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
	would bring to our existing business of developing,
	manufacturing and marketing products for the commercial wireless
	telecommunications business and for the synergies it would have
	on the Companys fund raising abilities.
	 
	Goodwill is tested for impairment annually in the fourth quarter
	after the annual planning process, or earlier if events occur
	which require an impairment analysis be performed. The Company
	operates in a single business segment as a single reporting
	unit. The first step of the impairment test, used to identify
	potential impairment, compares the fair value based on market
	capitalization of the entire Company with its book value of its
	net assets, including goodwill. (The market capitalization of
	the Company is based on the closing price of its common stock as
	traded on NASDAQ multiplied by its outstanding common shares.)
	If the fair value of the Company exceeds the book value of its
	net assets, goodwill of the Company is not considered impaired.
	If the book value of the net assets of the Company exceeds its
	fair value, the second step of the goodwill impairment test
	shall be performed to measure the amount of impairment loss. The
	second step of the goodwill impairment test, used to measure the
	amount of impairment loss, compares the implied fair value of
	the goodwill with the book value of that goodwill. If the
	carrying amount of the reporting unit goodwill exceeds the
	implied fair value of that goodwill, an impairment loss shall be
	recognized in an amount equal to that excess. By July 1,
	2006, the Companys market capitalization had declined to
	$25.5 million, an amount less than the total book value of
	the Company. We concluded that our declining stock price
	constituted an event under FAS 142 and required us to test
	for goodwill impairment as of July 1, 2006. We then
	proceeded with step two of the impairment analysis 
	determining the fair values of all the tangible and intangible
	assets of the Company and then aggregating and subtracting these
	values from the fair value of the Company. Our analysis was not
	complete at the time we filed our quarterly report for the
	second quarter, but our preliminary analysis led us to
	reasonably estimate at that time that the Companys fair
	market value was less than its net assets excluding goodwill.
	Accordingly, we recorded a full write-down of the goodwill
	($20.1 million) in the second quarter. We completed this
	exercise in the third quarter and confirmed that an impairment
	loss had occurred.
	 
	Long-Lived
	Assets
	 
	The realizability of long-lived assets is evaluated periodically
	as events or circumstances indicate a possible inability to
	recover the carrying amount. Long-lived assets that will no
	longer be used in the business are written off in the period
	identified since they will no longer generate any positive cash
	flows for the Company. Periodically, long lived assets that will
	continue to be used by the Company need to be evaluated for
	recoverability. Such evaluation is based on various analyses,
	including cash flow and profitability projections. The analyses
	necessarily involve significant management judgment. In the
	event the projected undiscounted cash flows are less than net
	book value of the assets, the carrying value of the assets will
	be written down to their estimated fair value. We tested our
	long lived assets for recoverability during fiscal 2006 and
	determined there was no impairment.
	 
	Restructuring
	Expenses
	 
	Liability for costs associated with an exit or disposal activity
	are recognized when the liability is incurred.
	 
	Loss
	Contingencies
	 
	In the normal course of business the Company is subject to
	claims and litigation, including allegations of patent
	infringement. Liabilities relating to these claims are recorded
	when it is determined that a loss is probable and the amount of
	the loss can be reasonably estimated. The costs of defending the
	Company in such matters are expensed as incurred. Insurance
	proceeds recoverable are recorded when deemed probable.
	 
	Income
	Taxes
	 
	The Company accounts for income taxes under the provisions of
	Statement of Financial Accounting Standards No. 109
	(SFAS 109), Accounting for Income
	Taxes. SFAS 109 utilizes an asset and liability
	approach that requires the recognition of deferred tax assets
	and liabilities for the expected future tax consequences of
	events that have been recognized in the Companys financial
	statements or tax returns. In estimating future tax
	consequences,
	F-10
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
	SFAS 109 generally considers all expected future events
	other than enactments of changes in the tax laws or rates.
	Valuation allowances are established when necessary to reduce
	deferred tax assets to the amount expected to be realized.
	 
	Marketing
	Costs
	 
	All costs related to marketing and advertising the
	Companys products are expensed as incurred or at the time
	the advertising takes place. Advertising costs were not material
	in each of the three years in the period ended December 31,
	2006.
	 
	Net
	Loss Per Share
	 
	Basic and diluted net loss per share is computed by dividing net
	loss available to common stockholders by the weighted average
	number of common shares outstanding in each year. Net loss
	available to common stockholders is computed after deducting
	accumulated dividends on cumulative preferred stock, deemed
	dividends and accretion of redemption value on redeemable
	preferred stock for the period and beneficial conversion
	features on issuance of convertible preferred stock. Potential
	common shares are not included in the calculation of diluted
	loss per share because their effect is antidilutive.
	 
	Stock-based
	Compensation
	 
	Effective January 1, 2006, we adopted the provisions of
	Statement of Financial Accounting Standards (SFAS)
	No. 123(revised 2004), Share-Based Payment
	(SFAS No. 123(R)). Under this provision,
	the share-based compensation cost recognized beginning
	January 1, 2006 includes compensation cost for (i) all
	share-based payments granted prior to, but not vested as of
	January 1, 2006, based on the grant date fair value
	originally estimated in accordance with the provisions of
	SFAS No. 123, Accounting for Stock-Based
	Compensation, (SFAS No. 123) and
	(ii) all share-based payments granted subsequent to
	January 1, 2006, based on the grant date fair value
	estimated in accordance with the provisions of
	SFAS No. 123(R). Compensation cost under
	SFAS No. 123(R) is recognized ratably using the
	straight-line attribution method over the expected vesting
	period. Prior periods are not restated under this transition
	method.
	 
	As a result of adopting SFAS 123R, the impact to the
	Consolidated Statement of Operations for the year ended
	December 31, 2006 on net income, for stock options and
	awards, was an expense of $280,000 and $0.02 on basic and
	diluted earnings per share. No stock compensation cost was
	capitalized during the period.
	 
	In the years prior to 2006, as permitted under Statement of
	Financial Accounting Standards No. 123
	(SFAS 123), Accounting for Stock-Based
	Compensation, the Company elected to follow Accounting
	Principles Board Opinion No. 25, Accounting for Stock
	Issued to Employees in accounting for its stock options
	and other stock-based employee awards. Pro forma information
	regarding net loss and loss per share, as calculated under the
	provisions of SFAS 123, are disclosed in the notes to the
	financial statements. The Company accounted for equity
	securities issued to non-employees in accordance with the
	provision of SFAS 123 and Emerging Issues Task Force
	96-18.
	 
	In 2004 and 2005 the Company did not recognize compensation
	expense for its employee awards. If the Company had elected to
	recognize compensation expense for employee awards based upon
	the fair value at the
	F-11
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
	grant date consistent with the methodology prescribed by
	SFAS 123, the Companys net loss and net loss per
	share would have been increased to the pro forma amounts
	indicated below:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	For the Years Ended December 31,
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	2004
 | 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
| 
	 
 | 
| 
 
	Net loss:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	As reported
 
 | 
	 
 | 
	$
 | 
	(31,217,000
 | 
	)
 | 
	 
 | 
	$
 | 
	(14,213,000
 | 
	)
 | 
| 
 
	Stock-based employee compensation
	included in net loss
 
 | 
	 
 | 
	 
 | 
	48,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Stock-based compensation expense
	determined under fair value method
 
 | 
	 
 | 
	 
 | 
	(5,543,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(6,459,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Pro forma
 
 | 
	 
 | 
	$
 | 
	(36,712,000
 | 
	)
 | 
	 
 | 
	$
 | 
	(20,672,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Basic and diluted loss per
	share
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	As reported
 
 | 
	 
 | 
	$
 | 
	(3.71
 | 
	)
 | 
	 
 | 
	$
 | 
	(1.24
 | 
	)
 | 
| 
 
	Stock-based compensation expense
	determined under fair value method
 
 | 
	 
 | 
	 
 | 
	(0.66
 | 
	)
 | 
	 
 | 
	 
 | 
	(0.57
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Pro forma
 
 | 
	 
 | 
	$
 | 
	(4.37
 | 
	)
 | 
	 
 | 
	$
 | 
	(1.81
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
	Use of
	Estimates
	 
	The preparation of financial statements in conformity with
	generally accepted accounting principles requires management to
	make estimates and assumptions that affect the reported amounts
	of assets and liabilities and disclosure of contingent assets
	and liabilities at the date of the financial statements and the
	reported amounts of revenues and expenses during the reporting
	periods. The significant estimates in the preparation of the
	financial statements relate to the assessment of the carrying
	amount of accounts receivable, inventory, fixed assets,
	intangibles, goodwill, estimated provisions for warranty costs,
	accruals for restructuring and lease abandonment costs, contract
	revenues, income taxes and disclosures related to the
	litigation. Actual results could differ from those estimates and
	such differences may be material to the financial statements.
	 
	Fair
	Value of Financial Instruments
	 
	The carrying amount of cash and cash equivalents, accounts
	receivable, accounts payable and accrued expenses approximate
	fair value due to the short-term nature of these instruments.
	The Company estimates that the carrying amount of the debt
	approximates fair value based on the Companys current
	incremental borrowing rates for similar types of borrowing
	arrangements.
	 
	Comprehensive
	Income
	 
	The Company has no items of other comprehensive income in any
	period and consequently does not report comprehensive income.
	 
	Segment
	Information
	 
	The Company operates in a single business segment, the research,
	development, manufacture and marketing of high performance
	products used in cellular base stations to maximize the
	performance of wireless telecommunications networks by improving
	the quality of uplink signals from mobile wireless devices. Net
	commercial product revenues are primarily derived from the sales
	of the Companys SuperLink, AmpLink and SuperPlex products.
	The Company currently sells most of its products directly to
	wireless network operators in the United States. Net revenues
	derived principally from government research and development
	contracts are presented separately on the statement of
	operations for all periods presented.
	F-12
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
	 
	Reverse
	Stock Split
	 
	On March 2, 2006, we announced that our Board of Directors
	had authorized a
	one-for-ten
	(1:10) reverse split of the common stock. We made the reverse
	stock split effective as of the open of business on
	March 13, 2006. The reverse stock split had been approved
	by our stockholders at the 2005 Annual Meeting.
	 
	Certain
	Risks and Uncertainties
	 
	The Companys long-term prospects are dependent upon the
	continued and increased market acceptance for the product.
	 
	The Company currently sells most of its products directly to
	wireless network operators in the United States and its product
	sales have historically been concentrated in a small number of
	customers. In 2006, the Company had three customers that
	represented 44%, 20% and 16% of total net revenues. At
	December 31, 2006, these three customers represented 66% of
	accounts receivable. In 2005, the Company these three customers
	that represented 31%, 37% and 15% of total net revenues and in
	2004 the Company had two customers that represented 46% and 17%
	of total net revenues. The loss of or reduction in sales, or the
	inability to collect outstanding accounts receivable, from any
	of these customers could have a material adverse effect on the
	Companys business, financial condition, results of
	operations and cash flows.
	 
	The Company currently relies on one supplier for purchase of
	high quality substrates for growth of high-temperature
	superconductor films and a limited number of suppliers for other
	key components of its products. The loss of any of these
	suppliers could have material adverse effect on the
	Companys business, financial condition, results of
	operations and cash flows.
	 
	In connection with the sales of its commercial products, the
	Company indemnifies, without limit or term, its customers
	against all claims, suits, demands, damages, liabilities,
	expenses, judgments, settlements and penalties arising from
	actual or alleged infringement or misappropriation of any
	intellectual property relating to its products or other claims
	arising from its products. The Company cannot reasonably develop
	an estimate of the maximum potential amount of payments that
	might be made under its guarantee because of the uncertainty as
	to whether a claim might arise and how much it might total.
	 
	Recent
	Accounting Pronouncements
	 
	In February 2007, the FASB issued SFAS No. 159,
	The Fair Value Option for Financial Assets and Financial
	Liabilities (SFAS 159). Under the provisions of
	SFAS 159, Companies may choose to account for eligible
	financial instruments, warranties and insurance contracts at
	fair value on a
	contract-by-contract
	basis. Changes in fair value will be recognized in earnings each
	reporting period. SFAS 159 is effective for financial
	statements issued for fiscal years beginning after
	November 15, 2007, and interim periods within those fiscal
	years. The Company is currently evaluating the requirements of
	SFAS 159 and have not yet determined the impact on the
	financial statements.
	 
	In September 2006, the FASB issued SFAS No. 157,
	Fair Value Measurements, which defines fair value,
	establishes a framework for using fair value to measure assets
	and liabilities, and expands disclosures about fair value
	measurements. The Statement applies whenever other statements
	require or permit assets or liabilities to be measured at fair
	value. SFAS No. 157 is effective for fiscal years
	beginning after November 15, 2007. We are currently
	evaluating the impact this Statement will have on our
	consolidated financial statements.
	 
	In September 2006, the SEC issued Staff Accounting Bulletin
	(SAB) No. 108, Considering the Effects of
	Prior Year Misstatements when Quantifying Misstatements in
	Current Year Financial Statements, which provides
	interpretive guidance regarding the consideration given to prior
	year misstatements when determining materiality in current year
	financial statements. SAB No. 108 is effective for
	fiscal years ending after November 15, 2006 and had no
	impact on our consolidated financial statements.
	F-13
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
	 
	In June 2006, the Financial Accounting Standards Board (FASB)
	issued FASB Interpretation Number 48 (FIN 48),
	Accounting for Uncertainty in Income Taxes  an
	interpretation of FASB Statement No. 109. The
	interpretation contains a two step approach to recognizing and
	measuring uncertain tax positions accounted for in accordance
	with SFAS No. 109. The first step is to evaluate the
	tax position for recognition by determining if the weight of
	available evidence indicates it is more likely than not that the
	position will be sustained on audit, including resolution of
	related appeals or litigation processes, if any. The second step
	is to measure the tax benefit as the largest amount which is
	more than 50% likely of being realized upon ultimate settlement.
	The provisions are effective for the company beginning in the
	first quarter of 2007. We are evaluating the impact this
	statement will have on our financial statements.
	 
	In March 2006, the Emerging Issues Task Force (EITF)
	issued EITF Issue
	06-03,
	How Taxes Collected from Customers and Remitted to
	Governmental Authorities Should Be Presented in the Income
	Statement (That Is, Gross versus Net Presentation). A
	consensus was reached that entities may adopt a policy of
	presenting sales taxes in the income statement on either a gross
	or net basis. If taxes are significant, an entity should
	disclose its policy of presenting taxes and the amounts of
	taxes. The guidance is effective for periods beginning after
	December 15, 2006. We present revenues net of sales taxes.
	This issue has not impacted our method for presenting these
	sales taxes in our consolidated financial statements.
	 
	Note 3 
	Short Term Borrowings
	 
	The Company has a line of credit with a bank. The line of credit
	expires June 15, 2007 and is structured as a sale of
	accounts receivable. The agreement provides for the sale of up
	to $5 million of eligible accounts receivable, with
	advances to the Company totaling 80% of the receivables sold.
	Advances under the agreement are collateralized by all the
	Companys assets. Under the terms of the agreement, the
	Company continues to service the sold receivables and is subject
	to recourse provisions.
	 
	Advances bear interest at the prime rate (8.25% at
	December 31, 2006) plus 2.50% subject to a
	minimum monthly charge. There was no amount outstanding under
	this borrowing facility at December 31, 2006.
	 
	The agreement contains representations and warranties,
	affirmative and negative covenants and events of default
	customary for financings of this type. The failure to comply
	with these provisions, or the occurrence of any one of the
	events of default, would prevent any further borrowings and
	would generally require the repayment of any outstanding
	borrowings. Such representations, warranties and events of
	default include (a) non-payment of debt and interest
	hereunder, (b) non-compliance with terms of the agreement
	covenants, (c) insolvency or bankruptcy, (d) material
	adverse change, (e) merger or consolidation where the
	Companys shareholders do not hold a majority of the voting
	rights of the surviving entity, (f) transactions outside
	the normal course of business, or (g) payment of dividends.
	 
	On April 28, 2004, in connection with modification of the
	existing credit facility with Silicon Valley Bank and
	$2.0 million bridge loan, the Company issued to the bank
	warrants to purchase 10,000 shares of common stock at
	$18.50 per share and to the bridge lender warrants to purchase
	50,000 shares of common stock at $18.50 per share. The
	warrant to the bridge lender contains antidilution provisions.
	These warrants expire on April 28, 2011. The fair value of
	the warrants issued in connection with the bridge loans were
	estimated using the Black-Scholes option pricing method, totaled
	$802,000 and were accounted for as debt issuances costs and
	amortized over the term of the loan. Assumptions used in the
	calculation were: dividends of zero percent each year, expected
	volatilities of 112%, contractual life of 7 years and risk
	free interest rate of 3.99%.
	 
	As a result of common stock issuances in 2004 and 2005, the
	exercise price and the number of shares of the warrants issued
	to a bridge lender under the 2004 Bridge Loan was adjusted to
	$13.30 and 69,549, respectively. The Silicon Valley Bank warrant
	remains unchanged.
	F-14
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
	 
	Note 4 
	Retirement of Companys Chief Executive Officer
	 
	On March 15, 2005, the Companys Chief Executive
	Officer and President retired. In connection with the
	retirement, the Company agreed to the continuation of his salary
	and benefits for one year and to immediately vest and extend all
	his outstanding stock options and the executive agreed to
	provide certain consulting services as requested by the Company.
	Also, in connection with the retirement, a $150,000 loan made to
	the Companys Chief Executive Officer in 2001, and in
	accordance with the existing terms of a promissory note which
	were in effect prior to the adoption of the Sarbanes-Oxley Act
	of 2002, was forgiven. The Company recognized expense of
	$565,000 relating to the retirement of the CEO in the year ended
	December 31, 2005.
	 
	Note 5 
	Notes Receivable From Stockholder
	 
	Mr. Shalvoy, a director and stockholder, executed two notes
	aggregating $820,244 in principal in connection with the
	exercise in December 2000 of two options to purchase Conductus,
	Inc. common stock prior our acquisition of Conductus, Inc. in
	December 2002. Through the third quarter of, 2005, we carried
	the principal (as Notes Receivable from
	Stockholder) and accrued interest (as Prepaid
	Expenses and Other Current Assets) for both notes as
	assets on our balance sheet.
	 
	We filed a lawsuit against Mr. Shalvoy on December 21,
	2005 in the California Superior Court (Case
	No. 1186812) to collect both notes. In that same
	quarter, due to Mr. Shalvoys refusal to pay the notes
	voluntarily we recorded a reserve for the value of the notes
	(principal plus accrued interest) in excess of the market value
	of the collateral securing the notes.
	 
	On March 2, 2007, we entered into a Settlement Agreement
	and Mutual Release of All Claims with Mr. Shalvoy to settle
	the lawsuit. The agreement provides for a payment of $610,000 to
	us on or before April 2, 2007 in payment of one note,
	including interest and attorneys fees, and the rescission
	of Mr. Shalvoys second purported option exercise
	including cancellation of the related note.
	 
	Note 6 
	Income Taxes
	 
	The Company has incurred a net loss in each year of operation
	since inception resulting in no current or deferred tax expense
	for the years ended December 31, 2004, 2005 and 2006.
	 
	The benefit for income taxes differs from the amount obtained by
	applying the federal statutory income tax rate to loss before
	benefit for income taxes for the years ended December 31,
	2004, 2005 and 2006 as follows:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	For the Year Ending December 31
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	2004
 | 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
| 
	 
 | 
| 
 
	Tax benefit computed at Federal
	statutory rate
 
 | 
	 
 | 
	 
 | 
	34.0
 | 
	%
 | 
	 
 | 
	 
 | 
	34.0
 | 
	%
 | 
	 
 | 
	 
 | 
	34.0
 | 
	%
 | 
| 
 
	Increase (decrease) in taxes due
	to:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Change in valuation allowance
 
 | 
	 
 | 
	 
 | 
	(39.8
 | 
	)
 | 
	 
 | 
	 
 | 
	(39.8
 | 
	)
 | 
	 
 | 
	 
 | 
	(16.7
 | 
	)
 | 
| 
 
	State taxes, net of federal benefit
 
 | 
	 
 | 
	 
 | 
	5.8
 | 
	 
 | 
	 
 | 
	 
 | 
	5.8
 | 
	 
 | 
	 
 | 
	 
 | 
	5.8
 | 
	 
 | 
| 
 
	Impairment of Goodwill (not
	deductible for tax)
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	(23.1
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	%
 | 
	 
 | 
	 
 | 
	
 | 
	%
 | 
	 
 | 
	 
 | 
	
 | 
	%
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	F-15
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
	The significant components of deferred tax assets (liabilities)
	at December 31 are as follows:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	For the Year Ended December 31,
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
| 
	 
 | 
| 
 
	Loss carryforwards
 
 | 
	 
 | 
	$
 | 
	90,521,000
 | 
	 
 | 
	 
 | 
	$
 | 
	101,519,000
 | 
	 
 | 
| 
 
	Capitalized research and
	development
 
 | 
	 
 | 
	 
 | 
	5,236,000
 | 
	 
 | 
	 
 | 
	 
 | 
	3,972,000
 | 
	 
 | 
| 
 
	Depreciation
 
 | 
	 
 | 
	 
 | 
	2,306,000
 | 
	 
 | 
	 
 | 
	 
 | 
	2,430,000
 | 
	 
 | 
| 
 
	Tax credits
 
 | 
	 
 | 
	 
 | 
	3,538,000
 | 
	 
 | 
	 
 | 
	 
 | 
	3,226,000
 | 
	 
 | 
| 
 
	Inventory
 
 | 
	 
 | 
	 
 | 
	1,311,000
 | 
	 
 | 
	 
 | 
	 
 | 
	559,000
 | 
	 
 | 
| 
 
	Purchase accounting adjustments
 
 | 
	 
 | 
	 
 | 
	138,000
 | 
	 
 | 
	 
 | 
	 
 | 
	93,000
 | 
	 
 | 
| 
 
	Acquired intellectual property
 
 | 
	 
 | 
	 
 | 
	(383,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(286,000
 | 
	)
 | 
| 
 
	Other
 
 | 
	 
 | 
	 
 | 
	632,000
 | 
	 
 | 
	 
 | 
	 
 | 
	640,000
 | 
	 
 | 
| 
 
	Less: valuation allowance
 
 | 
	 
 | 
	 
 | 
	(106,299,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(112,153,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
	The valuation allowance increased by $5,854,000 in 2006 and
	decreased by $330,000 in 2005.
	 
	As of December 31, 2006, the Company has net operating loss
	carryforwards for federal and state income tax purposes of
	approximately $275.1 million and $143.4 million
	,
	respectively, which expire in the years 2007 through 2026.
	Of these amounts $91.2 million and $23.5 million,
	respectively, resulted from the acquisition of Conductus.
	Included in the net operating loss carryforwards are deductions
	related to stock options of approximately $24.1 million and
	$13.1 million for federal and California income tax
	purposes, respectively. To the extent net operating loss
	carryforwards are recognized for accounting purposes the
	resulting benefits related to the stock options will be credited
	to stockholders equity. In addition, the Company has
	research and development and other tax credits for federal and
	state income tax purposes of approximately $2.4 million and
	$983,000, respectively, which expire in the years 2007 through
	2026. Of these amounts $661,000 and $736,000, respectively
	resulted from the acquisition of Conductus.
	 
	Due to the uncertainty surrounding their realization, the
	Company has recorded a full valuation allowance against its net
	deferred tax assets. Accordingly, no deferred tax asset has been
	recorded in the accompanying balance sheet.
	 
	Section 382 of the Internal Revenue Code imposes an annual
	limitation on the utilization of net operating loss
	carryforwards based on a statutory rate of return (usually the
	applicable federal funds rate, as defined in the
	Internal Revenue Code) and the value of the corporation at the
	time of a change of ownership as defined by
	Section 382. Recently the Company completed an analysis of
	its equity transactions and determined that it had a change in
	ownership in August 1999 and December 2002. Therefore, the
	ability to utilize net operating loss carryforwards incurred
	prior to the change of ownership totaling $98.0 million
	will be subject in future periods to an annual limitation of
	$1.3 million. In addition, the Company acquired the right
	to Conductus net operating losses, which are also subject
	to the limitations imposed by Section 382. Conductus
	underwent three ownership changes, which occurred in February
	1999, February 2001 and December 2002. Therefore, the ability to
	utilize Conductus net operating loss carryforwards of
	$91.2 million incurred prior to the ownership changes will
	be subject in future periods to annual limitation of $700,000.
	Net operating losses incurred by the Company subsequent to the
	ownership changes totaled $86.4 million and are not subject
	to this limitation.
	 
	Note 7 
	Stockholders Equity
	 
	Preferred
	Stock
	 
	Pursuant to the Companys Certificate of Incorporation, the
	Board of Directors is authorized to issue up to
	2,000,000 shares of preferred stock (par value
	$.001 per share) in one or more series and to fix the
	rights,
	F-16
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
	preferences, privileges, and restrictions, including the
	dividend rights, conversion rights, voting rights, redemption
	price or prices, liquidation preferences, and the number of
	shares constituting any series or the designation of such series.
	 
	Common
	Stock
	 
	The Company raised no money from the sale of its common stock in
	2006.
	 
	In August 2005, the Company raised net proceeds of $11,441,000,
	net of offering costs of $1,059,000, from the public sale of
	1,712,329 shares of common stock at $7.30 per share
	and
	5-year
	warrants to purchase an additional 342,466 shares of common
	stock exercisable at $11.10 per share. The warrants become
	exercisable on February 16, 2006. The warrant agreement
	also contains the following significant terms: (i) in the
	event of changes in the outstanding Common Stock of the Company,
	the number of shares and their price under the warrant shall be
	correspondingly adjusted and (ii) if, at any time while the
	warrants are outstanding, the Company issues additional shares
	at an effective price less than the warrant price the number of
	shares and their price will be adjusted. This transaction caused
	the exercise price and the number of shares of the warrants
	issued to a bridge lender under the 2004 bridge loan to be
	adjusted to $13.30 and 69,549, respectively, under the
	anti-dilution provisions of the warrants.
	 
	In November 2004 the Company raised net proceeds of $10,065,000,
	net of offering costs of $855,000, from the public sale of
	1,560,000 shares of common stock at $7.00 per share
	based on a negotiated discount to market. This transaction
	caused the exercise price and the number of shares of the
	warrants issued to a bridge lender under the 2004 Bridge Loan to
	be adjusted to $14.60 and 63,356, respectively.
	 
	In May 2004 the Company raised net proceeds of $16,699,000, net
	of offering costs of $1,701,000, from the public sale of
	2,300,000 shares of common stock at $8.00 per share
	based on a negotiated discount to market. This transaction
	caused the exercise price and the number of shares of the
	warrants issued to a bridge lender under the 2004 bridge loan to
	be adjusted to $15.90 and 58,176, respectively.
	 
	Stock
	Options
	 
	The Company has five stock option plans, the 1992 Stock Option
	Plan, the nonstatutory 1992 Directors Stock Option Plan,
	1998 and 1999 Stock Option Plans and the 2003 Equity Incentive
	Plan (collectively, the Stock Option Plans). The
	1988 Stock Option Plan expired in 1998 and the 1992 Stock Option
	Plan and the nonstatutory 1992 Directors Stock Option Plan
	expired in 2002. During 2003, the 1998 and 1999 Stock Option
	Plans were replaced by the 2003 Equity Incentive Plan. Under the
	2003 Equity Incentive Plan, stock awards may consist of stock
	options, stock appreciation rights, restricted stock awards,
	performance awards, and performance share awards. Stock awards
	may be made to directors, key employees, consultants, and
	non-employee directors of the Company. Stock options granted
	under these plans must be granted at prices no less than 100% of
	the market value on the date of grant. Both stock options and
	restricted stock awards have been granted under these plans.
	Generally, stock options become exercisable in installments over
	a minimum of four years, beginning one year after the date of
	grant, and expire not more than ten years from the date of
	grant, with the exception of 10% or greater stockholders which
	may have options granted at prices no less than the market value
	on the date of grant, and expire not more than five years from
	the date of grant. There have been no stock option exercises in
	2005 or 2006.
	 
	At the Companys 2005 Annual Meeting, the stockholders
	approved an increase in the total shares available for grants
	under the 2003 Equity Plan from 600,000 shares of common
	stock to 1,200,000 shares of common stock. The stockholders
	also approved a corresponding increase in the related sublimits
	under the plan.
	 
	During 2005, the Companys President and Chief Executive
	Officer, as well as another board member, retired. In connection
	with these retirements, the Company modified the terms of all
	the stock options held by these individuals to fully vest them
	and to extend the term until the earlier of the fifth
	anniversary of the retirement or the
	F-17
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
	normal expiration date. Since these options had no intrinsic
	value at the date of modification, the modifications did not
	impact the Companys statement of operations.
	 
	In 2005, the Compensation Committee of the Board of Directors
	made grants of performance based stock options totaling 40,816
	to the Companys officers and certain managers. The
	Compensation Committee determined that the financial performance
	criteria for these options was not met and therefore these
	options were canceled.
	 
	On December 1, 2005, the Compensation Committee of the
	Companys Board of Directors approved the accelerated
	vesting of all time-vested outstanding
	out-of-the-money
	stock options held by current employees or consultants. For this
	purpose, the Compensation Committee defined
	out-of-the-money
	options as options having an exercise price equal to or
	greater than $5.80 per share (the market price on the date
	of the committees decision to accelerate the vesting). The
	acceleration of vesting increased the pro forma expense in 2005
	by $3.7 million.
	 
	The Company accelerated the vesting of these options in
	anticipation of the impact of Statement of Financial Accounting
	Standard No. 123R (SFAS 123R) Share-Based
	Payment. The primary purpose of the accelerated vesting was to
	minimize the amount of compensation expense recognized in
	relation to the underwater options in future periods following
	the adoption by the Company of SFAS 123R. In addition,
	because these options had exercise prices in excess of current
	market values and were not fully achieving their original
	objectives of incentive compensation and employee retention, the
	Company believes that the acceleration has had a positive effect
	on employee morale and retention.
	 
	For the year ended December 31, 2006, the weighted average
	fair value has been estimated at the date of the grant using the
	Black-Scholes option-pricing model. The following are the
	significant weighted average assumptions used for estimating the
	fair value under our stock option plans:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Year Ended
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	December 31, 2006
 | 
	 
 | 
| 
	 
 | 
| 
 
	Per share fair value at grant date
 
 | 
	 
 | 
	$
 | 
	2.55
 | 
	 
 | 
| 
 
	Risk free interest rate
 
 | 
	 
 | 
	 
 | 
	4.82
 | 
	%
 | 
| 
 
	Expected volatility
 
 | 
	 
 | 
	 
 | 
	95
 | 
	%
 | 
| 
 
	Dividend yield
 
 | 
	 
 | 
	 
 | 
	0
 | 
	%
 | 
| 
 
	Expected life in years
 
 | 
	 
 | 
	 
 | 
	4.0
 | 
	 
 | 
	 
	The Expected life was based on the contractual term of the
	options and the expected employee exercise behavior. Typically,
	options to our employees have a 4 year vesting term and a
	10 year contractual term. Options to Board Members have a
	2 year vesting term and a 10 year contractual term.
	Four year vesting term options vest at 25% after one year and
	ratably, on a monthly basis, thereafter. Two year vesting term
	options vest at 50% after one year and 50% after two years. The
	risk-free interest rate is based on the U.S. Treasury
	zero-coupon issues with a remaining term equal to the expected
	option life assumed at the grant date. The future volatility is
	based on our 4 year historical volatility. The Company used
	an expected dividend yield of 0% because the Company has never
	paid a dividend and does not anticipate paying dividends. The
	Company assumed a 10% forfeiture rate based on historical stock
	option cancellation rates over the last 4 years.
	 
	The impact to the Consolidated Statement of Operations for the
	year ended December 31, 2006 on net income was an expense
	of $187,000 and $0.01 on basic and diluted earnings per share.
	No stock compensation cost was capitalized during the period.
	The total compensation cost related to non-vested awards not yet
	recognized is $219,000 and the weighted-average period over
	which the cost is expected to be recognized is 1.3 years.
	Prior to 2006, we did not recognize compensation expense for
	issuance of stock options.
	F-18
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
	 
	At December 31, 2006, 44,413 shares of common stock
	were available for future grant of options and 1,154,941 options
	had been granted but not yet exercised. Option activity during
	the three years ended December 31, 2006 was as follows:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	Weighted
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Number of
 
 | 
	 
 | 
	 
 | 
	Average Exercise
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Shares
 | 
	 
 | 
	 
 | 
	Price
 | 
	 
 | 
| 
	 
 | 
| 
 
	Outstanding at
	December 31, 2003
 
 | 
	 
 | 
	 
 | 
	754,532
 | 
	 
 | 
	 
 | 
	 
 | 
	62.830
 | 
	 
 | 
| 
 
	Granted
 
 | 
	 
 | 
	 
 | 
	312,616
 | 
	 
 | 
	 
 | 
	 
 | 
	35.520
 | 
	 
 | 
| 
 
	Canceled
 
 | 
	 
 | 
	 
 | 
	(111,445
 | 
	)
 | 
	 
 | 
	 
 | 
	53.860
 | 
	 
 | 
| 
 
	Exercised
 
 | 
	 
 | 
	 
 | 
	(8,978
 | 
	)
 | 
	 
 | 
	 
 | 
	27.800
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Outstanding at
	December 31, 2004
 
 | 
	 
 | 
	 
 | 
	946,275
 | 
	 
 | 
	 
 | 
	 
 | 
	55.210
 | 
	 
 | 
| 
 
	Granted
 
 | 
	 
 | 
	 
 | 
	453,206
 | 
	 
 | 
	 
 | 
	 
 | 
	8.020
 | 
	 
 | 
| 
 
	Canceled
 
 | 
	 
 | 
	 
 | 
	(197,555
 | 
	)
 | 
	 
 | 
	 
 | 
	37.180
 | 
	 
 | 
| 
 
	Exercised
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Outstanding at
	December 31, 2005
 
 | 
	 
 | 
	 
 | 
	1,202,376
 | 
	 
 | 
	 
 | 
	$
 | 
	40.380
 | 
	 
 | 
| 
 
	Granted
 
 | 
	 
 | 
	 
 | 
	80,900
 | 
	 
 | 
	 
 | 
	 
 | 
	3.702
 | 
	 
 | 
| 
 
	Canceled
 
 | 
	 
 | 
	 
 | 
	(128,335
 | 
	)
 | 
	 
 | 
	 
 | 
	34.643
 | 
	 
 | 
| 
 
	Exercised
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Outstanding at
	December 31, 2006
 
 | 
	 
 | 
	 
 | 
	1,154,941
 | 
	 
 | 
	 
 | 
	$
 | 
	38.334
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
	The following table summarizes information concerning currently
	outstanding and exercisable stock options at December 31,
	2006:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	Weighted
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	Average
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	Exercisable
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	Remaining
 
 | 
	 
 | 
	 
 | 
	Weighted
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	Weighted
 
 | 
	 
 | 
	Range of
 
 | 
	 
 | 
	Number
 
 | 
	 
 | 
	 
 | 
	Contractual
 
 | 
	 
 | 
	 
 | 
	Average
 
 | 
	 
 | 
	 
 | 
	Number
 
 | 
	 
 | 
	 
 | 
	Average
 
 | 
	 
 | 
| 
 
	Exercise Prices
 
 | 
	 
 | 
	Outstanding
 | 
	 
 | 
	 
 | 
	Life
 | 
	 
 | 
	 
 | 
	Exercise Price
 | 
	 
 | 
	 
 | 
	Exercisable
 | 
	 
 | 
	 
 | 
	Exercise Price
 | 
	 
 | 
| 
	 
 | 
| 
 
	$ 1.43 - $ 6.90
 
 | 
	 
 | 
	 
 | 
	322,000
 | 
	 
 | 
	 
 | 
	 
 | 
	8.590
 | 
	 
 | 
	 
 | 
	$
 | 
	6.12
 | 
	 
 | 
	 
 | 
	 
 | 
	239,350
 | 
	 
 | 
	 
 | 
	$
 | 
	6.87
 | 
	 
 | 
| 
 
	$ 7.02 - $10.40
 
 | 
	 
 | 
	 
 | 
	277,760
 | 
	 
 | 
	 
 | 
	 
 | 
	7.217
 | 
	 
 | 
	 
 | 
	$
 | 
	10.01
 | 
	 
 | 
	 
 | 
	 
 | 
	273,683
 | 
	 
 | 
	 
 | 
	$
 | 
	10.04
 | 
	 
 | 
| 
 
	$10.50 - $37.50
 
 | 
	 
 | 
	 
 | 
	209,577
 | 
	 
 | 
	 
 | 
	 
 | 
	5.005
 | 
	 
 | 
	 
 | 
	$
 | 
	28.19
 | 
	 
 | 
	 
 | 
	 
 | 
	208,671
 | 
	 
 | 
	 
 | 
	$
 | 
	28.26
 | 
	 
 | 
| 
 
	$38.00 - $66.40
 
 | 
	 
 | 
	 
 | 
	204,272
 | 
	 
 | 
	 
 | 
	 
 | 
	4.255
 | 
	 
 | 
	 
 | 
	$
 | 
	55.16
 | 
	 
 | 
	 
 | 
	 
 | 
	204,270
 | 
	 
 | 
	 
 | 
	$
 | 
	55.16
 | 
	 
 | 
| 
 
	$68.80 - $493.75
 
 | 
	 
 | 
	 
 | 
	141,332
 | 
	 
 | 
	 
 | 
	 
 | 
	3.705
 | 
	 
 | 
	 
 | 
	$
 | 
	158.11
 | 
	 
 | 
	 
 | 
	 
 | 
	141,322
 | 
	 
 | 
	 
 | 
	$
 | 
	158.11
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	1,154,941
 | 
	 
 | 
	 
 | 
	 
 | 
	6.245
 | 
	 
 | 
	 
 | 
	$
 | 
	38.334
 | 
	 
 | 
	 
 | 
	 
 | 
	1,067,296
 | 
	 
 | 
	 
 | 
	$
 | 
	41.133
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
	The outstanding options expire by the end of November 2016. The
	weighted-average contractual term of stock options currently
	exercisable is slightly less than 6.2 years. At
	December 31, 2006 only 5,600 shares of outstanding
	stock options and no exercisable options had an exercise price
	less than the current market value and had an intrinsic value of
	$808 and zero, respectively. The number of options exercisable
	and weighted average exercise price at December 31, 2004
	and 2005 totaled 500,119 and $62.02 and 1,162,330 and $41.32,
	respectively.
	 
	Prior to 2006 the Company had adopted the disclosure-only
	provisions of Statement of Financial Accounting Standards
	No. 123, (SFAS 123), Accounting for
	Stock-Based Compensation. Accordingly, no compensation
	cost had been recognized for the stock-based compensation other
	than for non-employees.
	 
	The fair value of these options for purposes of the pro forma
	amounts in Note 2 was estimated at the date of grant using
	the Black-Scholes option-pricing model with the following
	weighted-average assumptions for the years ended
	December 31, 2004, and 2005, respectively: dividend yields
	of zero percent each year; expected volatilities of
	65-112%
	and
	93.85-95%; risk-free interest rates of 3.44-3.99% and
	4.28-4.62%; and expected life of 4.0 years.
	F-19
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
	All options granted during, 2004 and 2005 were granted at the
	then fair market value of the Companys common stock. The
	weighted average fair value of options granted in 2004 and 2005
	for which the exercise price equals the market price on the
	grant date was $20.20 and $5.50
	,
	respectively.
	 
	Restricted
	Stock Awards
	 
	In July 2006 the Company, for the first time, issued restricted
	stock awards. A total of 331,000 shares were granted and
	will fully vest in one single installment on the second
	anniversary of the grant date in July 2008. The per share
	weighted average grant-date fair value was $1.50. A 10%
	forfeiture rate was assumed.
	 
	The impact to the Consolidated Statement of Operations for the
	twelve months ended December 31, 2006 on net income was an
	expense of $93,000 and $0.01 on basic and diluted earnings per
	share. No stock compensation cost was capitalized during the
	period. The total compensation cost related to non-vested awards
	not yet recognized is $362,000 and the weighted-average period
	over which the cost is expected to be recognized is
	1.6 years.
	 
	Warrants
	 
	The following is a summary of outstanding warrants at
	December 31, 2006:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Common Shares
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	Price
 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	Currently
 
 | 
	 
 | 
	 
 | 
	per
 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Total
 | 
	 
 | 
	 
 | 
	Exercisable
 | 
	 
 | 
	 
 | 
	Share
 | 
	 
 | 
	 
 | 
 
	Expiration Date
 
 | 
| 
	 
 | 
| 
 
	Warrants and options related to
	issuance of common stock
 
 | 
	 
 | 
	 
 | 
	342,466
 | 
	 
 | 
	 
 | 
	 
 | 
	342,466
 | 
	 
 | 
	 
 | 
	$
 | 
	11.10
 | 
	 
 | 
	 
 | 
	August 16, 2010
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	39,786
 | 
	 
 | 
	 
 | 
	 
 | 
	39,786
 | 
	 
 | 
	 
 | 
	 
 | 
	55.00
 | 
	 
 | 
	 
 | 
	March 10, 2007
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	140,658
 | 
	 
 | 
	 
 | 
	 
 | 
	140,658
 | 
	 
 | 
	 
 | 
	 
 | 
	11.90
 | 
	 
 | 
	 
 | 
	December 17, 2007*
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	116,279
 | 
	 
 | 
	 
 | 
	 
 | 
	116,279
 | 
	 
 | 
	 
 | 
	 
 | 
	29.00
 | 
	 
 | 
	 
 | 
	June 24, 2008*
 | 
| 
 
	Warrants related to April 2004
	Bridge Loans
 
 | 
	 
 | 
	 
 | 
	69,549
 | 
	 
 | 
	 
 | 
	 
 | 
	69,549
 | 
	 
 | 
	 
 | 
	 
 | 
	13.30
 | 
	 
 | 
	 
 | 
	April 28, 2011* **
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	10,000
 | 
	 
 | 
	 
 | 
	 
 | 
	10,000
 | 
	 
 | 
	 
 | 
	 
 | 
	18.50
 | 
	 
 | 
	 
 | 
	April 28, 2011*
 | 
| 
 
	Warrants assumed in connection
	with the Conductus, Inc. acquisition
 
 | 
	 
 | 
	 
 | 
	109,500
 | 
	 
 | 
	 
 | 
	 
 | 
	109,500
 | 
	 
 | 
	 
 | 
	 
 | 
	45.83
 | 
	 
 | 
	 
 | 
	September 27, 2007
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	600
 | 
	 
 | 
	 
 | 
	 
 | 
	600
 | 
	 
 | 
	 
 | 
	 
 | 
	312.50
 | 
	 
 | 
	 
 | 
	September 1, 2007
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Total
 
 | 
	 
 | 
	 
 | 
	828,838
 | 
	 
 | 
	 
 | 
	 
 | 
	828,838
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
	 
| 
 | 
 | 
 | 
| 
	* 
 | 
 | 
	The terms of these warrants contain net exercise provisions,
	wherein instead of a cash exercise holders can elect to receive
	common stock equal to the difference between the exercise price
	and the average closing sale price for common shares over
	10-30 days
	immediately preceding the exercise date.
 | 
| 
	 
 | 
| 
	**
 | 
 | 
	The terms of these warrants contain antidilution adjustment
	provisions.
 | 
	 
	No warrants were exercised during the year ended
	December 31, 2005 and 2006
	 
	During the year ended December 31, 2004 the following
	warrants were exercised:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	Common Shares Issued
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Warrants
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	In Accordance with
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Warrants
 
 | 
	 
 | 
	 
 | 
	Price per
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	Net Exercise
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Exercised
 | 
	 
 | 
	 
 | 
	Share
 | 
	 
 | 
	 
 | 
	For Cash
 | 
	 
 | 
	 
 | 
	Provisions
 | 
	 
 | 
| 
	 
 | 
| 
 
	Warrants related to bank borrowings
 
 | 
	 
 | 
	 
 | 
	12,353
 | 
	 
 | 
	 
 | 
	$
 | 
	30 - 32.50
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	7,131
 | 
	 
 | 
| 
 
	Warrants related to issuance of
	common stock
 
 | 
	 
 | 
	 
 | 
	4,286
 | 
	 
 | 
	 
 | 
	 
 | 
	55.00
 | 
	 
 | 
	 
 | 
	 
 | 
	4,286
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Total
 
 | 
	 
 | 
	 
 | 
	16,639
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	4,286
 | 
	 
 | 
	 
 | 
	 
 | 
	7,131
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	F-20
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
	Note 8 
	Employee Savings Plan
	 
	In December 1989, the Board of Directors approved a 401(k)
	savings plan (the 401(k) Plan) for the employees of
	the Company that became effective in 1990. Eligible employees
	may elect to make contributions under the terms of the 401(k)
	Plan; however, contributions by the Company are made at the
	discretion of management. The Company has made no contributions
	to the 401(k) Plan.
	 
	Note 9 
	Commitments and Contingencies
	 
	Operating
	Leases
	 
	The Company leases its offices and production facilities under a
	non-cancelable operating lease that expires in five years. This
	lease contains a minimum rent escalation clause that requires
	additional rental amounts after the first year. Rent expense for
	this lease with minimum annual rent escalation is recognized on
	a straight line basis over the minimum lease term. This lease
	also requires the Company to pay utilities, insurance, taxes and
	other operating expenses and contains one five-year renewal
	option at 95% of the then current market rental value.
	 
	For the years ended December 31, 2004, 2005, and 2006, rent
	expense was $1,262,000, $1,158,000 and $1,152,000, respectively.
	 
	Capital
	Leases
	 
	The Company leases certain property and equipment under a
	capital lease arrangement that expires in 2007. The lease bears
	interest at 14.95%.
	 
	Patents
	and Licenses
	 
	The Company has entered into various licensing agreements
	requiring royalty payments ranging from 0.13% to 2.5% of
	specified product sales. Certain of these agreements contain
	provisions for the payment of guaranteed or minimum royalty
	amounts. In the event that the Company fails to pay minimum
	annual royalties, these licenses may automatically be
	terminated. These royalty obligations terminate in 2009 to 2020.
	Royalty expenses totaled $429,000 in 2004, $211,000 in 2005 and
	$156,000 in 2006. Under the terms of certain royalty agreements,
	royalty payments made may be subject to audit. There have been
	no audits to date and the Company does not expect any possible
	future audit adjustments to be significant.
	 
	The minimum lease payments under operating and capital leases
	and license obligations are as follows:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Year Ending December 31,
 
 | 
	 
 | 
	Licenses
 | 
	 
 | 
	 
 | 
	Operating Leases
 | 
	 
 | 
	 
 | 
	Capital Leases
 | 
	 
 | 
| 
	 
 | 
| 
 
	2007
 
 | 
	 
 | 
	$
 | 
	150,000
 | 
	 
 | 
	 
 | 
	$
 | 
	1,303,000
 | 
	 
 | 
	 
 | 
	$
 | 
	15,000
 | 
	 
 | 
| 
 
	2008
 
 | 
	 
 | 
	 
 | 
	150,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,304,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	2009
 
 | 
	 
 | 
	 
 | 
	150,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,349,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	2010
 
 | 
	 
 | 
	 
 | 
	150,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,396,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	2011
 
 | 
	 
 | 
	 
 | 
	150,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,313,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Thereafter
 
 | 
	 
 | 
	 
 | 
	1,200,000
 | 
	 
 | 
	 
 | 
	 
 | 
	0
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Total payments
 
 | 
	 
 | 
	$
 | 
	1,950,000
 | 
	 
 | 
	 
 | 
	$
 | 
	6,665,000
 | 
	 
 | 
	 
 | 
	 
 | 
	15,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Less: amount representing interest
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	(1,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Present value of minimum lease
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	14,000
 | 
	 
 | 
| 
 
	Less current portion
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	(14,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Long term portion
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	F-21
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
	Note 10 
	Contractual Guarantees and Indemnities
	 
	During its normal course of business, the Company makes certain
	contractual guarantees and indemnities pursuant to which the
	Company may be required to make future payments under specific
	circumstances. The Company has not recorded any liability for
	these contractual guarantees and indemnities in the accompanying
	consolidated financial statements.
	 
	Warranties
	 
	The Company establishes reserves for future product warranty
	costs that are expected to be incurred pursuant to specific
	warranty provisions with its customers. The Companys
	warranty reserves are established at the time of sale and
	updated throughout the warranty period based upon numerous
	factors including historical warranty return rates and expenses
	over various warranty periods.
	 
	Intellectual
	Property Indemnities
	 
	The Company indemnifies certain customers and its contract
	manufacturers against liability arising from third-party claims
	of intellectual property rights infringement related to the
	Companys products. These indemnities appear in development
	and supply agreements with our customers as well as
	manufacturing service agreements with our contract
	manufacturers, are not limited in amount or duration and
	generally survive the expiration of the contract. Given that the
	amount of any potential liabilities related to such indemnities
	cannot be determined until an infringement claim has been made,
	the Company is unable to determine the maximum amount of losses
	that it could incur related to such indemnifications.
	 
	Director
	and Officer Indemnities and Contractual Guarantees
	 
	The Company has entered into indemnification agreements with its
	directors and executive officers, which require the Company to
	indemnify such individuals to the fullest extent permitted by
	Delaware law. The Companys indemnification obligations
	under such agreements are not limited in amount or duration.
	Certain costs incurred in connection with such indemnifications
	may be recovered under certain circumstances under various
	insurance policies. Given that the amount of any potential
	liabilities related to such indemnities cannot be determined
	until a lawsuit has been filed against a director or executive
	officer, the Company is unable to determine the maximum amount
	of losses that it could incur relating to such indemnifications.
	Historically, any amounts payable pursuant to such director and
	officer indemnifications have not had a material negative effect
	on the Companys business, financial condition or results
	of operations.
	 
	The Company has also entered into severance and change in
	control agreements with certain of its executives. These
	agreements provide for the payment of specific compensation
	benefits to such executives upon the termination of their
	employment with the Company.
	 
	General
	Contractual Indemnities/Products Liability
	 
	During the normal course of business, the Company enters into
	contracts with customers where it agreed to indemnify the other
	party for personal injury or property damage caused by the
	Companys products. The Companys indemnification
	obligations under such agreements are not generally limited in
	amount or duration. Given that the amount of any potential
	liabilities related to such indemnities cannot be determined
	until a lawsuit has been filed against a director or executive
	officer, the Company is unable to determine the maximum amount
	of losses that it could incur relating to such indemnifications.
	Historically, any amounts payable pursuant to such guarantees
	have not had a material negative effect on the Companys
	business, financial condition or results of operations. The
	Company maintains general and product liability insurance as
	well as errors and omissions insurance which may provide a
	source of recovery to the Company in the event of an
	indemnification claim.
	F-22
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
	 
	Short
	Term Borrowings
	 
	Advances under the agreement are collateralized by all the
	Companys assets. Under the terms of the agreement, the
	Company continues to service the sold receivables and is subject
	to recourse provisions. Under the terms of the agreement, if the
	bank determines that there is a material adverse change in the
	Companys business, they can exercise all their rights and
	remedies under the agreement, including demanding immediate
	payment of outstanding amounts. There was no amount outstanding
	under this facility at December 31, 2006.
	 
	Contractual
	Contingency
	 
	The Company has a contract to deliver several custom products to
	a government contractor. The Company is unable to manufacture
	the products for technical reasons. The Company has discussed
	the problem with the contractor and its government customer.
	They are considering the problem, and further discussions are
	expected. The Company does not believe that a loss, if any, is
	reasonably estimable at this time and therefore has not recorded
	any liability relating to this matter. The Company will
	periodically reassess its potential liability as additional
	information becomes available. If it later determines that a
	loss is probable and the amount reasonably estimable, the
	Company will record a liability for the potential loss. All
	costs have been expensed and no revenues recognized on this
	contract.
	 
	Note 11 
	Legal Proceedings
	 
	Settlement
	of Shalvoy Litigation
	 
	Mr. Shalvoy, a director and stockholder, executed two notes
	aggregating $820,244 in principal in connection with the
	exercise in December 2000 of two options to purchase Conductus,
	Inc. common stock prior our acquisition of Conductus, Inc. in
	December 2002. Through the third quarter of, 2005, we carried
	the principal (as Notes Receivable from
	Stockholder) and accrued interest (as Prepaid
	Expenses and Other Current Assets) for both notes as
	assets on our balance sheet.
	 
	We filed a lawsuit against Mr. Shalvoy on December 21,
	2005 in the California Superior Court (Case
	No. 1186812) to collect both notes. In that same
	quarter, due to Mr. Shalvoys refusal to pay the notes
	voluntarily we recorded a reserve for the value of the notes
	(principal plus accrued interest) in excess of the market value
	of the collateral securing the notes.
	 
	On March 2, 2007, we entered into a Settlement Agreement
	and Mutual Release of All Claims with Mr. Shalvoy to settle
	the lawsuit. The agreement provides for a payment of $610,000 to
	us on or before April 2, 2007 in payment of one note,
	including interest and attorneys fees, and the rescission
	of Mr. Shalvoys second purported option exercise
	including cancellation of the related note.
	 
	Routine
	Litigation
	 
	The Company may be involved in routine litigation arising in the
	ordinary course of its business, and, while the results of the
	proceedings cannot be predicted with certainty, the Company
	believes that the final outcome of such matters will not have a
	material adverse effect on the financial position, operating
	results or cash flows of the Company.
	 
	Note 12 
	Earnings Per Share
	 
	The computation of per share amounts for 2004, 2005 and 2006 is
	based on the average number of common shares outstanding for the
	period. Options and warrants to purchase 1,555,976, 2,031,213
	and 1,983,779 shares of common stock during 2004, 2005, and
	2006 respectively, were not considered in the computation of
	diluted earnings per share because their inclusion would have
	been antidilutive.
	F-23
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
	 
	Note 13 
	Restructuring Expenses and Impairment Charges
	 
	In connection with the Companys 2005 annual planning
	process performed in the fourth quarter of 2004, the Company
	concluded that it would no longer use its thallium high
	temperature superconducting related technology beyond 2005
	because alternative technologies were determined to be more cost
	effective and the Company decided it no longer wanted to support
	two HTS material technologies. As a result, the Company recorded
	non-cash charges of $715,000 primarily relating to the write-off
	of thallium related manufacturing equipment, patents and
	licenses since they will not be recovered from future cash
	flows. Also, during the Companys annual planning process
	the Company concluded that it would no longer continue to
	develop or maintain and would abandon certain other non-core
	business patents and patents no longer considered blocking in
	its business and certain purchased technology. As a result of
	the abandonment of the purchased technology and patents, the
	Company recorded non-cash charges of $842,000 during the fourth
	quarter of 2004 relating to the write-off of these patents and
	purchased technology since they will not be recovered from
	future cash flows.
	 
	During the first quarter of 2005, the Company implemented
	another restructuring program and reduced its workforce by
	another 27 positions and vacated a portion of its leased
	facility in Santa Barbara.
	 
	As discussed in Notes Receivable from Stockholder the
	Company recorded an impairment charge of $969,000 related to
	these notes in the fourth quarter of 2005. The impairment charge
	is included in Restructuring Expenses and Impairment Charges.
	 
	The following summarizes the restructuring and impairment
	charges for the years ended December 31, 2004, 2005 and
	2006:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	For the Years Ended December 31,
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Restructuring
 
 | 
	 
 | 
	 
 | 
	Impairment
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	Restructuring
 
 | 
	 
 | 
	 
 | 
	Impairment
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	Restructuring
 
 | 
	 
 | 
	 
 | 
	Impairment
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Charges for
 
 | 
	 
 | 
	 
 | 
	Charges for
 
 | 
	 
 | 
	 
 | 
	Total for
 
 | 
	 
 | 
	 
 | 
	Charges for
 
 | 
	 
 | 
	 
 | 
	Charges for
 
 | 
	 
 | 
	 
 | 
	Total for
 
 | 
	 
 | 
	 
 | 
	Charges for
 
 | 
	 
 | 
	 
 | 
	Charges for
 
 | 
	 
 | 
	 
 | 
	Total for
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	2004
 | 
	 
 | 
	 
 | 
	2004
 | 
	 
 | 
	 
 | 
	2004
 | 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
| 
	 
 | 
| 
 
	Severance costs
 
 | 
	 
 | 
	$
 | 
	826,000
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
	 
 | 
	$
 | 
	826,000
 | 
	 
 | 
	 
 | 
	$
 | 
	178,000
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
	 
 | 
	$
 | 
	178,000
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Fixed assets write-offs
 
 | 
	 
 | 
	 
 | 
	803,000
 | 
	 
 | 
	 
 | 
	 
 | 
	403,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,206,000
 | 
	 
 | 
	 
 | 
	 
 | 
	137,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	137,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Patent, licenses and purchased
	technology write-off
 
 | 
	 
 | 
	 
 | 
	1,051,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,171,000
 | 
	 
 | 
	 
 | 
	 
 | 
	2,222,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Lease abandonment costs
 
 | 
	 
 | 
	 
 | 
	279,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	279,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Facility consolidation costs
 
 | 
	 
 | 
	 
 | 
	268,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	268,000
 | 
	 
 | 
	 
 | 
	 
 | 
	6,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	6,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Employee relocation costs
 
 | 
	 
 | 
	 
 | 
	382,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	382,000
 | 
	 
 | 
	 
 | 
	 
 | 
	16,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	16,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Goodwill write-off
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	20,107,000
 | 
	 
 | 
	 
 | 
	 
 | 
	20,107,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Impairment charge for notes
	receivable from shareholder and board member
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	969,000
 | 
	 
 | 
	 
 | 
	 
 | 
	969,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	38,000
 | 
	 
 | 
	 
 | 
	 
 | 
	38,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Total
 
 | 
	 
 | 
	 
 | 
	3,609,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,574,000
 | 
	 
 | 
	 
 | 
	 
 | 
	5,183,000
 | 
	 
 | 
	 
 | 
	 
 | 
	337,000
 | 
	 
 | 
	 
 | 
	 
 | 
	969,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,306,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	20,145,000
 | 
	 
 | 
	 
 | 
	 
 | 
	20,145,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Fixed assets write-off and
	severance costs included in cost of goods sold
 
 | 
	 
 | 
	 
 | 
	669,000
 | 
	 
 | 
	 
 | 
	 
 | 
	386,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,055,000
 | 
	 
 | 
	 
 | 
	 
 | 
	109,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	109,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Expense included in operating
	expenses
 
 | 
	 
 | 
	$
 | 
	2,940,000
 | 
	 
 | 
	 
 | 
	$
 | 
	1,188,000
 | 
	 
 | 
	 
 | 
	$
 | 
	4,128,000
 | 
	 
 | 
	 
 | 
	$
 | 
	228,000
 | 
	 
 | 
	 
 | 
	$
 | 
	969,000
 | 
	 
 | 
	 
 | 
	$
 | 
	1,197,000
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
	 
 | 
	$
 | 
	20,145,000
 | 
	 
 | 
	 
 | 
	$
 | 
	20,145,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	F-24
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
| 
 | 
 | 
| 
	Note 14 
 | 
	 Details
	of Certain Financial Statement Components and Supplemental
	Disclosures of Cash Flow Information and Non-Cash
	Activities
 | 
	 
	Balance Sheet Data
	:.
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	December 31,
 
 | 
	 
 | 
	 
 | 
	December 31,
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
| 
	 
 | 
| 
 
	Accounts receivable:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Accounts receivable-trade
 
 | 
	 
 | 
	$
 | 
	1,930,000
 | 
	 
 | 
	 
 | 
	$
 | 
	1,117,000
 | 
	 
 | 
| 
 
	U.S. government accounts
	receivable-billed
 
 | 
	 
 | 
	 
 | 
	311,000
 | 
	 
 | 
	 
 | 
	 
 | 
	493,000
 | 
	 
 | 
| 
 
	Less: allowance for doubtful
	accounts
 
 | 
	 
 | 
	 
 | 
	(75,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(75,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	$
 | 
	2,166,000
 | 
	 
 | 
	 
 | 
	$
 | 
	1,535,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	December 31,
 
 | 
	 
 | 
	 
 | 
	December 31,
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
| 
	 
 | 
| 
 
	Inventories:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Raw materials
 
 | 
	 
 | 
	$
 | 
	3,328,000
 | 
	 
 | 
	 
 | 
	$
 | 
	2,368,000
 | 
	 
 | 
| 
 
	Work-in-process
 
 | 
	 
 | 
	 
 | 
	2,384,000
 | 
	 
 | 
	 
 | 
	 
 | 
	716,000
 | 
	 
 | 
| 
 
	Finished goods
 
 | 
	 
 | 
	 
 | 
	2,861,000
 | 
	 
 | 
	 
 | 
	 
 | 
	4,261,000
 | 
	 
 | 
| 
 
	Less inventory reserves
 
 | 
	 
 | 
	 
 | 
	(3,209,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(1,367,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	$
 | 
	5,364,000
 | 
	 
 | 
	 
 | 
	$
 | 
	5,978,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	December 31,
 
 | 
	 
 | 
	 
 | 
	December 31,
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
| 
	 
 | 
| 
 
	Property and
	Equipment:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Equipment
 
 | 
	 
 | 
	$
 | 
	18,000,000
 | 
	 
 | 
	 
 | 
	$
 | 
	17,187,000
 | 
	 
 | 
| 
 
	Leasehold improvements
 
 | 
	 
 | 
	 
 | 
	6,647,000
 | 
	 
 | 
	 
 | 
	 
 | 
	6,732,000
 | 
	 
 | 
| 
 
	Furniture and fixtures
 
 | 
	 
 | 
	 
 | 
	451,000
 | 
	 
 | 
	 
 | 
	 
 | 
	451,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	25,098,000
 | 
	 
 | 
	 
 | 
	 
 | 
	24,370,000
 | 
	 
 | 
| 
 
	Less: accumulated depreciation and
	amortization
 
 | 
	 
 | 
	 
 | 
	(17,295,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(18,599,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	$
 | 
	7,803,000
 | 
	 
 | 
	 
 | 
	$
 | 
	5,771,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
	At December 31, 2005 and December 31, 2006, equipment
	includes $237,000 of assets financed under capital lease
	arrangements, net of $210,000 and $226,000 of accumulated
	amortization, respectively. Depreciation expense amounted to
	$2,744,000, $2,548,000, and $2,277,000 respectively, in 2004,
	2005 and 2006.
	 
	F-25
 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	December 31,
 
 | 
	 
 | 
	 
 | 
	December 31,
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
| 
	 
 | 
| 
 
	Patents and Licenses:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Patents pending
 
 | 
	 
 | 
	$
 | 
	435,000
 | 
	 
 | 
	 
 | 
	$
 | 
	632,000
 | 
	 
 | 
| 
 
	Patents issued
 
 | 
	 
 | 
	 
 | 
	875,000
 | 
	 
 | 
	 
 | 
	 
 | 
	899,000
 | 
	 
 | 
| 
 
	Less accumulated amortization
 
 | 
	 
 | 
	 
 | 
	(230,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(286,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Net patents issued
 
 | 
	 
 | 
	 
 | 
	645,000
 | 
	 
 | 
	 
 | 
	 
 | 
	613,000
 | 
	 
 | 
| 
 
	Licenses
 
 | 
	 
 | 
	 
 | 
	563,000
 | 
	 
 | 
	 
 | 
	 
 | 
	563,000
 | 
	 
 | 
| 
 
	Less accumulated amortization
 
 | 
	 
 | 
	 
 | 
	(66,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(100,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Net licenses
 
 | 
	 
 | 
	 
 | 
	497,000
 | 
	 
 | 
	 
 | 
	 
 | 
	463,000
 | 
	 
 | 
| 
 
	Purchased technology
 
 | 
	 
 | 
	 
 | 
	1,706,000
 | 
	 
 | 
	 
 | 
	 
 | 
	1,706,000
 | 
	 
 | 
| 
 
	Less accumulated amortization
 
 | 
	 
 | 
	 
 | 
	(769,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(1,005,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Net purchased technology
 
 | 
	 
 | 
	 
 | 
	937,000
 | 
	 
 | 
	 
 | 
	 
 | 
	701,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	$
 | 
	2,514,000
 | 
	 
 | 
	 
 | 
	$
 | 
	2,409,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
	Amortization expense related to these items totaled $719,000,
	$329,000 and $326,000, respectively in 2004, 2005 and 2006.
	Amortization expenses related to these items are expected to
	total $350,000 in 2007 and approximately $350,000 in each of the
	years 2008 and 2009 and $119,000 in 2010.
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	December 31,
 
 | 
	 
 | 
	 
 | 
	December 31,
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
| 
	 
 | 
| 
 
	Accrued Expenses and Other Long
	Term Liabilities:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Salaries payable
 
 | 
	 
 | 
	$
 | 
	365,000
 | 
	 
 | 
	 
 | 
	$
 | 
	287,000
 | 
	 
 | 
| 
 
	Compensated absences
 
 | 
	 
 | 
	 
 | 
	423,000
 | 
	 
 | 
	 
 | 
	 
 | 
	379,000
 | 
	 
 | 
| 
 
	Compensation related
 
 | 
	 
 | 
	 
 | 
	253,000
 | 
	 
 | 
	 
 | 
	 
 | 
	299,000
 | 
	 
 | 
| 
 
	Warranty reserve
 
 | 
	 
 | 
	 
 | 
	491,000
 | 
	 
 | 
	 
 | 
	 
 | 
	428,000
 | 
	 
 | 
| 
 
	Lease abandonment costs
 
 | 
	 
 | 
	 
 | 
	225,000
 | 
	 
 | 
	 
 | 
	 
 | 
	8,000
 | 
	 
 | 
| 
 
	Product line exit costs
 
 | 
	 
 | 
	 
 | 
	402,000
 | 
	 
 | 
	 
 | 
	 
 | 
	319,000
 | 
	 
 | 
| 
 
	Severance costs
 
 | 
	 
 | 
	 
 | 
	32,000
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Deferred rent
 
 | 
	 
 | 
	 
 | 
	378,000
 | 
	 
 | 
	 
 | 
	 
 | 
	390,000
 | 
	 
 | 
| 
 
	Other
 
 | 
	 
 | 
	 
 | 
	150,000
 | 
	 
 | 
	 
 | 
	 
 | 
	104,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	2,719,000
 | 
	 
 | 
	 
 | 
	 
 | 
	2,214,000
 | 
	 
 | 
| 
 
	Less current portion
 
 | 
	 
 | 
	 
 | 
	(1,998,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(1,610,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Long term portion
 
 | 
	 
 | 
	$
 | 
	721,000
 | 
	 
 | 
	 
 | 
	$
 | 
	604,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
	F-26
 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	For the Year Ended,
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	December 31,
 
 | 
	 
 | 
	 
 | 
	December 31,
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
| 
	 
 | 
| 
 
	Warranty Reserve
	Activity:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Beginning balance
 
 | 
	 
 | 
	$
 | 
	419,000
 | 
	 
 | 
	 
 | 
	$
 | 
	491,000
 | 
	 
 | 
| 
 
	Additions
 
 | 
	 
 | 
	 
 | 
	204,000
 | 
	 
 | 
	 
 | 
	 
 | 
	140,000
 | 
	 
 | 
| 
 
	Deductions
 
 | 
	 
 | 
	 
 | 
	(273,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(203,000
 | 
	)
 | 
| 
 
	Change in estimate relating to
	previous warranty accruals
 
 | 
	 
 | 
	 
 | 
	141,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Ending balance
 
 | 
	 
 | 
	$
 | 
	491,000
 | 
	 
 | 
	 
 | 
	$
 | 
	428,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Lease Abandonment
	Costs:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Beginning balance
 
 | 
	 
 | 
	$
 | 
	1,336,000
 | 
	 
 | 
	 
 | 
	$
 | 
	225,000
 | 
	 
 | 
| 
 
	Additions
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Transfers from unfavorable lease
	costs
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Deductions
 
 | 
	 
 | 
	 
 | 
	(1,111,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(217,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Ending balance
 
 | 
	 
 | 
	$
 | 
	225,000
 | 
	 
 | 
	 
 | 
	$
 | 
	8,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Product Line Exit
	Costs:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Beginning balance
 
 | 
	 
 | 
	$
 | 
	885,000
 | 
	 
 | 
	 
 | 
	$
 | 
	402,000
 | 
	 
 | 
| 
 
	Additions
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Deductions
 
 | 
	 
 | 
	 
 | 
	(483,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(83,000
 | 
	)
 | 
| 
 
	Change in estimate relating to
	previous exit costs accrual
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Ending balance
 
 | 
	 
 | 
	$
 | 
	402,000
 | 
	 
 | 
	 
 | 
	$
 | 
	319,000
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Severance Costs:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Beginning balance
 
 | 
	 
 | 
	$
 | 
	36,000
 | 
	 
 | 
	 
 | 
	$
 | 
	32,000
 | 
	 
 | 
| 
 
	Additions
 
 | 
	 
 | 
	 
 | 
	218,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Deductions
 
 | 
	 
 | 
	 
 | 
	(222,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(32,000
 | 
	)
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Ending balance
 
 | 
	 
 | 
	$
 | 
	32,000
 | 
	 
 | 
	 
 | 
	$
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
	Supplemental
	Cash Flow Information:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Dec. 31,
 
 | 
	 
 | 
	 
 | 
	Dec. 31,
 
 | 
	 
 | 
	 
 | 
	Dec. 31,
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	2004
 | 
	 
 | 
	 
 | 
	2005
 | 
	 
 | 
	 
 | 
	2006
 | 
	 
 | 
| 
	 
 | 
| 
 
	Cash paid for interest
 
 | 
	 
 | 
	$
 | 
	443,000
 | 
	 
 | 
	 
 | 
	$
 | 
	116,000
 | 
	 
 | 
	 
 | 
	$
 | 
	49,000
 | 
	 
 | 
| 
 
	Non-cash investing and
	financing activities:
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Unpaid offering expenses
 
 | 
	 
 | 
	 
 | 
	792,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Insurance settlement receivable
 
 | 
	 
 | 
	 
 | 
	4,000,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
| 
 
	Legal settlement liability
 
 | 
	 
 | 
	$
 | 
	(4,000,000
 | 
	)
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
| 
 | 
 | 
| 
	Note 15 
 | 
	 Subsequent
	Event
 | 
	 
	Settlement
	of Shalvoy Litigation
	 
	Mr. Shalvoy, a director and stockholder, executed two notes
	aggregating $820,244 in principal in connection with the
	exercise in December 2000 of two options to purchase Conductus,
	Inc. common stock prior our acquisition of Conductus, Inc. in
	December 2002. Through the third quarter of, 2005, we carried
	the principal (as
	F-27
 
	 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	NOTES TO
	CONSOLIDATED FINANCIAL
	STATEMENTS
	  (Continued)
	Notes Receivable from Stockholder) and accrued
	interest (as Prepaid Expenses and Other Current
	Assets) for both notes as assets on our balance sheet.
	 
	We filed a lawsuit against Mr. Shalvoy on December 21,
	2005 in the California Superior Court (Case
	No. 1186812) to collect both notes. In that same
	quarter, due to Mr. Shalvoys refusal to pay the notes
	voluntarily we recorded a reserve for the value of the notes
	(principal plus accrued interest) in excess of the market value
	of the collateral securing the notes.
	 
	On March 2, 2007, we entered into a Settlement Agreement
	and Mutual Release of All Claims with Mr. Shalvoy to settle
	the lawsuit. The agreement provides for a payment of $610,000 to
	us on or before April 2, 2007 in payment of one note,
	including interest and attorneys fees, and the rescission
	of Mr. Shalvoys second purported option exercise
	including cancellation of the related note.
	 
	Quarterly
	Financial Data (Unaudited)
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	First Quarter
 | 
	 
 | 
	 
 | 
	Second Quarter
 | 
	 
 | 
	 
 | 
	Third Quarter
 | 
	 
 | 
	 
 | 
	Fourth Quarter
 | 
	 
 | 
| 
	 
 | 
| 
 
	2006
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Net revenues(1)
 
 | 
	 
 | 
	$
 | 
	4,840,000
 | 
	 
 | 
	 
 | 
	$
 | 
	5,021,000
 | 
	 
 | 
	 
 | 
	$
 | 
	5,910,000
 | 
	 
 | 
	 
 | 
	$
 | 
	5,307,000
 | 
	 
 | 
| 
 
	Loss from operations(2)(3)
 
 | 
	 
 | 
	 
 | 
	(3,340,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(22,755,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(2,164,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(1,712,000
 | 
	)
 | 
| 
 
	Net loss
 
 | 
	 
 | 
	 
 | 
	(3,226,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(22,659,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(2,092,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(1,647,000
 | 
	)
 | 
| 
 
	Basic and diluted loss per common
	share
 
 | 
	 
 | 
	$
 | 
	(0.26
 | 
	)
 | 
	 
 | 
	$
 | 
	(1.81
 | 
	)
 | 
	 
 | 
	$
 | 
	(0.17
 | 
	)
 | 
	 
 | 
	$
 | 
	(0.13
 | 
	)
 | 
| 
 
	Weighted average number of shares
	outstanding
 
 | 
	 
 | 
	 
 | 
	12,483,367
 | 
	 
 | 
	 
 | 
	 
 | 
	12,483,367
 | 
	 
 | 
	 
 | 
	 
 | 
	12,483,367
 | 
	 
 | 
	 
 | 
	 
 | 
	12,483,367
 | 
	 
 | 
| 
 
	2005
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Net revenues(1)
 
 | 
	 
 | 
	$
 | 
	4,354,000
 | 
	 
 | 
	 
 | 
	$
 | 
	8,553,000
 | 
	 
 | 
	 
 | 
	$
 | 
	3,917,000
 | 
	 
 | 
	 
 | 
	$
 | 
	7,385,000
 | 
	 
 | 
| 
 
	Loss from operations(4)(5)(6)
 
 | 
	 
 | 
	 
 | 
	(5,555,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(2,065,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(3,696,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(3,123,000
 | 
	)
 | 
| 
 
	Net loss
 
 | 
	 
 | 
	 
 | 
	(5,537,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(2,046,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(3,623,000
 | 
	)
 | 
	 
 | 
	 
 | 
	(3,007,000
 | 
	)
 | 
| 
 
	Basic and diluted loss per common
	share
 
 | 
	 
 | 
	$
 | 
	(0.51
 | 
	)
 | 
	 
 | 
	$
 | 
	(0.19
 | 
	)
 | 
	 
 | 
	$
 | 
	(0.31
 | 
	)
 | 
	 
 | 
	$
 | 
	(0.24
 | 
	)
 | 
| 
 
	Weighted average number of shares
	outstanding
 
 | 
	 
 | 
	 
 | 
	10,771,103
 | 
	 
 | 
	 
 | 
	 
 | 
	10,771,103
 | 
	 
 | 
	 
 | 
	 
 | 
	11,655,492
 | 
	 
 | 
	 
 | 
	 
 | 
	12,483,431
 | 
	 
 | 
	 
	 
| 
 | 
 | 
 | 
| 
	(1)
 | 
 | 
	Our revenues vary from quarter to quarter as our customers
	provide minimal lead-time prior to the release of their purchase
	orders and have non-binding commitments to purchase from us.
 | 
| 
	 
 | 
| 
	(2)
 | 
 | 
	Includes sale of previously written-off inventory of $119,000,
	$273,000, $309,000 and none, respectively.
 | 
| 
	 
 | 
| 
	(3)
 | 
 | 
	Includes increased reserve for inventory obsolescence of
	$90,000, $90,000, $90,000 and $90,000, respectively.
 | 
| 
	 
 | 
| 
	(4)
 | 
 | 
	Includes restructuring expense of $133,000, $204,000, none and
	none, respectively.
 | 
| 
	 
 | 
| 
	(5)
 | 
 | 
	Includes increased reserve for inventory obsolescence of
	$90,000, $90,000, $432,000 and $372,000, respectively.
 | 
| 
	 
 | 
| 
	(6)
 | 
 | 
	Includes sale of previously written-off inventory of none, none,
	$319,000, and $806,000, respectively.
 | 
	F-28
 
	SUPERCONDUCTOR
	TECHNOLOGIES INC.
	 
	Schedule II-
	Valuation and Qualifying Accounts
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	Additions
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	Charge to
 
 | 
	 
 | 
	 
 | 
	Charge to
 
 | 
	 
 | 
	 
 | 
	Charge to
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Beginning
 
 | 
	 
 | 
	 
 | 
	Costs &
 
 | 
	 
 | 
	 
 | 
	Other
 
 | 
	 
 | 
	 
 | 
	Other
 
 | 
	 
 | 
	 
 | 
	Ending
 
 | 
	 
 | 
| 
	 
 | 
	 
 | 
	Balance
 | 
	 
 | 
	 
 | 
	Expenses
 | 
	 
 | 
	 
 | 
	Accounts
 | 
	 
 | 
	 
 | 
	Deductions
 | 
	 
 | 
	 
 | 
	Balance
 | 
	 
 | 
| 
	 
 | 
| 
 
	Year Ended December 31,
	2006
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Allowance for Uncollectible
	Accounts
 
 | 
	 
 | 
	$
 | 
	75,000
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
	 
 | 
	$
 | 
	75,000
 | 
	 
 | 
| 
 
	Impairment for
	Notes Receivable from Stockholder
 
 | 
	 
 | 
	 
 | 
	969,000
 | 
	 
 | 
	 
 | 
	 
 | 
	38,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	1,007,000
 | 
	 
 | 
| 
 
	Reserve for Inventory Obsolescence
 
 | 
	 
 | 
	 
 | 
	3,209,000
 | 
	 
 | 
	 
 | 
	 
 | 
	360,000
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	(2,202,000
 | 
	)
 | 
	 
 | 
	 
 | 
	1,367,000
 | 
	 
 | 
| 
 
	Reserve for Warranty
 
 | 
	 
 | 
	 
 | 
	491,000
 | 
	 
 | 
	 
 | 
	 
 | 
	140,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	(203,000
 | 
	)
 | 
	 
 | 
	 
 | 
	428,000
 | 
	 
 | 
| 
 
	Deferred Tax Asset Valuation
	Allowance
 
 | 
	 
 | 
	 
 | 
	106,299,000
 | 
	 
 | 
	 
 | 
	 
 | 
	5,854,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	112,153,000
 | 
	 
 | 
| 
 
	Year Ended December 31,
	2005
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Allowance for Uncollectible
	Accounts
 
 | 
	 
 | 
	 
 | 
	77,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	(2,000
 | 
	)
 | 
	 
 | 
	 
 | 
	75,000
 | 
	 
 | 
| 
 
	Impairment for
	Notes Receivable from Stockholder
 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	969,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	969,000
 | 
	 
 | 
| 
 
	Reserve for Inventory Obsolescence
 
 | 
	 
 | 
	 
 | 
	5,402,000
 | 
	 
 | 
	 
 | 
	 
 | 
	984,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	(3,177,000
 | 
	)
 | 
	 
 | 
	 
 | 
	3,209,000
 | 
	 
 | 
| 
 
	Reserve for Warranty
 
 | 
	 
 | 
	 
 | 
	419,000
 | 
	 
 | 
	 
 | 
	 
 | 
	204,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	(132,000
 | 
	)
 | 
	 
 | 
	 
 | 
	491,000
 | 
	 
 | 
| 
 
	Deferred Tax Asset Valuation
	Allowance
 
 | 
	 
 | 
	 
 | 
	106,629,000
 | 
	 
 | 
	 
 | 
	 
 | 
	(330,000
 | 
	)
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	106,299,000
 | 
	 
 | 
| 
 
	Year Ended December 31,
	2004
 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Allowance for Uncollectible
	Accounts
 
 | 
	 
 | 
	 
 | 
	64,000
 | 
	 
 | 
	 
 | 
	 
 | 
	13,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	77,000
 | 
	 
 | 
| 
 
	Reserve for Inventory Obsolescence
 
 | 
	 
 | 
	 
 | 
	803,000
 | 
	 
 | 
	 
 | 
	 
 | 
	4,836,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	(237,000
 | 
	)
 | 
	 
 | 
	 
 | 
	5,402,000
 | 
	 
 | 
| 
 
	Reserve for Warranty
 
 | 
	 
 | 
	 
 | 
	494,000
 | 
	 
 | 
	 
 | 
	 
 | 
	84,000
 | 
	 
 | 
	 
 | 
	 
 | 
	
 | 
	 
 | 
	 
 | 
	 
 | 
	(159,000
 | 
	)
 | 
	 
 | 
	 
 | 
	419,000
 | 
	 
 | 
| 
 
	Deferred Tax Asset Valuation
	Allowance
 
 | 
	 
 | 
	$
 | 
	94,576,000
 | 
	 
 | 
	 
 | 
	$
 | 
	12,053,000
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
	 
 | 
	$
 | 
	
 | 
	 
 | 
	 
 | 
	$
 | 
	106,629,000
 | 
	 
 | 
	F-29
 
	SIGNATURES
	 
	Pursuant to the requirements of Section 13 or 15(d) of the
	Securities Exchange Act of 1934, the Registrant has duly caused
	this Report to be signed on its behalf by the undersigned,
	thereunto duly authorized, on this 30th day of March 2007.
	 
	SUPERCONDUCTOR TECHNOLOGIES INC.
	 
| 
 | 
 | 
 | 
| 
	 
 | 
	By: 
 | 
 
	/s/  Jeffrey
	A. Quiram
 
 | 
	Jeffrey A. Quiram
	President and Chief Executive Officer
	 
	POWER OF
	ATTORNEY
	 
	KNOW ALL THESE PERSONS BY THESE PRESENTS, that each person whose
	signature appears below constitutes and appoints William J.
	Buchanan, his
	attorney-in-fact,
	with full power of substitution, for him in any and all
	capacities, to sign any and all amendments to this Report on
	Form 10-K,
	and to file the same, with exhibits thereto and other documents
	in connection therewith, with the Securities and Exchange
	Commission, hereby ratifying and confirming all that said
	attorney-in-fact
	or his substitute or substitutes, may do or cause to be done by
	virtue hereof.
	 
	Pursuant to the requirements of the Securities Exchange Act of
	1934, this Report on
	Form 10-K
	has been signed below by the following persons on behalf of the
	Registrant and in the capacities and on the dates indicated:
	 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	Signature
 
 | 
	 
 | 
 
	Title
 
 | 
	 
 | 
 
	Date
 
 | 
| 
	 
 | 
| 
 
	/s/  Jeffrey
	A. Quiram
 
 
 
	Jeffrey
	A. Quiram
 | 
	 
 | 
	President, Chief Executive Officer
	and Director (Principal Executive Officer)
 | 
	 
 | 
	March 30,2007
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	/s/  William
	J. Buchanan
 
 
 
	William
	J. Buchanan
 | 
	 
 | 
	Controller (Principal Accounting
	Officer) (Principal Financial Officer)
 | 
	 
 | 
	March 30,2007
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	/s/  David
	W. Vellequette
 
 
 
	David
	W. Vellequette
 | 
	 
 | 
	Director
 | 
	 
 | 
	March 30,2007
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	/s/  Lynn
	J. Davis
 
 
 
	Lynn
	J. Davis
 | 
	 
 | 
	Director
 | 
	 
 | 
	March 30,2007
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	/s/  Dennis
	J. Horowitz
 
 
 
	Dennis
	J. Horowitz
 | 
	 
 | 
	Director
 | 
	 
 | 
	March 30,2007
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	/s/  Martin
	A. Kaplan
 
 
 
	Martin
	A. Kaplan
 | 
	 
 | 
	Director
 | 
	 
 | 
	March 30,2007
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	/s/  John
	D. Lockton
 
 
 
	John
	D. Lockton
 | 
	 
 | 
	Chairman of the Board
 | 
	 
 | 
	March 30,2007
 | 
| 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
	 
 | 
| 
 
	   
	 
 
 
 
	Charles
	E. Shalvoy
 | 
	 
 | 
	Director
 | 
	 
 | 
	 
 | 
	S-1